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CHAPTER 1 
 
Expanding the evidence base for the 
effectiveness and cost-effectiveness of long-
term psychoanalytic treatment  
 
 
Based on: Zevalkink, J., & Berghout, C.C. (2006). Expanding the evidence base for the 
cost-effectiveness of long-term psychoanalytic treatment. Journal of the American 
Psychoanalytic Association, 54, 1313-1319. 
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INTRODUCTION 
 
A survey in 1943 by Obendorf was oriented toward answering the multifaceted question “What type 
of treatment is best suited to what kind of patient, suffering from what kind of illness, at what point in 
life, when treated by what kind of analyst, in what manner?” (Galatzer-Levy, Bachrach, Skolnikoff, & 
Waldron, 2000, p. 53). In recent years, the question of cost-effectiveness can be added to these 
concerns. Despite the long history of posing the right questions, research into the effectiveness of 
psychoanalysis and psychoanalytic psychotherapy has been hampered by vexing methodological, 
technical, theoretical, and ethical problems, not to mention a diverse array of opposing viewpoints on 
scientific and empirical research itself (Gerber, 2004). Nevertheless, we consider systematic empirical 
research relevant to the study of psychoanalytic treatment1. To overcome some of the daunting 
difficulties in this area, it is important to choose a theoretical framework, research instruments, and a 
research design adequate to addressing these questions. This introduction aims to explain the choice of 
theoretical framework, instruments, and design of our study into the effectiveness of psychoanalytic 
treatment for which data collection started in January 2005. The project was a collaboration of four 
mental health institutes and was intended to evaluate the health- and cost-effectiveness of ambulatory 
government-funded psychoanalytic psychotherapy and psychoanalysis in regular clinical practice in 
the Netherlands. This was done by using a routine outcome monitoring system developed for 
monitoring change in long-term psychotherapeutic treatments. In addition, the project evaluated the 
usefulness of the monitoring system for quality assurance purposes. At first, we performed a pilot 
study on the characteristics (e.g., level of psychopathology) of patients assigned to long-term 
psychoanalytic treatment in order to investigate the feasibility of doing effectiveness research in this 
setting. The pilot study intended to provide a detailed description of the patient population in regular 
clinical practice. Subsequently, we performed a large effectiveness study using a multiple cohort 
design.  
 
THEORETICAL FRAMEWORK 
 
A theoretical framework accompanying research on the effectiveness of psychoanalytic treatment 
should provide a conceptual model and hypotheses about the domains in which patients might benefit 
from the treatment. Psychoanalytic treatment refers to a range of therapeutic strategies –based on a 
variety of theoretical models– that are designed to treat psychological disorders. Psychoanalysis and 
psychoanalytic psychotherapy are two particular forms of long-term ambulatory treatment, which will 
be the treatments under investigation here. The varying theoretical models that underpin both 
treatments all highlight the significance of mental disorders of early development, current and past 
relationships with attachment figures, imagination and fantasy (particularly in relation to mental 
states), and enduring mental structures that derive from these experiences (Fonagy & Target, 2009). 
The essence of psychoanalytic treatment is to explore those aspects of self that are not fully known, 
which can be manifested and influenced in the therapeutic relationship (Shedler, 2010). Fonagy and 
Target (2009) described the aim of psychoanalytic or psychodynamic treatment as follows:  
 
“All psychodynamic therapies aim to strengthen patients’ ability to understand 
the motivations for and meanings of their own and others’ subjective 
experiences, behavior, and relationships. The therapist aims to expand patients’ 
conscious awareness of these mechanisms and influences so that they are better 
able to use their increased emotional awareness to manage continuing pressures.” 
(p.4)  
 
Although symptom reduction may be seen as an important target of long-term psychoanalytic 
treatment, the broader goal is to achieve structural change (Gabbard, 2009; Shedler, 2010). Theories 
and measurements of this concept vary widely, leading to a range of contrasting definitions. Many 
                                               
 
1 In the literature, the terms psychodynamic and psychoanalytic are often used interchangeable. In this thesis, we 
will mainly use the term psychoanalytic treatment. 
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psychoanalytic theories have been developed in the area of interpersonal functioning and object 
relations (Fairbairn, 1952; Kernberg, 1976; Klein, 1957). Object relations theory focuses on 
understanding psychopathology in terms of mental representations of dyadic self and object 
relationships, which are rooted in past relationships, and later grow to encompass multiple 
relationship representations (Fonagy & Target, 2009). Efforts to grapple the complexity of the 
psychological dynamics in psychoanalytic treatment have often fragmented the field, resulting in a 
broad range of hypotheses (Fonagy, 1999). Most of the theoretical and clinical assumptions were not 
studied empirically or at least not according to the current state of science in this field. In contrast, a 
particularly coherent theoretical framework for studying structural change is provided by attachment 
theory (Ainsworth & Bowlby, 1965; Bowlby, 1969, 1973, 1980, 1988) and its later refinements, such 
as the theory on mental processing and reflective functioning developed by Fonagy and colleagues 
(e.g., Fonagy, Gergely, Jurist, & Target, 2002), which is also particularly well suited for empirical 
research. Within this well-defined and well-researched theory of intrapsychic and interpersonal 
processes, several instruments have been developed with good psychometric properties. Moreover, 
these instruments can be used alongside a-theoretical instruments measuring symptomatic change and 
improvement in functioning (Gerber, 2004). 
   
INSTRUMENTS 
 
As Gerber (2004) has observed, “Rather than there being too few measures of structural change, it is 
impressive to see how many measures have been devised in the past quarter century.” Unfortunately, 
most of these measures have been found to be too abstract, not sufficiently reliable, or too highly 
correlated with global, generic symptom measures. As things stand, more than enough well-
established measures of symptoms already exist that have the additional benefit of having been used in 
non-psychoanalytic effectiveness studies. The current project includes a number of these symptoms 
measures. For instance, the Symptom Checklist-90-Revised (SCL-90-R; Derogatis, 1983) has been 
used widely as a general dimensional measure of psychopathology and can be easily used in repeated 
measurements. Of course, it is also important to include theoretically based instruments that are 
relevant to change in psychoanalytic treatment and take into account the complexity and richness of 
human experience. An example of a theoretically based instrument is the Adult Attachment Interview 
(AAI; George, Kaplan, & Main, 1996; Main, Goldwyn, & Hesse, 2003). This instrument meets several 
criteria as a useful measure of structural change: it has a cohesive theoretical base; is experience-near; 
is based on an observer rating scheme; and has amassed a sizable empirical literature demonstrating its 
reliability and validity in clinical samples (Gerber, 2004). Another example of a theoretically based 
instrument is the Inventory of Interpersonal Problems, which aims to identify dysfunctional patterns in 
interpersonal relations (IIP-64; Horowitz, Alden, Wiggins, & Pincus, 2000). 
We focused on symptomatic functioning and on structural change at interpersonal and 
intrapsychic levels, using them as primary outcome measures. Symptomatic functioning was measured 
using the following questionnaires: Symptom Checklist-90-Revised (SCL-90-R; Derogatis, 1983), 
Beck Depression Inventory II (BDI-II; Beck, Steer, and Brown, 1996), and the State-Trait Anxiety 
Inventory (STAI; Spielberger, 1983). Structural change was measured using the Minnesota 
Multiphasic Personality Inventory-2 (MMPI-2; Butcher, Dahlstrom, Graham, Tellegen, & Kaemmer, 
1989), the Adult Attachment Interview (AAI; George et al., 1996; Main et al., 2003), the Rorschach 
(scored according to the Comprehensive System; Exner, 2003), and the Inventory of Interpersonal 
Problems (IIP-64; Horowitz et al., 2000). As primary effect parameter in the economic evaluation we 
computed quality-adjusted life years (QALYs) based on preference-based health values assessed with 
the Short Form-36 Health Survey (SF-36; Ware, Snow, Kolinski, & Gandeck, 1993). Direct and 
indirect costs were measured by assessing treatment costs at each mental health clinic and by a 
questionnaire for each patient: Trimbos/iMTA questionnaire for direct and indirect costs associated 
with psychiatric illness (TiC-P; Hakkaart-van Roijen, van Straten, Donker, & Tiemens, 2002). 
 
DESIGN 
 
Research on the effectiveness of long-term psychoanalytic treatments can encounter several 
difficulties. The long duration of the treatment makes it complicated to design an effect study meeting 
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the highest scientific standards. With regard to primary data collection, Randomized Controlled Trials 
(RCTs) are considered the ‘gold standard’ for research in (mental) health care. However, research on 
long-term treatments following the RCT method faces some serious methodological difficulties 
(Fonagy, 2002; de Maat, Dekker, Schoevers, & de Jonghe, 2007; Seligman, 1995). For one, in 
randomized trials on long-term treatments it is methodologically and ethically very difficult to design 
an alternative treatment condition and keep patients in that condition. Patients actively seek their 
treatments, interrupt those which they are not satisfied with, and seek other, new treatments (Sandell et 
al., 2000). Earlier attempts have shown that recruitment and attrition of research subjects are major 
problems with this type of study design. It seems that there is a trade-off between experimental rigor 
on the one hand and clinical representativeness and feasibility on the other hand. The more internal 
validity is emphasized, the less clinically representative the study becomes. Another problem with 
applying the RCT method to research on long-term treatments is that such studies are extremely 
expensive, both in terms of money and time. In applying for funding, we encountered the following 
restriction: a research grant of The Netherlands Organisation for Health Research and Development 
(ZonMw) was available for a period of only three years. The external and internal restrictions forced 
us to choose a research design that enabled us to investigate the effectiveness of long-term 
psychoanalytic treatments within this relatively short period of time. Cohort studies provide the best 
available evidence when randomized controlled trials (RCTs) are not feasible (Centre of Evidence 
Based Medicine Oxford, 2009). In this study, we used a quasi-experimental longitudinal cohort design 
with repeated (overlapping) measurements. This method is also called an ‘accelerated longitudinal 
design’ or ‘cohort sequential design for longitudinal research’ (Anderson, 1995; Raudenbush & Chan, 
1992). We were inspired by a design from the noteworthy study of Sandell and colleagues (Blomberg, 
Lazar, & Sandell, 2001; Sandell et al., 2000). 
The effectiveness of long-term psychoanalytic treatment was studied by following patients in 
four cohorts that differed in the phase of treatment they were in: before treatment, one year into 
treatment, at the end of treatment, and two years after treatment (follow-up). The patients in each 
cohort were followed for a period of one year. During this year they were assessed three times, each 
measurement being six months apart (T0 = 0 months, T1 = after 6 months, T2 = after 12 months). The 
three assessments included questionnaires about symptoms and interpersonal problems. The more 
time-consuming structural measures, namely the MMPI-2, the AAI, and the Rorschach, were only 
administered at T0. Power analyses were performed using a clinical trials design program to 
investigate the minimal number of patients in relation to the estimated effect size. We expected a 
conservative estimated effect size after one year of treatment of 0.50 and an effect size of 1.00 at the 
end of treatment. We calculated that we needed 65 appraisable patients in each cohort, with a total 
sample size of 260. To increase the power, we used one-way analyses of covariance (ANCOVA) and 
related statistical methods. To study the effectiveness of a treatment one must compare the treatment 
results with patients in a control condition. As a good alternative to placebo, waiting-list or treatment-
as-usual control groups, we used data from natural remission of diagnostically comparable patient 
groups. We also made comparisons with scores from clinical and non-clinical groups to determine 
what proportion of patients scored within the non-clinical range across the different stages of 
psychoanalytic treatment.  
The assumption of comparability of the cohorts is the cornerstone of an accelerated 
longitudinal design. It was therefore essential to control for this, in order to ensure the quality of the 
study. The comparability of the cohorts was increased by introducing overlap between measurement 
points across different cohorts. In that way, we could make comparisons on the different outcome 
measures and look at possible age-cohort and period-cohort interaction effects. The comparability of 
cohorts was also investigated by checking the pretreatment status of all patients in each cohort. If the 
cohorts were in fact comparable at the outset, mean pretreatment Global Assessment of Functioning 
(GAF) scores (DSM-IV-R) and sociodemographic data would not differ significantly between the four 
cohorts. It was important to determine whether clinicians’ decision making in assigning patients to 
psychoanalytic treatment has changed notably over the past ten years. We investigated this by 
providing a select group of psychoanalysts with a random selection of ‘blinded’ pretreatment reports 
from patient files and we asked them whether they would refer this patient to psychoanalysis, 
psychoanalytic psychotherapy, or some other form of treatment. Table 1 provides a visual summary of 
our checks on the comparability of the cohorts.  
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Table 1. Chart of comparability checks 
 
 
In the cost-utility analysis we examined the Incremental Cost-Effectiveness Ratio (ICER) of 
high-dosage versus lower-dosage psychoanalytic treatment, because in cost-utility analyses it is 
always necessary to compare one form of treatment with another. Following this line of investigation, 
we also studied further differences between psychoanalysis and psychoanalytic psychotherapy 
regarding patient characteristics, course of improvement and treatment effectiveness exploratively. 
Because we could not randomize or match patients to the two treatment modalities, we realize that we 
have to be careful in interpreting the observed differences.  
 
HYPOTHESES 
 
We expected psychoanalytic treatment to be effective in reducing the patient’s symptoms after one 
year of treatment and to improve the patient’s interpersonal and intrapsychic functioning and overall 
wellbeing to a non-clinical level after three to five years of psychoanalytic treatment, with dose and 
frequency of sessions correlating positively with improvement rates. Health care utilization and work 
impairment of patients after psychoanalytic treatment was expected to be significantly lower in 
comparison to that of patients before psychoanalytic treatment.   
 
OVERVIEW OF THE THESIS 
 
Chapters 2 and 3 describe the results from the pilot study about the characteristics of patients assigned 
to psychoanalytic treatment. Chapter 2 deals with the question whether patients assigned to 
psychoanalytic treatment present ‘enough’ mental health problems to justify such an intensive 
treatment. A common assumption is that psychoanalytic treatment is for the ‘worried well’. Therefore 
we investigated how the levels of symptoms, interpersonal problems, and personality pathology relate 
to those of non-clinical samples and other clinical samples. We also combined the test scores of the 
different instruments to assess the number of clinical cases at the start of long-term psychoanalytic 
treatment. In chapter 3 we investigated differences in mental health characteristics between patients 
assigned to psychoanalysis and patients assigned to psychoanalytic psychotherapy. 
 The following chapters are based on the results of the multiple cohort study. We have 
identified three sections: effectiveness, longitudinal measurements, and cost-effectiveness. Chapters 4 
and 5 deal with the effectiveness of long-term psychoanalytic treatment, and describe results from 
cross-sectional cohort comparisons. In these chapters we reported the differences between patients in 
the four phases of treatment (pre, during, post, follow-up) regarding symptoms and personality 
functioning. In chapter 4 the main focus is on comparing group means and calculating effect sizes with 
subsequent attention to potential moderators of treatment outcome. Chapter 5 deals with the clinical 
significance of the results and compares test scores to normative samples.  
Time 
Cohort 1 
Comparison of 
pre-treatment 
characteristics 
Cohort 2 
Cohort 3 
Cohort 4 
T0 
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The results of the longitudinal measurements of symptoms and interpersonal problems during 
the first two years of psychoanalysis and psychoanalytic psychotherapy are reported in chapter 6. 
Longitudinal measurements can provide important information regarding varieties in developmental 
trajectories of patients in long-term treatment. We used an accelerated longitudinal design with five 
consecutive measurement points across two cohorts of patients to model the courses of improvement 
in both treatment groups. 
The results of the cost-effectiveness data of long-term psychoanalytic treatment are described 
in chapters 7 and 8. Long-term psychoanalytic treatment is perceived as an expensive ambulatory 
treatment for mental illnesses. In chapter 7 we investigated the effects of long-term psychoanalytic 
treatment on health care utilization and work impairment and also calculated the associated societal 
costs. In chapter 8 we examined the incremental cost-effectiveness ratio of high-dosage versus lower-
dosage psychoanalytic treatment which estimates the additional costs that need to be invested to 
achieve an extra QALY when choosing psychoanalysis over psychoanalytic psychotherapy. 
In the final chapter of this thesis we provide a general discussion of the conclusions that can 
be drawn from the studies. We comment on the clinical and economical implications, discuss the 
research methodology, and provide suggestions for future research.  
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CHAPTER 2 
 
Identifying clinical cases among patients 
assigned to psychoanalytic treatment 
 
 
Berghout, C.C. & Zevalkink, J. (2008). Identifying clinical cases among patients assigned 
to psychoanalytic treatment. Bulletin of the Menninger Clinic, 72, 163-178.  
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ABSTRACT 
 
The present study compared 89 patients assigned to long-term psychoanalytic psychotherapy or 
psychoanalysis in the Netherlands with psychiatric and nonclinical norm groups with regard to 
symptoms and personality pathology as assessed with six instruments. Patients filled in four self-report 
questionnaires (Symptom Checklist-90-Revised [SCL-90-R], Beck Depression Inventory-II [BDI-II], 
State-Trait Anxiety Inventory [STAI], Inventory of Interpersonal Problems-64 [IIP-64]) and 
underwent a personality assessment (Minnesota Multiphasic Personality Inventory-2 [MMPI-2], 
Rorschach-CS). The authors used statistically defined cutoff values for each measure. For each 
instrument separately, about 50% of the patients reported clinical levels of psychopathology, some 
patients being more depressed and others reporting other symptoms. By combining the test scores of 
the different instruments, the authors found that 91% of the patients were identified as clinical cases. 
Compared to psychiatric norm groups, these patients appeared to report lower levels of symptom 
distress, but similar levels of personality pathology. The next step will be to investigate the level of 
improvement after long-term psychoanalytic treatment. 
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INTRODUCTION 
 
Although several countries (e.g., Norway, Belgium, Germany, Canada, The Netherlands) provide 
government funding for long-term ambulatory psychotherapy, such as psychoanalysis and 
psychoanalytic psychotherapy, not much is known about the characteristics of the patients assigned to 
these treatments. Do they resemble the general psychiatric population, or do they report 
psychopathology at a similar level as a nonclinical norm group? The present study aims to investigate 
whether patients assigned to long-term psychotherapy can be identified as clinical cases or not. In 
concordance with previous research (Derogatis & Lazarus, 1994; Sandell et al., 2000), we calculated 
the proportion of patients whose test scores were above a statistically defined cutoff score on the 
different instruments to estimate the percentage of patients that are clinical cases. The answer to this 
research question might be relevant to researchers and policy makers, as well as clinicians.  
First, researchers will know whether outcome studies into the effectiveness of long-term 
psychotherapy are feasible with the instruments selected for the current project. If the results of this 
study would show that these patients resemble patients in psychiatric care more than they resemble 
nonpatients, it would mean that the instruments apparently are sensitive enough to detect the mental 
health problems associated with this patient population and would therefore be useful in detecting 
improvements as a result of treatment. Second, policy makers will gain knowledge about the 
characteristics and distribution of illnesses of patients before psychoanalytic treatment, which they can 
use in order to provide more effective services (Howard et al., 1996). 
Third, clinicians will get information and/or confirmation about the range of mental health 
characteristics they can expect from patients assigned to long-term ambulatory treatments (e.g., Health 
Council of the Netherlands, 2001). In the Netherlands, a routine outcome monitoring system was 
implemented to follow patients before and during psychoanalytic treatment (Zevalkink, 2004). The 
system included the Symptom Checklist-90-Revised (SCL-90-R), Beck Depression Inventory-II (BDI-
II), State-Trait Anxiety Inventory (STAI), Inventory of Interpersonal Problems-64 (IIP-64), Minnesota 
Multiphasic Personality Inventory-2 (MMPI-2), and the Rorschach inkblot test1. We intended to 
determine where patients applying for long-term psychoanalytic treatment would fit within the clinical 
spectrum of patients with mental health problems on the basis of these six instruments. The present 
study was a first step in a larger project of assessing the (cost-)effectiveness of long-term 
psychoanalytic psychotherapy and psychoanalysis in a naturalistic setting (Zevalkink & Berghout, 
2006). 
Recent meta-analyses showed that psychoanalytic treatment proved to be an effective 
treatment for depression (Leichsenring, 2001) and personality disorders (Leichsenring & Leibing, 
2003). For the present study, we first conducted a systematic review of the research literature to 
investigate the results of other naturalistic studies on ambulatory psychoanalytic treatment that used 
similar instruments. 
With regard to the symptom questionnaires, patients at onset of psychoanalytic treatment were 
found to score significantly higher on general symptomatology (SCL-90-R), depression (BDI-II), 
anxiety (STAI), and interpersonal problems (IIP-64) compared to nonclinical norm groups, though not 
all patients had clinically elevated scores on all instruments (Finland: Knekt & Lindfors, 2004; 
Germany: Brockman, Schlüter, Brodbeck, & Eckert, 2002; Leichsenring, Biskup, Kreische, & Staats, 
2005; Puschner, Kraft, & Bauer, 2004; Sweden: Blomberg, Lazar, & Sandell, 2001; Sandell et al., 
2000; United States: Vaughan et al., 2000). 
Next, for each of the six instruments the number of clinical cases in the norm groups―as 
reported in the manuals―was examined. This confirmed that not every patient in the psychiatric norm 
group could be identified as a clinical case. For example, the percentage of psychiatric patients with a 
clinically elevated mean score (calculated according to Sandell et al., 2000) on the BDI-II appeared to 
be 69% (van der Does, 2002), and on the STAI (Trait score) 48% of the psychiatric patients scored 
above the clinical cutoff (van der Ploeg, 2000). 
                                               
 
1 The Adult Attachment Interview (AAI; George, Kaplan, & Main, 1996) is included in the monitoring system as 
well, but results from this instrument are not available for this group of patients. 
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Relatively few studies using the MMPI-2 have been done with patients in psychoanalytic 
treatment. In the United States, Gordon (2001) administered the MMPI to outpatients receiving long-
term psychoanalytic psychotherapy. He showed that patients at onset of treatment scored within the 
clinical range on several scales and started to change significantly after 2 years of treatment (Gordon, 
2001). Studies on the Rorschach showed that patients at onset of ambulatory psychoanalytic treatment 
had clinically elevated mean scores on most of the selected Comprehensive System indices of 
adjustment difficulty, and thus fulfilled the clinical criteria of maladjustment (Knekt & Lindfors, 2004; 
Weiner & Exner, 1991). With regard to the Special Indices of the Rorschach, Weiner and Exner 
(1991) studied two indices and found that 32% of their patients had an elevated Coping Deficit Index 
(CDI > 3) and 60% had an elevated Depression Index (DEPI > 4). We expected patients applying for 
psychoanalytic treatment in the Netherlands to show similar patterns. 
Patients assigned to long-term psychoanalytic treatment (“intention-to-treat”) were compared 
with two reference groups, one consisting of patients in regular clinical practice and the other of 
nonclinical subjects. For this comparison, we used standardized means as reported in each of the 
instrument’s manuals to constitute the two reference groups. The data in these manuals consists of 
established, up-to-date, and reliable reference groups. Furthermore, we examined whether or not our 
patients could be identified as clinical cases according to specific criteria. In this, we followed other 
researchers who had shown that it is possible to use statistically defined cutoff values and combine 
different instruments to come to a global assessment of the percentage of clinical cases in a certain 
patient population (Blomberg et al., 2001; Puschner, Kraft, Kächele, & Kordy, 2007; Sandell et al., 
2000). 
 
METHOD 
 
Subjects 
The total sample consisted of 89 subjects (76% female) who were indicated for long-term ambulatory 
psychoanalytic treatment. The mean age at intake was 30.8 years (SD = 7.1; range 18-48). Of this 
group, 31% had a spouse and 16% had children. The majority of patients was employed (78%) and 
had received higher education (76%). Eleven percent had a non-Western cultural background. With 
regard to treatment history, we found that 65% of our patients had received previous 
(psychotherapeutic) treatment before applying for long-term psychoanalytic treatment. Most 
commonly diagnosed DSM-IV-TR disorders were: mood disorders (51%; in particular dysthymia 
35%), anxiety disorders (18%), and adjustment disorders (8%), where 18% were diagnosed with more 
than one Axis I disorder. Seventy-four percent of the patients was diagnosed with an additional V-
code, of which identity problems and relational problems were most common. Twenty percent of the 
patients was diagnosed with no Axis I disorder, only a V-code. Due to administrative problems, no 
systematic data were available with regard to Axis II disorders. The average GAF score was 59.9 (SD 
= 8.8). 
 
Procedure 
All patients who applied for treatment between June 2002 and November 2004 at a community mental 
health clinic specialized in long-term ambulatory psychoanalytic treatment were asked to fill in four 
self-report questionnaires (SCL-90-R, BDI-II, STAI, and IIP-64). After this, a personality assessment 
was carried out consisting of the MMPI-2 and the Rorschach inkblot test. The administration and 
scoring of the Rorschach were done by well-trained psychologists according to the Comprehensive 
System (Exner, 2001, 2003). In total, 89 patients who participated in the personality assessment 
received an indication for long-term psychoanalytic treatment at our facility. Rorschach and MMPI-2 
data for all patients were complete. However, for 4 patients the data of the screening questionnaires 
were not complete. 
 
Measures 
Symptom questionnaires. In the Netherlands, norms and translation of the SCL-90-R were 
developed by Arrindell and Ettema (2003). The Global Severity Index (GSI) gives an indication of the 
general symptomatology. The BDI-II measures depressive symptoms, and van der Does (2002) 
developed norm scores in the Netherlands. The IIP-64 is used to systematically examine different 
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types of interpersonal problems (Horowitz, Alden, Wiggins, & Pincus, 2000). The translation and 
norm scores of the STAI were developed by van der Ploeg (2000). 
 Personality assessment. The MMPI-2 aims to give a quantitative measurement of the 
individual’s level of emotional adjustment and attitude toward test taking, resulting in clusters of 
personality variables (Groth-Marnat, 1997). In concordance with other research, we used eight clinical 
scales, because scales 5-Masculinity-Femininity (Mf) and 0-Social Introversion (Si) are usually not 
considered as clinical scales (Nieberding et al., 2003; Terlidou et al., 2004). Derksen, de Mey, Sloore, 
and Hellenbosch (2006) translated the MMPI-2 and developed norms for use in the Netherlands. The 
relatively new Personality Psychopathology Five (PSY-5) scales were also included: Aggressiveness, 
Psychoticism, Disconstraint, Negative Emotionality/Neuroticism, and Introversion/Low Positive 
Emotionality (Harkness & McNulty, 2006). The Rorschach is useful for predicting and evaluating 
outcome and provides an assessment of someone’s personality structure and dynamics (Groth-Marnat, 
1997; Viglione, 1999). In this study, we used the six Special Indices: Perceptual-Thinking, 
Depression, Coping Deficit, Suicide Constellation, Hypervigilance, and Obsessive Style. Norm scores 
were derived from Exner (2001). We included scores on the Ego Impairment Index-2 (EII-2), which is 
a relatively new Rorschach composite. The EII-2 measures psychological impairment and thought 
disturbance (Viglione, Perry, & Meyer, 2003). For descriptive purposes, we also examined the 
emotional coping style (EB). The EB gives an indication of a person’s predominant emotional coping 
style: ambitent (varied use of external and internal resources), extratensive (mostly use external 
resources for gratification of basic needs), introversive (mostly use inner life for satisfaction of 
important needs), or avoidant (tend to minimize the importance of the stimulus field) (Exner, 2003). 
On the emotional coping style (EB) we found the following results: 44% ambitent, 12% extratensive, 
35% introversive, and 9% avoidant. 
 
Statistical analyses 
Comparison with nonclinical and psychiatric norm groups. We examined differences and 
similarities by comparing test scores of our patients with those of the psychiatric reference groups and 
nonclinical norm groups that are mentioned in the manuals of the different instruments (t-test, chi-
square). 
Criterion for clinical case. To estimate the percentage of patients that could be identified as 
clinical cases, we calculated the proportion of patients whose test scores were located above a 
statistically defined cutoff score on the different instruments. In concordance with previous research 
(Derogatis & Lazarus, 1994; Sandell et al., 2000), we used the value that divides the 10% worst 
scoring persons in the nonclinical norm group from the 90% best scoring persons. This division 
corresponds to 1.28 standard deviation above the mean in a normal distribution. The overall criterion 
for clinical case was established as patients with scores within the clinical range on at least two of the 
screening questionnaires and/or two clinical scales of the MMPI-2 and/or two of the Rorschach 
Special Indices. 
 
RESULTS 
 
Symptom questionnaires: Comparisons with nonclinical and psychiatric norm groups 
Table 1 shows the mean scores and standard deviations on the four questionnaires. Our patient group 
scored significantly higher (i.e., more complaints/problems) on all questionnaires in comparison to the 
nonclinical norm groups. Subscale scores are not mentioned in Table 1, but without exception they 
were all significantly higher in our patient group compared to the nonclinical norm groups. Table 1 
also shows that our patients scored significantly lower than other psychiatric norm groups regarding 
general symptomatology (SCL-90-R), depression (BDI-II), and interpersonal problems (IIP-64). On 
trait anxiety (STAI Trait) there was no significant difference between our patients and the psychiatric 
norm group. 
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Table 1. Means and standard deviations on the four symptom questionnaires and comparisons with 
psychiatric and non-clinical norm groups 
Group Comparison 
1 2 3 1 vs. 2 1 vs. 3 
Questionnaire M (SD) M (SD) M (SD) t t 
SCL-90-R GSI score 0.98 (0.50) 1.26 (0.68) 0.31 (0.36) -5.19 *** 12.42 *** 
BDI-II Total score 17.9 (8.5) 21.4 (12.2) 6.2 (6.2) -2.96 ** 12.27 *** 
IIP-64 Total score 92.0 (30.3) 112.2 (34.2) 51.5 (34.3) -5.65 *** 11.58 *** 
STAI Trait score 52.9 (9.0) 51.6 (11.6) 38.4 (10.8) 0.92  12.99 *** 
Note. Group 1 = Patients before psychoanalytic treatment (N = 85-87); Group 2 = Psychiatric norm group; Group 
3 = Non-clinical norm group. Data from the psychiatric and non-clinical norm group for the SCL-90-R were 
derived from Arrindell & Ettema (2003); BDI-II: Van der Does (2002); IIP-64: Horowitz, Alden, Wiggins & 
Pincus (2000); and STAI: Van der Ploeg (2000). 
**p < .01; ***p < .001.  
 
Personality assessment: Comparisons with nonclinical and psychiatric norm groups 
Table 2 shows the mean scores and standard deviations on the clinical scales of the MMPI-2. On all 
MMPI-2 clinical scales except scale 9-Hypomania, patients applying for psychoanalytic treatment 
scored significantly higher than the nonclinical norm group. However, comparisons with the 
psychiatric norm group showed that our patients scored significantly lower on scales 1- 
Hypochondriasis, 2-Depression, 3-Hysteria, 6-Paranoia, 8-Schizophrenia, and 9-Hypomania. No 
differences were found on the other clinical scales. We also investigated the percentage of patients 
who had clinically elevated scores on the PSY-5 variables. We found no significant deviations from 
the percentages in the nonclinical reference group on the first three variables, but on the scale for 
Negative Emotionality/Neuroticism 38% had an elevated score and on Introversion/Low Positive 
Emotionality 39% scored within the clinical range. 
 
Table 2. Means and standard deviations on the clinical scales of the Minnesota Multiphasic 
Personality Inventory-2 and comparisons with psychiatric and non-clinical norm groups 
Group Comparison 
1 2 3 1 vs. 2 1 vs. 3 
MMPI-2 scale M (SD) M (SD) M (SD) t t 
1-Hypochondriasis 55.8 (10.9) 61.6  (5.9) 50 (10) -4.39 *** 4.86 *** 
2-Depression 62.9 (12.7) 67.9 (11.6) 50 (10) -2.66 ** 9.39 *** 
3-Hysteria 61.0 (13.0) 66.9 (9.3) 50 (10) -3.41 *** 7.84 *** 
4-Psychopathic deviate 67.1 (10.8) 66.2 (9.8) 50 (10) 0.53   14.49 *** 
6-Paranoia 61.5 (11.7) 65.4 (10.5) 50 (10) -2.27 * 9.10 *** 
7-Psychasthenia 67.0 (12.5) 66.2 (8.8) 50 (10) 0.49  12.58 *** 
8-Schizophrenia 63.4 (10.8) 69.1 (13.0) 50 (10) -3.11 ** 11.38 *** 
9-Hypomania 52.0 (11.0) 62.5 (8.3) 50 (10) -7.03 *** 1.70  
Note. Group 1 = Patients before psychoanalytic treatment (N = 89); Group 2 = Psychiatric norm group; Group 3 
= Non-clinical norm group. Data from the psychiatric and non-clinical norm group were derived from Derksen, 
de Mey, Sloore & Hellenbosch (2006). 
*p < .05; **p < .01; ***p < .001.  
 
Table 3 shows the percentage of patients with clinically elevated scores on the Special Indices of the 
Rorschach. On all Special Indices except the Obsessive Style Index, significantly more of our patients 
appeared to have clinically elevated scores in comparison to the nonclinical norm group. Comparisons 
with the psychiatric norm group showed that in our patient group, significantly fewer patients had a 
clinically elevated score on the Obsessive Style Index. However, on the Perceptual-Thinking Index, 
Depression Index, Suicide Constellation, and Hypervigilance Index, our patient group had 
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significantly more clinically elevated scores than the psychiatric norm group. No significant difference 
was found on the Coping Deficit Index. Next, we analyzed Ego Impairment Index-2 scores. We found 
that 47% of the patients had high scores, indicating moderate to severe impairment (EII-2 > 0.7). More 
than half of these patients even had significant impairment (EII-2 > 1.3). 
 
Table 3. Percentage of patients with clinically elevated scores on the six Rorschach Special Indices in 
comparison to clinical and non-clinical reference groups  
Group Comparison 
1 2 3 1 vs. 2 1 vs. 3 
Rorschach Special Indices % % % χ² χ² 
Perceptual-Thinking (PTI > 2) 15 2 0 28.3 *** 74.1 *** a 
Depression (DEPI > 4) 53 20 5 43.5 *** 178.5 *** 
Coping Deficit (CDI > 3) 25 31 4 1.4  55.4 *** 
Suicide Constellation (S-CON > 7) 7 0 0 23.9 *** a 33.4 *** a 
Hypervigilance (HVI Positive) 26 11 3 13.7 *** 72.3 *** 
Obsessive Style (OBS Positive) 1 8 1 4.7 * a 0.1  a 
Note. Group 1 = Patients before psychoanalytic treatment (N = 89); Group 2 = Psychiatric norm group; Group 3 
= Non-clinical norm group. Data from the psychiatric and non-clinical norm group were derived from Exner 
(2001). 
aχ² with Yates correction. 
*p < .05; ***p < .001. 
 
Combining instruments: Clinical cases across instruments 
We first combined the test scores from the four symptom questionnaires and calculated the 
percentages of patients who scored within the clinical range on SCL-90-R GSI score, BDI-II Total 
score, STAI Trait score, or IIP-64 Total score. We found that 60% of our patients had clinically 
elevated scores on at least two questionnaires. To be more specific, 16% scored within the clinical 
range on two questionnaires, 18% on three questionnaires, and 26% on all four symptom 
questionnaires. Then we combined the test scores from the two personality assessment instruments and 
looked at the percentage of patients who had clinically elevated scores on either the MMPI-2 (at least 
two clinical scales) or the Rorschach (at least two Special Indices). We found that 85% of our patients 
met these criteria. More specifically, 50% of the patients had clinically elevated scores on the MMPI-2 
but not on the Rorschach; 9% of the patients scored clinically elevated on the Rorschach but not on the 
MMPI-2; and 26% of the patients had clinically elevated scores on both the MMPI-2 and the 
Rorschach. Finally, we combined the results from the symptom questionnaires with the personality 
assessment instruments. A clinical case was defined as someone who scored within the clinical range 
on at least two symptom questionnaires and/or at least two MMPI-2 clinical scales and/or at least two 
Rorschach Special Indices. On these criteria, 91% of the patients assigned to long-term psychoanalytic 
treatment were identified as clinical cases. 
 
DISCUSSION 
 
In the present study we gave a description of patients assigned to long-term ambulatory psychoanalytic 
treatment in the Netherlands on the basis of six instruments. Four screening questionnaires and two 
personality assessment instruments were used. Compared to psychiatric norm groups, our patients 
appeared to report lower levels of symptom distress, whereas with regard to personality problems our 
patients presented similar levels of psychopathology. Patients assigned to long-term psychoanalytic 
treatment were characterized by high levels of depression, hypervigilance, trait anxiety, and problems 
in reality testing. In addition, we found that most of these patients had an introversive style of coping 
with emotional difficulties or made varied use of external and internal resources. This particular 
personality pathology in combination with the high prevalence of (chronic) mood disorders shows that 
this patient population occupies its own niche within mental health care. For clinicians, it is important 
to identify the particulars of this patient group, so that better decisions can be made regarding 
treatment assignment. This concerns patients who seemingly have few symptoms or complaints and 
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can therefore function reasonably well in certain areas of life, but nonetheless suffer from high levels 
of hidden distress and personality problems for which they seek help. Scores on the Rorschach EII-2, 
for example, suggest that problem-solving failures or ineffective and idiosyncratic thinking in complex 
and demanding life situations were very common in our patient sample. These problems exist on a 
deeper personality level, which seem hard to capture with short self-report questionnaires. The PSY-5 
scales of the MMPI-2 showed that many patients assigned to psychoanalytic treatment had a tendency 
to focus on problematic aspects of experiences/stimuli, or, in other words, to worry about and 
anticipate the “worst case scenario”. Moreover, many of these persons seem to have developed an 
introvert style of dealing with emotional problems as a result of early life experiences. These 
results are in concordance with those of other studies on patients before psychoanalytic treatment 
(Blatt & Shahar, 2004; Fonagy et al., 1996; Holmes, 2001; Horowitz, Rosenberg, & Bartholomew, 
1993; Levy et al., 2006). The results of these studies suggested that patients with an avoidant 
attachment style and patients with “introjective” psychopathology might improve significantly more 
after a high-frequency and long-term treatment in contrast to a low-frequency and short-term 
treatment. 
As reported elsewhere, the clinicians’ assignment to long-term treatments seems to be in line 
with the research findings (e.g., Zevalkink & Berghout, 2008). Perhaps the stereotype of 
psychoanalytic treatment being for the “worried well” is based on the observation that these patients 
report fewer symptoms in comparison with other psychotherapy patients. With the aid of personality 
assessments, however, the current study shows that the majority of these patients were in fact clinical 
cases, although in less easily detectable areas of social and emotional functioning. In line with other 
researchers, we suggest that long-term treatments are especially well suited for patients with 
personality disorders and/or recurrent or chronic depression, because of the complexity of the 
underlying problems (Bateman & Fonagy, 1999; Doidge et al., 2002; Perry, Banon, & Ianni, 1999). 
Some limitations can be noted with regard to the generalizability of our results. First, with 
regard to sociodemographic characteristics, results were comparable with those in other studies of 
patients assigned to psychoanalytic treatment: mainly women, highly educated, and without a spouse 
(e.g., Sandell et al., 2000). We could not compare this with characteristics of patients in the reference 
groups, because these data were not mentioned in the manuals of the instruments. Results from Olfson 
and Pincus (1994) did show that long-term psychotherapy users tended to have a higher education than 
either short-term psychotherapy users or those who did not use psychotherapy. Therefore, the 
generalizability of these results might apply only to patients assigned to long-term treatment. Second, 
the generalizability depends on the quality of the instruments. We selected instruments with good 
psychometric properties. Most controversial in our test battery is the Rorschach inkblot test. The 
Rorschach, scored according to the Comprehensive System, has good psychometric qualities (Exner, 
2003; Meyer & Archer, 2001) but has not yet been researched extensively in the Netherlands (Evers, 
van Vliet-Mulder, & Groot, 2000). Therefore, our results may have a bias with norm groups outside 
the Netherlands. More normative research is needed for the Rorschach in the Netherlands so that 
differences and similarities with other psychotherapy patients can be identified more accurately. Third, 
the definition of a clinical case is crucial in this discussion. In this, we followed other studies 
(Blomberg et al., 2001; Derogatis & Lazarus, 1994; Puschner et al., 2007; Sandell et al., 2000) and 
tried to make an even more conservative estimate of the number of clinical cases. This was done by 
adding the criteria that a person would be considered a clinical case if this shows on several symptom 
questionnaires and/or several MMPI-2 clinical scales and/or several Rorschach Special Indices. For 
instance, a person who had a clinically elevated score on just one of the questionnaires (e.g., BDI-II), 
one MMPI-2 clinical scale (e.g., scale 2-Depression), and only one of the Special Indices (e.g., DEPI) 
would not be considered a clinical case according to our criteria. In our sample, this was the case for 
9% of our patients. This number is in agreement with other research findings showing that 
approximately 15% of patients in ambulatory treatment report functioning in the nonclinical range on 
standardized tests at intake (Lambert, Okiishi, Finch, & Johnson, 1998). This, however, does not 
necessarily mean that these patients do not have substantial problems. It can also indicate that these 
patients’ problems are very hard to detect, even with well established assessment instruments. Further 
research is needed to find out if this tighter definition of a clinical case will be useful. Finally, no data 
on outcome are available yet. The next step is to investigate whether long-term psychoanalytic 
treatment is effective in reducing the number of clinical cases and realizing stable improvements in a 
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person’s emotional and social functioning. What we do know is that personality instruments play a 
crucial role in detecting clinical cases in this particular patient niche.  
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ABSTRACT 
 
The present study investigated mental health characteristics of 170 patients assigned to long-term 
psychoanalytic psychotherapy (PP) versus psychoanalysis (PA) across treatment and studies. Both 
univariate and multivariate statistics showed that the main difference between treatments was found in 
the interpersonal domain. PA patients reported significantly more interpersonal problems (as measured 
by the Inventory for Interpersonal Problems-64), scored higher on the avoidant coping style and lower 
on the perceptual thinking index of the Rorschach-Comprehensive System, and scored lower on 
Aggressiveness and Psychoticism Minnesota Multiphasic Personality Inventory-2 PSY-5 scales 
compared with PP patients. Compared with psychoanalytic patients in other studies, our patients had 
similar levels of mental health problems, although not always in the same health areas. Limitations of 
the study were noted, such as the lack of outcome data and other comparison groups. 
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INTRODUCTION 
 
Both psychoanalytic psychotherapy and psychoanalysis are particular forms of long-term 
psychotherapy (>50 sessions). Questions about the effectiveness of both treatments have been justly 
raised to determine with whom these long-term psychoanalytic treatments should be started (e.g., 
Doidge, 1997; Health Council of the Netherlands, 2001; Roth & Fonagy, 1996). For instance, recent 
theoretical and empirical insights into the development of interpersonal problems have shown that 
patients with an internal working model of relationships that reflect a defensive, avoiding style needed 
higher intensity psychoanalytic treatment in order to change compared with those with a more 
preoccupied internal working model (Blatt & Shahar, 2004; Fonagy et al., 1996; Holmes, 2001; 
Horowitz, Rosenberg, & Bartholomew, 1993). Do patients actually differ on these and related mental 
health aspects before starting on one of the two types of psychoanalytic treatments? Do therapists use 
this information in their treatment assignment? The present article examines whether systematic 
differences could be detected in mental health characteristics between patients assigned to either 
psychoanalysis or psychoanalytic psychotherapy and whether the mental health characteristics of these 
patients differed from psychoanalytic patients in other studies. Potential differences could show us the 
extent to which therapists’ treatment assignment was guided by systematic data on mental health 
characteristics (e.g., Erle & Goldberg, 2003; Scheidt et al., 2003). Comparing mental health 
characteristics across treatments and research projects is a necessary first step in assessing the 
effectiveness of long-term psychoanalytic psychotherapy and psychoanalysis in a naturalistic setting.  
Psychoanalysis is a three- to five-times-a-week treatment, with an average duration of 4 to 5 
years (e.g., Blomberg, Lazar, & Sandell, 2001; Erle & Goldberg, 2003). Doidge et al. (2002, pp. 582-
583) summarized the American Psychiatric Association guidelines in one sentence: ‘‘Psychoanalysis 
is indicated for patients whose chronic DSM disorders or symptoms are based both on intrapsychic 
conflict and developmental inhibition, for whom less intensive treatment would not work or would 
prolong or cause needless suffering, and who are ‘analyzable’.’’ Like psychoanalysis, psychoanalytic 
psychotherapy is a long-term but less intensive treatment, with a maximum frequency of two sessions 
a week. Clear guidelines have not yet been developed for psychoanalytic psychotherapy, although 
some attempts have been made in Germany (Brandl et al., 2004; Leichsenring, Biskup, Kreische, & 
Staats, 2005) and particular types of psychoanalytic psychotherapies have been manualized (e.g., 
Luborsky, 1984). Both types of treatment differ in setting (couch vs. chair), average dosage (600 vs. 
200 sessions), professional training of therapists, and technique, but empirical data on selective 
differences between both groups patients are not available yet (e.g., Fonagy, Roth, & Higgitt, 2005). 
Fortunately, both psychoanalysis and psychoanalytic psychotherapy are still available to all economic 
groups in the Netherlands because of its national mental health plan. This is comparable to the 
situation in countries like Canada, Australia, Germany, and Finland. To routinely measure outcome, a 
monitoring system was developed and implemented to register the patients’ mental health status 
before and during psychoanalytic treatment in the Netherlands (Zevalkink & Berghout, 2006). 
The monitoring system included both the quick assessment of symptoms and the more time-
consuming assessment of personality pathology. Although psychoanalytic theory generally 
deemphasizes the importance of assessing symptoms, their regular assessment is important for two 
reasons. First, instruments assessing symptoms are commonly used to study the effectiveness of other 
types of treatment (e.g., Crits-Christoph, Gladis, & Connolly, 2002) and, therefore, allow comparisons 
with other studies. Second, typical patterns of progress and deterioration in this particular group of 
patients can be empirically established and related to other results. Perhaps a subgroup of 
psychoanalytic patients deny symptoms at entry, deteriorate in the middle of treatment, and recover 
fully to a nonclinical level at the end of treatment (e.g., Sandell et al., 2000). Because of the diversity 
of mental health problems of patients entering the mental health clinic, four main themes were 
identified: general symptomatology (measured by the Symptom Checklist-90-Revised [SCL-90-R]; 
Derogatis, 1983), depression (measured by the Beck Depression Inventory-II [BDI-II]; Beck, Steer, & 
Brown, 1996), anxiety (measured by the State-Trait Anxiety Inventory [STAI]; Spielberger, 1983), 
and interpersonal problems (measured by the Inventory of Interpersonal Problems [IIP-64]; Horowitz, 
Alden,Wiggins, & Pincus, 2000). Personality pathology needs to be monitored as well because 
psychoanalytic treatment aims to change the structure of patients’ personality functioning (Galatzer-
Levy, Bachrach, Skolnikoff, & Waldron, 2000). Clarkin (2006) stated that ‘‘the essence of personality 
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pathology consists of difficulties with self-identity and chronic interpersonal dysfunction’’ (p. 1). To 
include a broad range of personality (dys)functioning, we focused on two different but complementary 
instruments: the Minnesota Multiphasic Personality Inventory-2 (MMPI-2; Groth-Marnat, 1997) and 
the Rorschach as scored with the Comprehensive System (Rorschach-CS; Groth-Marnat, 1997)1. 
Because relatively low correlations between them have been found, the combined use of 
Rorschach-CS and MMPI-2 data would increase the ability to predict personality functioning (e.g., 
Blais, Hilsenroth, Castlebury, Fowler, & Baity, 2001; Groth-Marnat, 1997; Hiller, Rosenthal, 
Bornstein, Berry, & Brunnell-Neuleib, 1999; Meyer, 1997). The MMPI-2 is widely used, but 
relatively few research studies have been published on psychoanalytic patients. In the United States, 
Gordon (2001) used the MMPI with 55 outpatients receiving long-term psychoanalytic psychotherapy. 
He showed that patients scored within the clinical range on several scales at onset and started to 
change significantly after 2 years of treatment (Gordon, 2001). The Rorschach has been used as a 
diagnostic tool and outcome instrument in psychoanalytic treatment for quite some time (e.g., 
Ganellen, 1996; Grønnerød, 2004). A large number of indexes have been identified and also more 
molar and less overlapping variables have been constructed (e.g., Blatt & Berman, 1984; Ganellen, 
1996), such as Exner’s (2003) six special indexes. A Finnish study on the effectiveness of ambulatory 
psychoanalytic treatment included the Rorschach-CS. For instance, they found that patients entering 
psychoanalysis scored significantly higher on the suicide constellation index (S-CON) compared with 
patients entering psychoanalytic psychotherapy (Knekt & Lindfors, 2004). Weiner and Exner (1991) 
studied North American patients in long-term dynamically oriented psychotherapy at the onset of 
treatment. With regard to the special indexes, they found that 32% of their patients had an elevated 
coping deficit index score (CDI>3) and 60% had an elevated depression index score (DEPI>4). 
A review of results on the assessment of symptoms for psychoanalytic patients at onset of 
treatment showed that some studies only included patients entering psychoanalysis (PA) and other 
studies only patients entering psychoanalytic psychotherapy (PP). In two German studies, PP patients 
had clinically elevated scores as measured with the SCL-90-R and IIP-D (Brockmann, Schlüter, 
Brodbeck, & Eckert, 2002; Leichsenring et al., 2005). Results from the Stockholm Outcome of 
Psychotherapy and Psychoanalysis Project (STOPP; Blomberg et al., 2001; Sandell et al., 2000) 
showed that both PA and PP patients were quite vulnerable and often highly distressed at onset. Mean 
scores on general psychopathology (SCL-90-R) were above the clinical cutoff score and not 
significantly different between groups (Blomberg et al., 2001). Initial results of a Finnish study 
showed that both PP and PA patients had clinically elevated scores on general symptomatology (SCL-
90-R), depression (BDI), and interpersonal problems (IIP) at onset of treatment, but no significant 
differences between the two patients groups were found on these tests (Knekt & Lindfors, 2004). In 
the United States, Vaughan et al. (2000) reported similar findings using the same three screening 
instruments. In addition, they found that patients starting long-term psychodynamic therapy, including 
psychoanalysis, had clinically elevated scores on the STAI. 
The current study was based on an intention-to-treat model. This means that the study did not 
investigate whether these patients actually did receive the treatment to which they were assigned. 
Based on previous findings, we expected PA patients to differ from PP patients in severity of 
psychopathological symptoms (i.e., higher mean scores on our assessment instruments) and to display 
more avoidance in interpersonal situations. The data were analyzed in two ways. First, global 
univariate analyses provided a rough picture of the variables that seemed best in characterizing the 
differences between the two groups. These results were then compared with those reported in the 
published literature, where the emphasis has been on the group means as such. Second, it must be kept 
in mind that the PA-PP classification represents a decision making process of the therapists 
themselves. This decision may take account of the results of the monitoring instruments as well as 
other variables not quantified with instruments. A predictive discriminant analysis was performed to 
determine the degree to which the patients could be classified into the treatment groups, given the 
instrument data that were collected. 
                                               
 
1 A third instrument was the Adult Attachment Interview developed by Main and Goldwyn (1998). Although the 
instrument is part of the routine outcome monitoring, these interviews have not been scored because of the costs 
of transcription and coding. 
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METHOD 
 
Participants 
The total sample consisted of 170 participants (127 [75%] female, 43 [25%] male) who applied for 
psychoanalytic treatment between June 2002 and November 2004 at a community mental health clinic 
specializing in long-term ambulatory psychoanalytic treatment. Fifty-four patients were assigned to 
PA and 116 patients to PP. The administration of the screening questionnaires started before that of 
the MMPI-2 and Rorschach so that, of the total sample of 170 patients, we had MMPI-2 data for 93 
patients and Rorschach data for 113 patients. 
 
Procedure 
Patients applied for treatment through self-referral, referral by their general practitioner or other 
medical specialist, or referral by another mental health care provider. At the end of their first 
interview, patients completed four self-report questionnaires, three on the computer (SCL-90-R, BDI-
II, and STAI) and one using a paper-and-pencil test (IIP-64). About 33% of these patients entered a 
second assessment period aimed at establishing suitability for long-term psychotherapy. During the 
second assessment, patients underwent three meetings with a therapist over a period of about 4 weeks 
while a psychodiagnostic assistant carried out an additional comprehensive personality assessment 
using a computerized version of the MMPI-2 and the Rorschach. The administration of the Rorschach 
followed the procedures developed by Exner (2003). After the data collection, the therapist met with 
two independent therapists in a staff meeting, and together they formulated a decision about the 
preferred treatment of choice: (a) PA, (b) PP, or (c) treatment elsewhere (e.g., cognitive-behavioral 
therapy, residential treatment). 
 
Measures 
Symptom questionnaires. The SCL-90-R measures symptoms in nine major areas of the 
patient’s psychological, somatic, and interpersonal functioning. The 90 items are scored on a 4-point 
Likert scale (Derogatis, 1983). In the Netherlands, norms (N = 2,368) and translations were developed 
by Arrindell and Ettema (2003). The 21-item BDI-II measures depressive symptoms, scored on a 4-
point Likert scale (Beck et al., 1996). In the Netherlands, Van der Does (2002) translated the BDI-II 
and developed norm scores (N = 505). The 40-item STAI assesses state and trait anxiety, scored on a 
4-point Likert scale (Spielberger, 1983). State anxiety reflects a momentary anxiety, and trait anxiety 
refers to a general tendency to respond with anxiety to perceived threats in the environment. The STAI 
was published in the Netherlands as the Zelfbeoordelings Vragenlijst (Van der Ploeg, 2000). The t 
scores for the STAI are based on a normative sample from the Netherlands (N = 387). The IIP consists 
of 64 items, scored on a 5-point Likert scale, that assess perceived interpersonal difficulties on eight 
subscales (Horowitz et al., 2000). The IIP-64 was translated into Dutch, and its psychometric qualities 
were investigated in clinical and nonclinical samples. The t scores for the IIP-64 are based on a 
normative sample from the United States (N = 800).  
Personality assessment. The MMPI-2, a 567-item self-report questionnaire, aims to 
quantitatively measure an individual’s level of emotional adjustment and attitude toward test taking, 
resulting in clusters of personality variables (Groth-Marnat, 1997). For the present study, we used 
eight clinical scales. Scales 5 and 0 are not considered clinical scales (Nieberding et al., 2003; 
Terlidou et al., 2004). The relatively new PSY-5 scales were also included: Aggressiveness, 
Psychoticism, Disconstraint, Negative Emotionality/Neuroticism, and Introversion/Low Positive 
Emotionality (Harkness & McNulty, 2006). Derksen, de Mey, and Sloore (1996) translated the MMPI-
2 and developed norms (N = 1,244) for use in the Netherlands. The Rorschach is useful for predicting 
and evaluating outcome (Viglione, 1999). It assesses clients’ personality structure, with particular 
emphasis on understanding how they respond to and organize their environment. In this way, it can 
also be considered a measure of perception and association (Weiner, 1998). It consists of a set of 10 
bilaterally symmetrical inkblots on sturdy cards. Two test psychologists with extensive training and 
experience in the CS scored the Rorschach (Exner, 2001, 2003). Based on age and gender-
differentiated norms of clinical and nonclinical individuals, the CS produces dichotomized scores on 
six special indexes: perceptual thinking (PTI; to assess problems in information processing, reality 
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testing, and thinking), depression, coping deficit, suicide potential, hypervigilance (HVI), and 
obsessive style. Separately, we investigated differences on emotional coping style (EB): ambitent 
(varied use of external and internal resources), extratensive (mostly use external resources for 
gratification of basic needs), introversive (mostly use inner life for satisfaction of important needs), 
and avoidant (tend to minimize the importance of the stimulus field; Exner, 2003). Norm scores were 
derived from Exner (2001). For research purposes, a standard procedure is to remove Rorschach 
protocols of patients with fewer than 14 responses (Exner, 2001). In this line, we excluded the results 
of two patients from further statistical analyses. 
 
RESULTS 
 
Comparing PA and PP Patients on Symptoms and Personality Assessment 
All test scores were examined for their approximation to a normal distribution using Kolmogorov-
Smirnov statistics. Results showed that there were no indications for nonnormality, so parametric tests 
could be used for further analyses. First, in line with other studies, univariate analyses were used to 
compare the average scores between PA and PP patients. Analyses of variance (ANOVAs) with the 
four screening instruments showed significant differences between the two patient groups (PA-PP) on 
the IIP-64 mean item score but not on the SCL-90-R Global Severity Index (GSI) score, BDI-II total 
score, and STAI-Trait score (Table 1). Further investigation of the IIP subscales showed that four of 
the eight contributed to this difference: Compared with PP patients, PA patients scored significantly 
higher on the subscales Cold (M = 10.8 vs. 8.3), F(1, 161) = 5.50, p < .05; Socially Avoidant (M = 
12.9 vs. 10.3), F(1, 161) = 6.01, p < .05; Nonassertive (M = 17.6 vs. 14.3), F(1, 161) = 9.30, p < .01; 
and Accommodating (M = 15.9 vs. 13.8), F(1, 161) = 3.91, p < .05. 
 
Table 1. Comparing PA-patients and PP-patients on four routine monitoring outcome questionnaires  
PA-patients 
(n = 54) 
PP-patients  
(n = 116) 
 
ANOVA 
 
M (SD) M (SD) F  
SCL-90-R GSI score 0.95 (0.49) 0.89 (0.53) n.s.  
BDI-II Total score 17.2 (9.10) 16.3 (9.11) n.s.  
IIP-64 Mean item score 1.48 (0.48) 1.31 (0.46) 4.91 * 
STAI Trait score 52.0 (10.0) 50.3 (11.0) n.s.  
* p < 0.05. 
 
Results with the two personality instruments were as follows. For the MMPI-2 clinical scales, 
ANOVAs showed no significant differences between the two treatment groups. However, two of the 
PSY-5 dimensions differed significantly, as shown in Table 2, with PA patients scoring significantly 
lower on Aggressiveness and Psychoticism compared with PP patients. This means that PA patients 
reported lower levels of offensive and instrumental aggression and less disconnection from reality 
compared with PP patients. For the Rorschach, we examined six special indexes and four emotional 
coping style variables. Pearson chi-square tests first showed that one of the six Rorschach special 
indexes significantly differed between the two patient groups: Significantly more PP patients had a 
clinically elevated score on the PTI (>2) compared with PA patients (23% vs. 7%, respectively), χ2(1, 
N = 111) = 4.401, p < .05. With regard to emotional coping style, we expected PA patients to have a 
more avoidant coping style and, therefore, tested a directional difference. We indeed found that 
significantly more PA patients were identified as avoidant compared with PP patients (15% vs. 4%, 
respectively), χ2 (1, N = 111) = 3.716, p < .05. No significant differences were found for the other 
three coping styles. The mean number of responses on the Rorschach did not differ significantly 
between PA and PP patients.  
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Table 2. Differences between PA- and PP-patients on the PSY-5 (MMPI-2)  
PA-patients  
(n = 36) 
PP-patients  
(n = 56) 
 
ANOVA 
MMPI-2 PSY-5 M SD M SD F  
Aggressiveness 43.6 8.94 48.9 11.83 5.31 * 
Psychoticism 49.3 8.33 53.6 10.96 4.12 * 
Disconstraint 51.9 8.07 53.2 9.42 n.s.  
Negative Emotionality 58.7 11.84 59.0 12.11 n.s.  
Introversion 60.4 12.60 57.9 10.90 n.s.  
*p < .05. 
 
Comparing Psychoanalytic Patient Samples  
Our results were compared with psychoanalytic patient data in other studies to investigate potential 
sample differences. With regard to the SCL-90, Knekt and Lindfors (2004) reported significantly 
higher SCL-90 GSI scores compared with our sample for both their Finnish PP patients (mean GSI = 
1.27, SD = 0.55), t(241) = 5.53, p < .001, and their PA patients (mean GSI = 1.34, SD = 0.52), t(83) = 
3.75, p < .001. The American population of Vaughan et al. (2000) had a significantly higher mean GSI 
of 2.1 (SD = 0.61) on the SCL-90-R compared with the combined PA and PP groups, t(26) = 8.96, p < 
.001. However, our PP patients were comparable to both German samples (Brockmann et al., 2002; 
Leichsenring et al., 2005) and the late-before group of the Swedish STOPP study (Blomberg et al., 
2001; Sandell et al., 2000) on the SCL-90-R. In sum, patients in the Netherlands reported lower levels 
of general psychopathology than Finnish and North American patients but were comparable to 
German and Swedish patients. 
With regard to interpersonal problems, PP patients in both German studies reported 
significantly more interpersonal problems—Leichsenring et al., 2005: M = 1.88, SD = 0.36, t(74) = 
7.67, p < .001; Brockmann et al., 2002: M = 1.69, SD = 0.43, t(50) = 4.32, p < .001—than our PP 
patients. The North American patient population of Vaughan et al. (2000) had a mean IIP item score 
of 2.0 (SD = 0.5), which was significantly higher compared with our patient sample, t(27) = 5.78, p < 
.001. Our PA and PP patients did not differ significantly from the Finnish PA and PP patients of Knekt 
and Lindfors (2004) on the IIP. In sum, patients in the Netherlands had lower levels of interpersonal 
problems compared with German and North American patients but similar levels as Finnish patients. 
With regard to depressive pathology (BDI), our PA and PP patients were comparable to the Finnish 
and the American samples. Compared with North American patients, no significant differences were 
reported on anxiety problems (STAI). 
With regard to pretreatment MMPI-2 scores, Gordon (2001) reported that his patients had 
mean t scores within the clinical range on three clinical scales (2, 4, and 7). In our patient group, t 
scores were within the clinical range on Scales 4 and 7 as well but not on Scale 2. No comparable 
reports were found on the new PSY-5. Comparing results for the Rorschach, we discovered that Knekt 
and Lindfors (2004) only investigated three special indexes (S-CON, DEPI, and HVI) and used 
different cutoff values to identify positive scores. After recalculation, we found that significantly more 
of our PP patients had a clinically elevated score on the S-CON (>6) compared with the Finnish PP 
patients (24.3% vs. 7.8%; 6% for S-CON > 7), χ2 (1, N = 198) = 10.43, p = .001. Furthermore, 
significantly more Finnish PA patients had a clinically elevated score on the depression index 
(DEPI>5) compared with PA patients in the Netherlands (41.5% vs. 17.1%; 54% for DEPI > 4), χ2 (1, 
N = 82) = 5.89, p = .015. The North American PP patients of Weiner and Exner (1991) did not differ 
significantly from our PP patients with regard to the special indexes CDI and DEPI. 
 
Classification Effectiveness of Instruments 
Finally, to evaluate the degree to which patients could be classified correctly into the two treatment 
groups, we focused our attention on a predictive discriminant analysis strategy (Huberty, 1994; Sherry, 
2006). We first did an exploratory check on which variables to include, following a descriptive 
discriminant analysis strategy. The subscales of the symptoms questionnaires were used instead of the 
total scores to find more detailed profiles. Conventional variable selection criteria based on statistical 
significance do not guarantee an optimal classification solution (Hand, 1981; Huberty, 1984). We, 
therefore, relaxed the significance cutoff points to .10 for inclusion and .20 for exclusion and then 
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performed both a stepwise forward and a backward elimination procedure. The backward elimination 
procedure was the more comprehensive, where the statistical selection criteria included the IIP-64 
subscales Cold and Nonassertive and the SCL-90-R subscale Interpersonal Sensitivity in the model. 
We then shifted to a predictive discriminant analysis strategy, which emphasizes the 
classification performance of the discriminant model (Sherry, 2006). Variables were added 
individually to the model (Hair, Black, Babin, Anderson, & Tatham, 2006), and the resulting 
classification table was examined to determine whether that variable improved the classification. The 
inclusion of the IIP-64 Vindictive, Socially Inhibited, and Intrusive subscales and the PSY-5 
Aggressiveness scale of the MMPI all improved the classification performance. None of the 
Rorschach indexes improved the discriminant classification. The resulting discriminant function with 
these seven selected variables resulted in an overall correct classification of 71%, with 81% and 65% 
correct classification of the PA patients and the PP patients, respectively. Table 3 summarizes the 
relevant statistics for the discriminant function. Despite the fact that the discriminant function 
accounted for only a small percentage of the total variance between the two groups (14%) and that the 
group centroids were close together, Wilks’s λ = .859, χ2(7, N = 86) = 12.2, p = .09), the classification 
results were reasonable. Conventionally, the discriminant function can be interpreted in two ways 
(Hair et al., 2006; Sherry, 2006). The standardized canonical discriminant function coefficients 
indicate the weight of the unique contribution of each variable in calculating the discriminant function 
score, with Interpersonal Sensitivity (SCL-90-IN), Vindictive (IIP-64-BC), and Cold (IIP-64-DE) 
contributing mostly to the discriminant function. The structure matrix coefficients reflect the pooled 
group correlations between the variables and the discriminant score. These imply that the meaning of 
the discriminant function classification can be understood primarily in terms of the negative 
interpersonal (SCL-90-IN, IIP-64-BC, IIP-64-NO) and aggressive (MMPI-PSY-5-Aggr) measures. 
The other subscales have a lower correlation with the discriminant score. This means that, on average, 
PP patients were characterized by high scores on these variables, whereas the PA patients were 
characterized more by lower scores on these variables. 
 
Table 3. Group means and Statistics of discriminant function analysis predicting correct classifications 
to Psychoanalysis (PA) and Psychoanalytic Psychotherapy (PP) based on selected variables 
 Treatment groups     
 PA PP Structure 
coefficient 
Standardized 
coefficient 
Variables M (SD) M (SD)     
Interpersonal sensitivity (SCL-90-IN) 18.09 (5.09) 21.70 (7.31) .66  .67  
Vindictive (IIP-64-BC) 6.63 (4.91) 8.72 (4.49) .55  .65  
Cold (IIP-64-DE) 10.12 (6.36) 9.05 (6.94) -.19  -.48  
Socially avoidant (IIP-64-FG) 12.84 (6.74) 11.43 (6.65) -.26  -.28  
Nonassertive (IIP-64-HI) 16.44 (5.92) 15.54 (6.78) -.17  -.08  
Intrusive (IIP-64-NO) 8.44 (5.87) 10.17 (5.76) .36  -.16  
Aggressivenes (MMPI-PSY-5-Aggr) 5.06 (2.26) 6.06 (3.07) .43  .20  
Discriminant statistics         
Group centroids -.52  .31      
Eigenvalue .164        
Canonical correlation .38        
Explained variance (%) 14%        
Wilks’ Lambda .859        
Chi-square 12.2        
p-value .09        
 
DISCUSSION 
 
The present study examined differences in mental health characteristics across treatments and across 
studies for patients in two types of long-term ambulatory psychotherapies: PA and PP. The results for 
three of the six instruments (IIP-64, MMPI-2, and Rorschach-CS) seem to strengthen the hypothesis 
that therapists might make use of available research evidence and more often assign avoidant patients 
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to a higher intensity treatment (e.g., Blatt & Shahar, 2004; Fonagy et al., 1996; Holmes, 2001; 
Horowitz et al., 1993). With regard to the IIP, patients assigned to psychoanalysis were found to be 
more socially avoidant, cold, nonassertive, and accommodating than PP patients. These significant 
differences had not been found in two other studies comparing PA and PP patients (Knekt & Lindfors, 
2004; Vaughan et al., 2000). Nonsignificant results in the feasibility study of Vaughan et al. can easily 
be explained by its small sample size (nine PA patients, 15 PP patients) and low recruitment rate in the 
PA group, where only 27% agreed to participate (vs. 83% in the PP group). Why no significant 
differences were found in the Knekt and Lindfors study is a more complicated issue, partly because we 
found that the level of interpersonal problems for our PA and PP patients was comparable to that for 
their patients. Closer inspection of the data showed that the standard deviations of their PA and PP 
samples were somewhat larger than those of our sample of PA and PP patients (0.58 vs. 0.48 and 0.50 
vs. 0.46, respectively), making it harder to find significant group differences. More research is clearly 
needed.  
For the MMPI, two of the relatively new MMPI-2 PSY-5 scales differed significantly between 
PA and PP patients. These scales were added to the MMPI-2 by Harkness and McNulty (2006) to 
measure structural personality characteristics. Interestingly, patients entering psychoanalysis scored 
lower on offensive and instrumental aggression (Aggressiveness) and beliefs disconnected from reality 
(Psychoticism) compared with PP patients. The results on the Psychoticism scale resembled and 
validated those on the Rorschach PTI and are discussed later. A high score on Aggressiveness 
describes persons who may enjoy intimidating others and may use aggression as a tool to accomplish 
goals (Harkness & McNulty, 2006). Theoretically, this might be in contrast to an avoiding and cold 
interpersonal style. Whether the level and type of aggressiveness resemble those of patients 
preoccupied with attachment issues or patients with borderline symptoms needs to be further 
examined. For instance, in case of preoccupied patients, Blatt and Shahar (2004) have shown that they 
indeed have higher improvement rates in a lower intensity treatment such as psychoanalytic 
psychotherapy compared with psychoanalysis. However, in the case of borderline symptoms, a 
mentalization-based intensive outpatient treatment might be a better option (Bateman & Fonagy, 2006, 
p. 43). 
The Rorschach results showed that PA and PP patients differed on two variables: the PTI and 
the avoidant emotional coping style. The PTI indicates that a person experiences problems in 
information processing, reality testing, or thinking. Conceptually, it might be related to the MMPI-2 
PSY-5 scale of Psychoticism, although the present study did not find a significant correlation between 
the two constructs. The PTI is a revision of what has been called the Schizophrenia Index (Exner, 
2003). We found that PA patients had fewer perceptual thinking problems than PP patients. These 
findings might relate to the Psychoanalytic Peer Review guidelines that state that analyzability 
includes ‘‘adequate ability to communicate through speech; accessible fantasy life [and] adequate 
capacity for introspection, including the ability to alternately experience and observe’’ (American 
Psychiatric Association, 1976, p. 50). On these grounds, PP patients might have been considered less 
analyzable (i.e., less suitable for psychoanalysis). In line with the IIP findings, more PA patients were 
found to fall into the group characterized by an avoidant emotional coping style compared with PP 
patients. The Rorschach assesses this style at a much less conscious level compared with the self-
report IIP.  
A predictive discriminant analysis was performed to determine the degree to which the 
patients could be classified correctly into the treatment groups, thereby modeling the therapists’ 
decision-making process. The distribution of the variables indicated a great deal of overlap in the 
regions defining the PA and PP patients. Whereas there was a region of the variable space that 
uniquely defined the PP patients, the region defining the PA patients was an island within this larger 
region. To elaborate, the PP patients seemed to be characterized by a higher degree of aggressiveness, 
as indicated by the relevant IIP subscale scores and the MMPI PSY-5 scale. When the Rorschach 
variables were included, this improved the PA classification only at the cost of a corresponding loss of 
accuracy in the classification of the PP patients. When all else was equal, the scores on the Rorschach 
variables determined whether the patient was placed in either the PA category or the PP category. This 
implies that decision making based on the results of the instruments might involve a trade-off between 
clinical severity indicated by the Rorschach and the degree of amenability to type of treatment, such as 
low aggressiveness and a more avoidant style, as indicated by the other scales. Using a discriminant 
 40 
analysis procedure to examine the decision-making process of the therapists has its own shortcomings. 
Primarily, it was limited to only the quantified variables that forced a solution to the best linear 
combination of those variables. The decision process used by therapists is probably based neither on a 
linear-additive procedure nor solely on these variables. These shortcomings notwithstanding, the 
results did show the existence of a separate classification dimension as well as a relatively large gray 
area of overlap between PA and PP patients. 
Mostly, nonsignificant findings between both patient groups on the clinical indicators of the 
six instruments outnumbered the differences. Before treatment, psychoanalytic patients reported 
similar levels of general psychopathology, depression, anxiety, and personality problems. Patients in 
the Netherlands had similar levels of mental health problems as psychoanalytic patients in most other 
studies, although not always in similar health areas. Several explanations for this lack of differences 
were considered. First, it is possible that the instruments were not sensitive enough to detect more 
relevant differences between PA and PP patients. By design, symptom questionnaires mostly detect 
whether a patient is in the clinical range or not (i.e., the possibility of a ceiling effect is, therefore, 
considerable). However, results with the personality instruments were mostly comparable and, 
therefore, did not support the lack of sensitivity assumption. Second, the group of PP patients might 
consist of patients with more extreme scores, both lower and higher, as suggested by Doidge et al. 
(2002). In that case, the use of group results (group average) in PP patients might be misleading, and 
two PP groups should be distinguished. Further investigation of the test scores showed that there was 
no reason to assume that variances were not equal between the two patient groups. Based on these 
results, it might be concluded that future effectiveness studies do not need to control for the majority 
of the investigated mental health characteristics when analyzing the outcome of treatment but that 
interpersonal differences (e.g., aggressiveness and avoidance) should be taken into account. 
Several limitations of the present study should be noted. First, this study used an intention-to-
treat model and, therefore, is not generalizable to a model aimed to predict whether patients actually 
enter treatment. Second, we did not compare findings with patients in other types of treatment. Our 
main goal was a comparison between both types of expensive psychotherapy treatment, because it had 
not been done in a relatively large sample. However, the present study makes it possible for other 
researchers to compare the results with those of other treatments. Third, no results were available on 
outcome of treatment. In future studies, we will try to determine whether the assignment to treatment 
was actually effective and helpful. Finally, although the IIP-64 and Rorschach EB-style data support 
the assumption that more avoidant patients are assigned to psychoanalysis, the major confirmation has 
to be provided by the gold standard of attachment representations: the Adult Attachment Interview. 
Because of the costly and time-consuming administration procedures, these data were not available for 
the current data set. 
Nevertheless, therapists did seem to make distinctions among patients in a theoretical and 
empirically plausible manner that was made visible by the six instruments. Whether these distinctions 
will be related to treatment outcome (e.g., Blatt & Shahar, 2004; Fonagy et al., 1996) is a matter of 
further research. In spite of the limitations, the results support earlier findings (e.g., Doidge, Simons, 
Gillies, & Ruskin, 1994) that patients applying for psychoanalytic treatment have high and comparable 
rates of mental health problems. 
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ABSTRACT 
 
The effectiveness of long-term psychoanalytic treatment was studied with patients in four cohorts (N = 
231) using symptom measures (SCL-90, BDI-II, STAI) and personality assessment instruments (IIP-
64, MMPI-2). Long-term psychoanalytic treatment was highly effective in reducing general distress (d 
= 1.19 – 1.27) and moderately effective in improving personality functioning (d = 0.52 – 0.79). These 
effects became apparent at treatment termination and at two-year follow-up. Effect sizes for 
psychoanalysis and psychoanalytic psychotherapy were fairly comparable, with a slight advantage for 
psychoanalysis. In general, we found that the effect of psychoanalytic treatment in reducing symptoms 
and improving personality functioning was significantly larger compared to the average control group 
effect. Gender moderated treatment outcome, in that women had better treatment outcome with regard 
to disadaptation and disorganization compared to men, in particular after psychoanalysis. Although the 
cohorts were comparable on pre-treatment variables, caution is necessary with regard to making causal 
inferences. 
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INTRODUCTION 
 
Both psychoanalytic psychotherapy and psychoanalysis are particular forms of long-term ambulatory 
psychotherapy. Questions about the effectiveness of both forms of long-term treatment have been 
justly raised because convincing research on its outcome has been lacking (e.g., Doidge, 1997; 
Fonagy, Roth, & Higgitt, 2005; Health Council of the Netherlands, 2001). The long duration and 
complexity of the treatments give rise to specific methodological, practical, and ethical issues in this 
type of research (Fonagy, 2002; Sandell, Blomberg, & Lazar, 1997; Seligman, 1995). After a review 
of evidence from both efficacy and effectiveness studies Gabbard, Gunderson, and Fonagy (2002, p. 
505) concluded that: “preliminary evidence suggests that psychoanalysis appears to be consistently 
helpful to patients with milder disorders and somewhat helpful to those with more severe 
disturbances”. A recent meta-analysis by Leichsenring and Rabung (2008) gave a thorough overview 
of outcome studies for long-term psychodynamic psychotherapy (LTPP, average treatment duration = 
94.8 weeks). Of the 23 studies included in the meta-analysis, the majority focused solely on the 
effectiveness of psychoanalytic psychotherapy while very few studies also included a psychoanalysis 
group. Moreover, in the studies where the effectiveness of psychoanalysis was investigated the sample 
sizes were generally rather small. Leichsenring and Rabung (2008) reported significantly higher 
outcomes in overall effectiveness, target problems, and personality functioning compared to shorter 
forms of psychotherapy. LTPP yielded large and stable effect sizes in the treatment of patients with 
personality disorders, multiple mental disorders, and chronic mental disorders (range 0.78 – 1.98). 
They did not find significant correlations of LTPP outcome with specific patient characteristics (e.g., 
age, gender, diagnostic group), therapist variables (e.g., years of clinical experience) or treatment 
duration. Results from the multiple-cohort study of Sandell et al. (2000) and Blomberg, Lazar, and 
Sandell (2001) showed that patients in psychoanalysis and psychoanalytic psychotherapy had similar 
outcome at treatment termination, but differed at follow-up with patients who had received 
psychoanalysis to further improve with regard to symptom distress. Furthermore, they found that 
patients with female therapists had significantly better treatment outcomes than patients with male 
therapists, irrespective of patient gender and treatment type (Sandell et al., 2000). Although 
considerable evidence about the effectiveness of psychoanalytic psychotherapy is available, more 
research is needed with regard to psychoanalysis and potential moderators or predictors of outcome in 
long-term psychoanalytic treatment.  
Long-term psychoanalytic treatment primarily aims for structural change in personality 
functioning, and often considers a decrease in the level of symptoms and complaints a logical side 
effect of the intervention (Blatt & Auerbach, 2003; Gabbard, 2005; Galatzer-Levy, Bachrach, 
Skolnikoff, & Waldron, 2000). Chronic interpersonal difficulties and problems with self-identity are 
two major areas of personality dysfunctioning (Clarkin, 2006; Livesley, 2001). Changing the 
individual’s dysfunctional internal working models (of self and others) is the focus of many 
psychotherapeutic interventions, whether based on theories of object relations, cognition, attachment, 
or otherwise (e.g., Blatt, 1995; Gurtman, 1996; Holmes, 2001). Clinical characteristics of 
dysfunctional internal working models are chronic immaturity in judgments of emotional 
relationships, difficulties in the commitment to intimate relations and work, and disturbances in sexual 
and love life (Clarkin, 2006). A recent study showed that complex emotional problems, chronic 
depressive symptoms, interpersonal difficulties, and other personality problems were distinctive of 
patients assigned to long-term psychoanalytic treatment (Zevalkink & Berghout, 2008). Because 
improved personality functioning is a major goal, research on the effectiveness of long-term 
psychotherapeutic treatments should pay particular attention to personality assessment. Often, even in 
long-term treatment, the effect of treatment on personality functioning is assessed mainly with short 
questionnaires (for a review see: de Maat, de Jonghe, Schoevers, & Dekker, 2009). Because of the 
complexity and diversity of psychopathology in this particular patient population it is wise to use 
multiple instruments to measure treatment outcome (Hill & Lambert, 2004). Also, differences between 
psychoanalysis and psychoanalytic psychotherapy might be expected. For instance, Grande et al. 
(2006) found that treatment type moderated outcome, in that patients who received psychoanalysis 
improved more with respect to interpersonal problems than patients who received psychoanalytic 
psychotherapy. In the present study, we investigate whether long-term psychoanalytic treatment is 
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effective in improving personality functioning, using both screening questionnaires and instruments 
aimed to measure structural personality functioning. 
Personality functioning can be defined in several ways depending on the theoretical 
framework (Livesley, 2001; Stone, 1993). For this study, we choose a pragmatic route and report the 
results of two widely used instruments aimed to assess personality functioning. The first instrument is 
the Minnesota Multiphasic Personality Inventory (MMPI; Hathaway & McKinley, 1943). The original 
version of the MMPI did not appear to be useful as an outcome measure (e.g., Smith & Glass, 1977; 
Hollon & Mandell, 1979). It is therefore no surprise that the revised version (MMPI-2; Butcher, 
Dahlstrom, Graham, Tellegen, & Kaemmer, 1989) was not popular in outcome research (Gordon, 
2001). However, a study by Gordon showed that the MMPI-2 was sensitive in detecting structural 
change during and after long-term psychoanalytic psychotherapy. Repeated measurements showed 
that scores on MMPI-scales did not change quickly (< 2 years), but in the long run (> 3 years) the 
scores on all but one clinical scale significantly improved. Gordon (2001) concluded that the MMPI-2 
is a useful outcome measure for long-term treatments, but not for short-term treatments. As a second 
instrument, we used the Inventory of Interpersonal Problems (IIP-64; Horowitz, Alden, Wiggins, & 
Pincus, 2000). Previous research into psychoanalytic treatment has often treated this short 
questionnaire as a personality measure (for a review: de Maat et al., 2009). Interpersonal problems are 
among the most frequent complaints that patients bring into psychotherapy (e.g., Haase et al., 2008; 
Horowitz, 2004; Monsen, Odland, Faugli, Daae, & Eilertsen, 1995). Interpersonal problems can be 
defined as inadequate or inappropriate interpersonal communication consisting of rigid, constricted, 
and/or extreme patterns of interpersonal behaviors (Kiesler as cited in Livesley, 2001). The literature 
reveals that some types of interpersonal problems improve more readily than others. For example, 
problems related to a dependent personality style (nonassertive) were more likely to improve in a short 
dynamic psychotherapy than problems related to antisocial (cold, vindictive) behavior (Horowitz, 
Rosenberg, & Bartholomew, 1993).  
Although the above-mentioned studies give support for the overall effectiveness of long-term 
psychoanalytic treatment, few studies have examined patients in psychoanalysis and they also have 
seldom included the MMPI-2 to assess personality functioning. The present study investigates the 
effectiveness of long-term psychoanalytic psychotherapy and psychoanalysis with a multiple-cohort 
design and multiple methods for measuring symptomatic distress and personality functioning. We first 
compared four cohorts of patients in different stages of psychoanalytic treatment (pre, during, post and 
follow-up) on each of the separate instruments or scales. Next, we compared pre–post and pre–follow-
up effect sizes separately for patients in psychoanalysis and psychoanalytic psychotherapy. We then 
performed factor analysis in order to reduce the number of outcome variables and calculated effect 
sizes of these outcome factors. These effect sizes were compared to the average control group effect as 
reported by Leichsenring and Rabung (2006) in a review of 26 psychotherapy studies. Finally, we 
investigated potential predictors of treatment outcome such as socio-demographic characteristics, 
treatment duration, and pre-treatment diagnostic classifications.  
 
METHOD 
 
Sample 
The total sample consisted of 231 participants from four mental health care organizations (Nederlands 
Psychoanalytisch Instituut, De Gelderse Roos, Mediant, Parnassia/Psy-Q) with 93 persons in 
psychoanalysis (PA) and 138 persons in psychoanalytic psychotherapy (PP). In this study we used a 
quasi-experimental, cross-sectional design with four cohorts differing in phase of treatment (pre, 
during, post, follow-up) in order to obtain information about the effects of long-term treatments within 
a relatively short period of time. Cohort studies provide the best available evidence when randomized 
controlled trials (RCTs) are not feasible (de Maat, Dekker, Schoevers, & de Jonghe, 2007). The four 
cohorts were representative samples of patients who followed a naturalistic route through the mental 
health clinic to ensure high external validity and generalizabilty of the findings (Leichsenring, 2004; 
Seligman, 1995; for a more extensive description of the methodology, cf. Zevalkink & Berghout, 
2006). Cohort 1 (PA: n = 25; PP: n = 39) consisted of patients who were about to start long-term 
psychoanalytic treatment; cohort 2 (PA: n = 15; PP: n = 34) of patients who were one year in 
treatment; cohort 3 (PA: n = 31; PP: n = 36) consisted of participants who had just finished long-term 
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psychoanalytic treatment (approximately 3 months after treatment termination); and participants in 
cohort 4 (PA: n = 22; PP: n = 29) had already finished their treatment two years ago (follow-up). Chi-
square analyses and ANOVAs revealed no significant pre-treatment differences between patients in 
PA and patients in PP for sociodemographic and diagnostic variables (age, treatment history, living 
situation, cultural background, educational level, employment status, DSM-IV diagnosis), except for 
gender distribution with more women in PP compared to PA (see Table 1).  
 
Table 1. Pre-treatment Characteristics of Participants in Psychoanalysis (PA) and Psychoanalytic 
Psychotherapy (PP) 
 PA PP  
Age, years: M (SD) 33.0 (7.7) 32.6 (8.1)  
Gender    
Female 61% 80% ** 
Received previous treatment 80% 74%  
Education level    
Middle 22% 26%  
Higher 78% 74%  
Western cultural background 91% 93%  
Living with partner 47% 42%  
Living with children 23% 19%  
Employed 83% 76%  
DSM-IV diagnoses    
Axis I diagnosis 99% 100%  
Axis II diagnosis 73% 73%  
GAF: M (SD) 64.6 (7.3) 62.7 (8.0)  
Note. n PA = 93, n PP= 138. 
** p < .01. 
 
The comparability of the four cohorts was investigated in two ways. First, in the total sample 
we examined pretreatment differences between cohorts with regard to sociodemographic patient 
characteristics, treatment assignment, and psychiatric diagnoses in order to be able to control for 
potential confounding pre-treatment differences (Bickman & Rog, 1998). Second, in a random 
subsample we investigated whether the four cohorts had experienced similar processes with regard to 
treatment assignment over time and mental health clinic with the aid of three independent clinicians 
who retrospectively assessed the pre-treatment GAF and treatment assignment (PP versus PA) from 
patient files in which all information regarding cohort status, mental health organization, pre-treatment 
psychiatric classification, and treatment assignment was removed and edited in a similar format. In the 
total sample, chi-square analyses and ANOVAs revealed no significant differences (p < .05) between 
the four cohorts on pre-treatment sociodemographic patient characteristics (gender, treatment history, 
living situation, cultural background, educational level, employment status), except for age at intake. 
Subjects in cohort 3 were younger at the start of treatment compared to subjects in the other cohorts, 
F(3, 230) = 3.68, p < .05. There were no significant differences across cohorts regarding the PA/PP 
distribution. Chi-square analyses on the frequencies of pre-treatment DSM-IV-R Axis I diagnoses did 
not reveal significant differences between the four cohorts. Almost all patients were diagnosed with at 
least one Axis I disorder. Most frequent diagnoses before treatment were mood disorders (47%), in 
particular dysthymic disorder (30%). Frequencies of Axis II diagnoses were comparable across 
cohorts except for the category ‘no personality disorder’ that was more often assigned to patients in 
cohort 3 and 4, χ2(3, N = 229) = 16.86, p < .01. Further, pre-treatment GAF scores of participants in 
cohort 4 were significantly higher compared to the other three cohorts, F(3, 226) = 6.72, p < .001. In 
recent years, it has become customary to estimate the GAF score lower in light of the threat of budget 
cuts (see also Doidge et al., 2002). An additional study in the subsample (n = 58) confirmed that it was 
a temporally influenced structural adjustment of the GAF score instead of a selection bias. 
Furthermore, the results from this subsample showed that clinical decision making did not change 
significantly over time (cohorts) nor differed across the four mental health organizations after the 
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treatment assignment was redone by experienced clinicians in 25% of the sample. In the statistical 
analyses reported below, we used age, presence of Axis II disorder, and GAF score as covariates.  
 
Treatments 
Both psychoanalytic psychotherapy and psychoanalysis are open-ended long-term psychotherapeutic 
treatments, defined as consisting of at least 25 sessions or lasting more than one year. These 
psychoanalytic treatments have been described in textbooks (e.g., Gabbard, 2005, 2009; Greenson, 
1967; Person, Cooper, & Gabbard, 2005; Wallerstein, 1995). Efforts have been made to manualize 
psychoanalytic treatment, but so far this work has been complicated by the relative long duration of 
the treatment and the complexity of the technique. In general, psychoanalytic treatments share some 
common theoretical assumptions and intend to influence the working of unconscious processes by 
either focusing on conflicts, object relations, the self, and/ or interactional processes (Gabbard, 2005). 
These long-term psychoanalytic treatments are covered by national health insurance in the Netherlands 
with a per session contribution of €15 for the patient. Psychoanalysis (PA) differs from psychoanalytic 
psychotherapy (PP) in that patients in psychoanalysis receive three or more sessions per week lying on 
the couch, while patients in psychoanalytic psychotherapy sit face-to-face and the frequency typically 
is one or two times a week. Treatment assignment is based on therapeutic judgments about patients’ 
ego strength, affect tolerance, capacity for reflection and insight, but also on practical considerations 
such as distance to the treatment facility, patient motivation and availability of therapists. The average 
length of treatment was 6.5 years for PA (SD = 2.7 yrs.) and 3.9 years for PP (SD = 2.5 yrs.). As could 
be expected, these treatment durations differed significantly, F(1, 117) = 29.0, p <.001. All therapists 
(N = 94) in the project were licensed clinicians (psychiatrists/ psychotherapists or psychologists/ 
psychotherapists) and member of one of the Netherlands psychoanalytic societies. Exactly 50% of the 
therapists (n = 47) had only one patient participating in the project. The mean age of the therapists was 
53.5 years (SD = 7.8), and the average amount of therapeutic experience was 24.0 years (SD = 9.5). 
 
Measures 
In line with methodological recommendations, we used multiple data collection methods to enhance 
validity (Bickman & Rog, 1998; Hill & Lambert, 2004). For this project, three symptom 
questionnaires (SCL-90-R, BDI-II, STAI) and two personality instruments (MMPI-2, IIP-64) were 
selected.  
Symptom questionnaires. The Symptom Checklist – 90 – Revised (SCL-90-R) measures 
symptoms in nine major areas of the patient’s psychological, somatic, and interpersonal functioning. 
The 90 items are scored on a 5-point Likert scale (Derogatis, 1983). In the Netherlands, norms and 
translations were developed by Arrindell and Ettema (2003). The 21-item Beck Depression Inventory- 
II (BDI-II) measures depressive symptoms, scored on a 4-point Likert scale (Beck, Steer, & Brown, 
1996). In the Netherlands, Van der Does (2002) translated the BDI-II and developed norm scores. The 
40-item State-Trait Anxiety Inventory (STAI) assesses state and trait anxiety, scored on a 4-point 
Likert scale (Spielberger, 1983). State anxiety reflects a momentary anxiety, and trait anxiety refers to 
a general tendency to respond with anxiety to perceived threats in the environment. The STAI was 
published in the Netherlands and norm scores were developed by Van der Ploeg (2000). For each of 
the questionnaires we only used the total or overall sum scores.  
Personality assessment. The Inventory of Interpersonal Problems – 64 (IIP-64) consists of 64 
items, scored on a 5-point Likert scale, that assess perceived interpersonal difficulties on eight 
subscales (Horowitz et al., 2000). Norms of the Dutch version of the IIP-64 were developed by 
Zevalkink, Katzko, Berghout, and Riksen-Walraven (2008). The Minnesota Multiphasic Personality 
Inventory – 2 (MMPI-2, Butcher et al., 1989), a 567-item self-report questionnaire, aims to 
quantitatively measure an individual’s level of emotional adjustment and attitude toward test taking, 
resulting in clusters of personality variables (Groth-Marnat, 1997). In concordance with other research 
on the MMPI-2 we did not use scale 5-Masculinity-Femininity (Mf), because this scale is usually not 
considered as a clinical scale that measures psychopathology (e.g., Nieberding et al., 2003; Terlidou et 
al., 2004). The nine clinical scales were: 1-Hypochondriasis; 2-Depression; 3-Hysteria; 4-
Psychopathic deviate; 6-Paranoia; 7-Psychasthenia; 8-Schizophrenia; 9-Mania; and 0-Social 
introversion. Besides these nine scales, we also examined the relatively new PSY-5 scales: 
Aggressiveness, Psychoticism, Disconstraint, Negative Emotionality, and Introversion (Harkness & 
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McNulty, 2006). Derksen, de Mey, Sloore, and Hellenbosch (2006) translated the MMPI-2 and 
developed norm scores for use in the Netherlands. In accordance with MMPI-2 research protocol 
(Derksen et al., 2006) we checked for invalid profiles (VRIN or TRIN > 80). We identified two 
patients who had a TRIN > 80, who were consequently excluded from further MMPI-2 analyses. 
Pearson correlation analyses between the personality instruments and the symptom questionnaires 
revealed that correlations coefficients were between .01 and .64, with the highest correlation between 
the MMPI-2 Depression scale and the STAI Trait anxiety score. Correlation coefficients between the 
IIP-64 and the MMPI-2 were between .02 and .57, with the highest correlation between the IIP-64 
total score and the MMPI-2 Social Introversion scale. 
 
Procedure 
Inclusion criteria for participation were a minimum age of 18 years, having mastery of the Dutch 
language, assignment to long-term psychoanalytic treatment (> 25 sessions or > 1 year, with a 
minimum frequency of once a week). Exclusion criteria were the presence of (acute) psychotic 
symptoms. All patients who met the inclusion criteria were approached via mail. In total we 
approached 383 persons, of whom 247 (65%) accepted, 81 (21%) declined, and 55 (14%) never 
responded. The response rate in cohort 4 differed significantly from that in the other cohorts, which 
was due to a higher percentage of non-responders, χ2(6, N = 383) = 13.02, p < .05. In this group, home 
addresses and telephone numbers appeared no longer up-to-date. A flow chart is shown in Figure 1. Of 
the 247 persons who agreed to participate and signed the informed consent, 16 eventually did not 
participate in the study due to various reasons (withdrawal from the study, never started the 
psychoanalytic treatment). The 16 drop-outs did not differ significantly on pre-treatment 
sociodemographic and diagnostic characteristics (gender, age, treatment history, living situation, 
cultural background, educational level, employment status, DSM-IV Axis I, II, and V diagnoses) from 
the 231 participants. 
When subjects returned a positive informed consent, they were phoned to make an 
appointment for the personality assessment (MMPI-2). Within two weeks, they received the 
questionnaires by regular mail, including a stamped addressed envelope. Data gathering was done in 
the period of January 2004 to June 2007. The personality assessments were conducted by clinicians or 
research assistants trained in psychodiagnostics. All subjects could indicate whether or not they liked 
to receive written personal feedback about their health status, to which 99% reacted positively. DSM-
IV diagnoses were based on clinical judgment and assessed during a consensus meeting of at least one 
psychiatrist, one or two experienced psychotherapists and a test-psychologist at the start of treatment. 
During the consensus meeting, input consisted of written reports of each of the previous meetings 
(average four) between clinicians (average two) and patient, results of questionnaires, and other 
psychodiagnostic material. This method approaches the LEAD standard as proposed by Spitzer 
(1983). 
 
Data analyses 
After replacing missing values (4.8%) by the mean group average of the corresponding cohort, we 
performed univariate ANCOVAs to investigate general differences between patients in each cohort on 
the raw data from all outcome measures and corrected for age, presence of DSM-IV Axis II disorder, 
and GAF score. To provide standardized estimations of effect sizes, we used Cohen’s d. When 
Cohen’s d exceeds 0.20, 0.50 and 0.80, it represents small, moderate and large effect sizes 
respectively. Because we used multiple instruments that consist of several subscales we combined 
these scales into composite scores or factors. This facilitates data examination and improves power of 
the statistical analyses (Hill & Lambert, 2004). To reduce the number of outcome variables, we 
performed factor analysis (Principal Components Analysis) to identify the specific areas in which 
improvement was achieved. To investigate the effectiveness of the psychoanalytic treatment in 
relation to no treatment, we compared psychoanalytic treatment outcome with the average control 
group effect as reported in a review by Leichsenring and Rabung (2006). These researchers 
systematically studied the changes that occurred in psychiatric patients (26 studies, N = 740) who did 
not receive long-term psychotherapeutic treatment (untreated control groups and treatments as usual) 
and found a mean effect size of 0.12 (95% confidence interval [CI] = 0.05 – 0.28). The effects 
occurring in the control conditions were independent of the duration of the wait or TAU condition 
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Figure 1. Patient Flow Chart 
 
 
Eligible subjects (n = 383) 
Responded to information letter (n = 328) 
Non-responders (n = 55) 
Agreed to participate (n = 247) 
Refusal (n = 81) 
Subjects assessed (n = 231) 
Withdrawal from study (n = 16) 
Cohort 2 (n = 49) Cohort 3 (n = 67) 
Sample losses 
Cohort 4 (n = 51) Cohort 1 (n = 64) 
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(Leichsenring & Rabung, 2006). The prevalence of psychiatric diagnoses reported in this review was 
similar to that of the patients in the current study sample. Finally, as explorative analyses we 
performed multivariate path analyses to investigate which variables were the best predictors of 
treatment outcome. For this purpose, we used General Linear Modeling (GLM) which allows for 
simultaneous linear transformations or linear combinations of multiple dependent variables. With 
GLM one can analyze both categorical (e.g., gender) and continuous (e.g., age) predictor variables. 
For the categorical variables, we used sigma-restricted parameterization which facilitates 
interpretation of the regression coefficient associated with the predictor variable (Cardinal & Aitken, 
2006). The analyses were done on participants who had already finished their treatments (cohorts 3 
and 4). In the GLM, full Bonferroni correction was used to adjust the alpha level. 
 
RESULTS 
 
ANCOVAs and effect sizes 
Univariate ANCOVAs on the raw data of the symptom questionnaires showed significant differences 
between the cohorts on all total scores after correcting for the following covariates: pre-treatment age, 
presence of DSM-IV Axis II disorder, and GAF score (Table 2). Patients before and during treatment 
(cohort 1 and 2) had significantly higher scores compared to participants at the end of treatment or two 
years later (cohort 3 and 4). Large effect sizes were found comparing the two groups after treatment to 
the group of patients before treatment. Patients who were one year in treatment did not notably differ 
from those before treatment.  
 Univariate ANCOVAs on the personality instruments also revealed significant differences 
between the cohorts. The IIP-64 showed a similar pattern to that of the symptom questionnaires 
described above. The MMPI-2 provided significant results for five of the nine clinical scales 
(Depression [scale 2], Psychopathic deviate [scale 4], Psychasthenia [scale 7], Schizophrenia [scale 8], 
Social introversion [scale 0]) and two of the five PSY-5 scales (Negative emotionality, Introversion) 
with scores being higher before treatment compared to after treatment. The results of the clinical 
scales showed that the presence and depth of depressive pathology (scale 2) had decreased 
significantly after long-term psychoanalytic treatment, as well as the level of social maladjustment and 
feelings of alienation (scale 4 and 8), and the level of (social) anxiety and self-doubt (scale 7 and 0). 
The differences between cohorts were always in the predicted direction, i.e. improved personality 
functioning after treatment (Table 2). The effect sizes for the IIP and the five MMPI-2 clinical scales 
were moderate to large. Effect sizes for patients one year in treatment differed from those before 
treatment across the range of negative to non-existent, with the exception of Psychopathic deviate for 
which a small effect size was found. 
For the comparison of effect sizes for psychoanalysis and psychoanalytic psychotherapy 
separately, we focused on the scales with significant cohort differences in the total sample. Table 3 
shows that effect sizes ranged from moderate to large, with the exception of introversion for which 
small effect sizes were found after psychoanalytic psychotherapy at follow-up. For the three symptom 
questionnaires, the average effect size for psychoanalysis was 1.19 at end of treatment and 1.25 at 
follow-up. For psychoanalytic psychotherapy it was 1.15 and 1.11 respectively. For the eight 
personality scales, we found an average effect size for psychoanalysis of 0.70 after treatment and 0.66 
at follow-up. For psychoanalytic psychotherapy it was 0.69 and 0.48 respectively.  
 
Outcome factors 
We performed factor analyses (Principal Components Analysis with varimax rotation) on the variables 
that showed significant differences between the cohorts. For standardization purposes we transformed 
the scores on the questionnaires to T-scores. These T-scores were calculated using the means and 
standard deviations from the non-clinical reference groups of the different questionnaires. The factor 
analyses were done on the total population as well as on different subgroups within the total sample 
and the determination of the number of extracted factors was based on Eigenvalues (> 1). This 
consistently resulted in a stable 3-factor solution (with a total explained variance of about 76%). We 
identified one general distress factor and two personality factors. Factor scores were computed by 
taking the unweighted average of the variables that define each factor. Internal reliability estimates 
(coefficient alpha) for the three factors were satisfactory: .88, .89, and .81 respectively. 
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Table 2. Means and Standard Deviations of the Scores on the Symptom Questionnaires and Personality Instruments, ANCOVAs and Effect Sizes  
Cohort  Comparison 
Effect size 
1 2 3 4  ANCOVA 1 – 2 1 – 3 1 – 4 
 M (SD) M (SD) M (SD) M (SD)  F  Post-hoc d d d 
SCL-90-R GSI a 0.74 (0.37) 0.73 (0.46) 0.36 (0.37) 0.40 (0.27)  11.7 *** 1, 2 > 3, 4 0.03 1.04 1.04 
BDI-II Total a 15.8 (8.1) 14.5 (10.7) 7.1 (8.6) 6.8 (6.5)  13.3 *** 1, 2 > 3, 4 0.14 1.05 1.21 
STAI Trait a 49.0 (9.3) 48.5 (10.5) 37.4 (8.3) 38.1 (8.1)  23.3 *** 1, 2 > 3, 4 0.05 1.33 1.25 
IIP-64 Total score a 91.3 (30.3) 95.0 (30.5) 61.7 (34.8) 66.8 (34.5)  10.8 *** 1, 2 > 3, 4 - 0.12 0.91 0.76 
MMPI-2 scale b                
1 Hypochondriasis 51.0 (10.1) 54.6 (11.8) 51.5 (8.9) 50.0 (10.7)  1.8   - 0.33 - 0.06 0.09 
2 Depression 59.7 (10.1) 62.2 (14.9) 52.1 (10.7) 53.0 (11.0)  7.5 *** 1, 2 > 3, 4 - 0.20 0.73 0.64 
3 Hysteria 56.8 (11.0) 59.5 (12.3) 55.3 (9.6) 55.3 (11.5)  1.7   - 0.24 0.14 0.13 
4 Psychopathic deviate 66.4 (10.8) 62.0 (9.5) 60.4 (8.4) 59.5 (11.0)  5.4 ** 1 > 2, 3, 4 0.42 0.62 0.63 
6 Paranoia 58.6 (9.5) 60.6 (10.1) 57.7 (8.1) 57.8 (9.9)  1.1   - 0.20 0.10 0.08 
7 Psychasthenia 64.6 (10.1) 65.2 (13.1) 56.7 (8.0) 57.4 (10.7)  6.0 ** 1, 2 > 3, 4 - 0.06 0.87 0.70 
8 Schizophrenia 60.8 (10.2) 63.0 (11.4) 55.8 (8.8) 56.7 (8.9)  3.8 * 1 > 3 
2 > 3, 4 
- 0.20 0.53 0.43 
9 Mania 51.0 (11.2) 50.2 (9.5) 49.2 (9.7) 48.8 (9.5)  0.5   0.08 0.18 0.21 
0 Social introversion 54.6 (10.2) 56.5 (13.2) 48.0 (11.1) 50.1 (11.7)  3.7 * 1 > 3 
2 > 3, 4 
- 0.17 0.62 0.41 
PSY-5 Aggressiveness 44.7 (8.9) 45.6 (7.1) 47.2 (7.6) 46.0 (8.2)  0.7   - 0.10 - 0.30 - 0.15 
PSY-5 Psychoticism 51.5 (11.2) 49.2 (8.1) 47.0 (7.9) 48.9 (8.7)  2.1   0.23 0.46 0.25 
PSY-5 Disconstraint 52.7 (10.1) 51.0 (7.1) 52.1 (9.1) 53.3 (10.6)  0.8   0.18 0.06 - 0.06 
PSY-5 Negative 
emotionality 
56.3 (8.8) 55.2 (9.0) 50.1 (8.8) 52.0 (10.5)  4.4 ** 1 > 3, 4 
2 > 3 
0.13 0.71 0.45 
PSY-5 Introversion 58.3 (11.3) 61.1 (15.5) 53.6 (11.0) 54.6 (11.4)  2.7 * 2 > 3, 4 - 0.22 0.42 0.32 
Note. Cohort 1 = Pre-treatment; Cohort 2 = 1 year during treatment; Cohort 3 = Post-treatment; Cohort 4 = Follow-up 2 years after treatment. We corrected for the following 
covariates: pre-treatment age, presense of DSM-IV Axis II disorder, and GAF score. 
a n cohort1 = 64, n cohort2 = 49, n cohort3 = 67, n cohort4 = 51.  
b n cohort1 = 64, n cohort2 = 49, n cohort3 = 66, n cohort4 = 50. 
* p < .05, ** p < .01, *** p < .001.
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Table 3. Effect sizes (pre–post and pre–follow-up) for Psychoanalysis and Psychoanalytic 
Psychotherapy 
Psychoanalysis 
 Psychoanalytic 
psychotherapy 
pre – post pre – follow-up  pre – post pre – follow-up 
 d d  d d 
SCL-90-R GSI a 1.39 1.25  0.86 0.91 
BDI-II Total a 1.16 1.06  0.95 1.31 
STAI Trait a 1.03 1.44  1.63 1.10 
IIP-64 Total score a 0.88 1.04  0.93 0.55 
MMPI-2 scale b      
2 Depression 0.58 0.73  0.90 0.57 
4 Psychopathic deviate 0.68 0.40  0.58 0.92 
7 Psychasthenia 1.09 0.89  0.71 0.58 
8 Schizophrenia 0.71 0.38  0.37 0.53 
0 Social introversion 0.59 0.66  0.70 0.19 
PSY-5 Negative emotionality 0.51 0.54  0.92 0.38 
PSY-5 Introversion 0.52 0.63  0.41 0.10 
a PA: n pre = 25, n post= 31, n follow-up = 22; PP: n pre= 39, n post= 36, n follow-up = 29. 
b PA: n pre = 25, n post= 31, n follow-up = 22; PP: n pre= 39, n post= 35, n follow-up = 28.  
 
Factor 1 ‘General distress’ is an aggregate measure for symptoms, complaints and general 
discontent (SCL-90-R GSI, BDI-II total, STAI Trait, IIP-64 total and MMPI-2 PSY-5 scale Negative 
emotionality). Factor 2 ‘Introversion’ reflects problems related to inhibition, depression and social 
avoidance (MMPI-2 clinical scales 2, 0 and PSY-5 scale Introversion). Factor 3 ‘Disadaptation and 
disorganization’ reflects disadaptation to society, feelings of estrangement, anxiety and disorganized 
mental states (MMPI-2 clinical scales 4, 7 and 8). We performed ANCOVAs (with correction for pre-
treatment age, presence of DSM-IV Axis II disorder, and GAF score) and calculated the effect sizes 
for these aggregate factors (see Table 4). We found large effect sizes on the general distress factor 
(95% C.I. pre- vs. post-treatment = 0.89 – 1.64, and 95% C.I. pre-treatment vs. follow-up = 0.78 – 
1.58), and moderate to large effect sizes on the two personality factors (Introversion: 95% C.I. pre- vs. 
post-treatment = 0.30 – 1.01, and 95% C.I. pre-treatment vs. follow-up = 0.14 – 0.89; Disadaptation 
and disorganization: 95% C.I. pre- vs. post-treatment = 0.43 – 1.14, and 95% C.I. pre-treatment vs. 
follow-up = 0.32 – 1.08).  
 
Comparisons with average control group effect 
In light of a lack of a study-own control group, we have made a comparison with the mean effect size 
reported by Leichsenring and Rabung (2006) of patients in the control condition (N = 740) of 26 
studies into the effectiveness of psychoanalytic treatment. They reported an average effect for not 
being treated, on a waiting list or receiving TAU of d = 0.12 (95% CI = 0.05 – 0.28). We compared 
this effect with that of effects found in our study on General distress, Introversion, and Disadaptation 
and disorganization at treatment termination. Table 4 shows that the effect of these three factors was 
significantly greater than the average control group effect at treatment termination and follow-up, with 
the exception of Introversion. At follow-up, the confidence interval of the effect on Introversion 
appeared to overlap with that of the average control group effect. This means that the effect of 
treatment on Introversion did not differ from that of the average control group two years after the end 
of treatment.  
 
Predictors of treatment outcomes 
We used the General Linear Model procedure (GLM) to test the relationships between eleven 
predictor variables and three outcome factors. The eleven predictors consisted of seven socio-
demographic characteristics (gender, age, previous treatment, living with partner, living with children, 
educational level, employment status), two diagnostic variables (personality disorders, GAF), and two 
treatment characteristics (duration of treatment, treatment type). Cultural background was not included 
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in the GLM analysis because its distribution was extremely skewed; almost all patients had a western 
cultural background. Table 5 shows the parameter estimates of the predictor variables on the outcome 
factors. In terms of interpreting the partial eta squares for the multivariate analysis, Cohen (1988) 
characterized η2 = .02 as small, η2 = .13 as medium, and η2 = .26 as a large effect size.  
The alpha level was adjusted to .0015 (α = .05 / 33). We found one statistically significant 
effect. Female patients had better treatment outcome with regard to Disadaptation and disorganization 
compared to male patients. The magnitude of this effect was in the small-to-medium range and the 
observed power was .53. Post-hoc ANOVAs showed that there was no significant difference on the 
factor score before treatment between men and women, F(1, 63) = 1.07, p = .31, but after treatment 
the difference was highly significant, F(1, 115) = 14.47, p < .001. Further analyses revealed that this 
moderating effect was particular for patients who had received psychoanalysis. Post-hoc ANOVAs 
showed that within the PA-group women had significantly better treatment outcome compared to men 
on Disadaptation and disorganization, F(1, 52) = 16.00, p < .001. In the PP-group we found no 
significant differences in outcome between men and women.  
 
DISCUSSION 
 
The present study supported previous findings that long-term psychoanalytic treatment was effective 
in reducing symptomatic distress and added some new findings in that it was also moderately effective 
in improving personality functioning, as found with both the MMPI-2 and the IIP-64. Our effect sizes 
were comparable to the findings from recent meta-analyses (Leichsenring & Rabung, 2008; de Maat et 
al., 2009). Effect sizes for psychoanalysis and psychoanalytic psychotherapy were fairly comparable, 
with a slight advantage for psychoanalysis on the separate instruments. The effect of psychoanalytic 
treatment in reducing symptoms and improving personality functioning was significantly larger 
compared to the average control group effect as reported by Leichsenring and Rabung (2006). 
Exploratory analysis revealed that gender moderated treatment outcome, with women having a better 
treatment outcome with regard to disadaptation and disorganization compared to men, in particular 
after psychoanalysis. 
Psychoanalytically trained psychotherapists do not generally regard symptom improvement as 
the most important goal of long-term psychoanalytic treatment. However, the effect sizes we found on 
all of the symptom measures need not be underestimated. Although we did not make direct 
comparisons with short-term treatments, the level of symptom improvement we found was comparable 
to that generally reported in the literature for short-term treatments specifically aimed at symptom 
reduction for less distressed patient populations (see review: de Maat et al., 2009). More importantly, 
after a two-year follow-up period patients functioned at a non-clinical level. This follow-up effect is 
not commonly found after short-term treatments (de Maat, Dekker, Schoevers, & de Jonghe, 2006). In 
line with other outcome studies of long-term psychoanalytic treatment, this study found moderate 
effect sizes for personality changes. In addition to other studies, we not only used a short questionnaire 
like the IIP-64 to assess personality functioning, but we added a comprehensive personality 
assessment instrument (MMPI-2). We consider this a major merit of our study. Several scales of the 
MMPI-2 were sensitive in picking up differences between the cohorts. We found large effect sizes on 
the MMPI-2 clinical scales for Depression (scale 2), Psychopathic deviate (scale 4), Psychasthenia 
(scale 7), Schizophrenia (scale 8) and Social introversion (scale 0). This means that the presence and 
depth of depression (scale 2), the level of social maladjustment and feelings of alienation (scale 4 and 
8), and the high levels of (social) anxiety and self-doubt (scale 7 and 0) that characterize patients who 
apply for psychoanalytic treatment were effectively reduced after long-term treatment, and remained 
stable in the long term. For the remaining four MMPI-2 clinical scales effect sizes were considerably 
smaller or absent. One explanation for this could be that we found that patients were already 
functioning relatively well in these areas before treatment, which automatically limits the potential 
magnitude of the effect sizes. Another explanation could be that these aspects of personality 
functioning were relatively stable and therefore less suitable to monitor change. Our results are in line 
with the findings of Gordon (2001), who also showed large treatment effects on most MMPI-variables, 
but not on all scales.  
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Table 4. Means and Standard Deviations of the Outcome Factors, ANCOVAs and Effect Sizes  
Cohort  Comparison 
Effect size 
1 2 3 4  ANCOVA 1 – 2 1 – 3 1 – 4 
Factor M (SD) M (SD) M (SD) M (SD)  F  Post-hoc d d d 
1. General distress 60.9 (8.0) 60.3 (9.9) 50.4 (8.5) 51.4 (7.9)  18.5 *** 1, 2 > 3, 4 0.07 1.27 1.19 
2. Introversion  57.5 (9.2) 60.0 (13.3) 51.2 (9.9) 52.6 (10.0)  5.5 ** 1 > 3 
2 > 3, 4 
- 0.22 0.66 0.52 
3. Disadaptation and 
disorganization 
63.9 (8.7) 63.4 (9.8) 57.6 (7.1) 57.9 (8.4)  5.9 ** 1, 2 > 3, 4 0.06 0.79 0.71 
Note. Cohort 1 = Pre-treatment; Cohort 2 = 1 year during treatment; Cohort 3 = Post-treatment; Cohort 4 = Follow-up 2 years after treatment. ncohort1 = 64, ncohort2 = 49, ncohort3 
= 66, ncohort4 = 50. We corrected for the following covariates: pre-treatment age, presence of DSM-IV Axis II disorder, and GAF score. 
** p < .01, *** p < .001. 
 
 
Table 5. Parameter Estimates of the Predictor Variables on the Outcome Factors 
General distress  Introversion  Disadaptation and disorganization 
Parameter 
B S.E. t  Partial 
η2 
 B S.E. t  Partial 
η2 
 B S.E. t  Partial 
η2 
(Intercept) 62.58 8.82     50.06 10.75     66.50 8.05    
Gender 0.09 0.99 0.09  .00  1.30 1.21 1.07  .02  3.06 0.91 3.37 * .13 
Age (pre-treatment) -0.01 0.14 -0.04  .00  0.34 0.17 1.98  .05  0.10 0.13 0.75  .01 
Previous treatment 0.53 1.12 0.48  .00  -0.34 1.36 -0.25  .00  0.76 1.02 0.74  .01 
Living with partner -0.43 1.04 -0.41  .00  -0.36 1.27 -0.29  .00  -0.20 0.95 -0.21  .00 
Living with children 0.43 1.40 0.31  .00  -0.35 1.70 -0.21  .00  0.17 1.27 0.13  .00 
Educational level -0.99 1.26 -0.79  .01  -1.19 1.54 -0.77  .01  -0.12 1.15 -0.10  .00 
Employment status 1.00 1.25 0.80  .01  0.11 1.53 0.08  .00  1.04 1.14 0.90  .01 
Personality disorder 1.42 0.90 1.58  .03  1.27 1.10 1.16  .02  1.06 0.82 1.29  .02 
GAF (pre-treatment) -0.19 0.11 -1.76  .04  -0.10 0.13 -0.75  .01  -0.17 0.10 -1.75  .04 
Duration treatment 0.00 0.03 0.04  .00  -0.04 0.04 -0.96  .01  -0.01 0.03 -0.33  .00 
Treatment type -0.90 0.99 -0.91  .01  -0.87 1.20 -0.73  .01  -0.59 0.90 -0.66  .01 
Note. n = 87 with complete data. 
* p < .05 (Bonferroni adjusted). 
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An interesting finding of this study was that the effect sizes of psychoanalysis and 
psychoanalytic psychotherapy were in the same range for the three factors, with the exception of the 
effect size at follow-up for personality problems after psychoanalytic psychotherapy which was lower 
compared to the effect size two years after psychoanalysis. The data seem to suggest that there was no 
significant difference between the effect of psychoanalysis and psychoanalytic psychotherapy. 
Although no significant difference in the level of mental health problems and patient characteristics 
was found before treatment, there are indications that we might be dealing with two different groups 
of patients. First of all, in this naturalistic study the therapists (and patients) decided when to finish the 
treatment. In the psychoanalysis group, this was significantly later than for patients in psychoanalytic 
psychotherapy. This might mean that the therapist decision might be based on having reached a 
satisfactory clinical effect that might be similar in kind but needed a longer period to achieve due to 
the type of problems of these patients. Secondly, the interpersonal problems of patients in 
psychoanalysis did not decrease significantly after the first two years of treatment, whereas more 
significant changes were found after two years of psychoanalytic psychotherapy (Berghout, Zevalkink, 
Katzko, & de Jong, 2009). We have not matched the patients in the two treatment groups on 
personality traits, chronicity of personality problems, motivation or other important indication criteria. 
If we had, we could have made better comparisons between the psychoanalysis and psychoanalytic 
psychotherapy groups. For future research we encourage comparative studies to control for differences 
in patient populations by matching patients on relevant variables or, even better, to use a randomized 
design if this is practically possible.  
The use of the PSY-5 scales is relatively new in outcome research and resulted in some 
interesting findings. The PSY-5 scales are intended to model the domain of disordered personality 
(Friedman, Lewak, Nichols, & Webb, 2001). Our factor analyses revealed that the PSY-5 scale for 
Negative emotionality clustered within the ‘general distress’ factor. Furthermore, the mean pre-
treatment level of distress on this PSY-5 variable was relatively low. Perhaps this scale is less useful 
as an outcome measure for psychoanalytic treatment, or less of a personality variable as originally 
conceived. Our results did provide support for the utility of the PSY-5 Introversion scale as a valuable 
outcome measure. We have found a significant decrease in Introversion at the end of treatment and at 
the two-year follow-up, compared to levels before treatment. Interestingly, in a study by Vendrig, 
Derksen, and de Mey (2000) on chronic-pain treatment, the PSY-5 scales were not used as outcome 
measures but rather as predictors of treatment outcome. Their results showed the PSY-5 Introversion 
scale to be a useful outcome predictor. Interestingly, in our attempt to reduce information by building 
factors of different aspects of therapeutic outcome – as also intended by the PSY-5 scales – we found 
that the IIP-64 and the MMPI-2 PSY-5 scale Negative emotionality clustered within the other 
screening questionnaires into the so-called general distress factor. It appears that the underlying 
personality issues of interpersonal distress and overly focusing on negative aspects also make a person 
report high levels of symptoms and complaints. 
The findings from the outcome factors suggest that long-term psychoanalytic treatment was 
especially effective in improving patients’ abilities to interact, and their adjustment to society. The 
biggest improvements were found in the interpersonal realm, as people became less introverted/ 
avoidant and better able to deal with all kinds of social situations. This suggests that psychoanalytic 
treatments are successful in changing dysfunctional representations of the self and other, and reducing 
patients’ chronic interpersonal difficulties – the essence of personality pathology (Clarkin, 2006). 
These findings are also in line with results of Monsen et al. (1995) who found marked changes in the 
quality of interpersonal relations and a better capacity to establish and maintain intimate relationships 
after long-term psychodynamic psychotherapy.  
The use of multiple cohorts has provided us with two major findings related to the pattern of 
improvement. The first finding was that after one year of treatment the level of symptoms and 
personality problems was roughly comparable to that before treatment. Small (or even negative) effect 
sizes were found for most comparisons between the pre-treatment cohort and the during-treatment 
cohort. In contrast to often found symptom decreases within the first year of (short-term) 
psychotherapy (Howard, Kopta, Krause, & Orlinsky, 1986; Kopta, Howard, Lowry, & Beutler, 1994), 
the current study has shown that in this particular patient population the level of symptoms and 
personality problems did not decrease that rapidly. This particular finding, in addition to the fact that 
77% of the patients had already tried a previous (short-term) treatment, might justify a longer 
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treatment process for this particular group of patients. Patients assigned to psychoanalytic treatment 
appeared to have complex emotional and personality problems, which was in line with previous 
findings in a different sample (Zevalkink & Berghout, 2008). Perhaps the small decrease in symptoms 
and personality problems after one year of treatment is because patients in psychoanalytic treatment 
follow a different (and slower) pattern of change compared to those in short-term therapies. The 
second finding is that treatment results were sustained at a two-year follow-up. Other studies have 
provided strong indications that the results of short-term therapies are more short-lived (de Maat et al., 
2006; Seligman, 1995). In contrast, in our study we found indications that the effects of long-term 
psychoanalytic treatment persist for a longer period of time after treatment termination. An 
explanation might be found in the fact that it reduces the vulnerability to become psychologically 
distressed when facing challenges after treatment in a way that protects from relapse. Several other 
psychoanalytic follow-up/outcome studies have been published on the long-term effects of 
psychoanalysis (e.g., Kantrowitz, Paolitto, Sashin, Solomon, & Katz, 1986; Kantrowitz, Katz, Paolitto, 
Sashin, & Solomon, 1987a; 1987b). These studies showed significant improvements in several areas 
of personality functioning (e.g., quality of object relations, affect modulation, reality testing) at a one-
year follow-up after psychoanalysis. Our study confirms that long-term psychoanalytic treatment is 
helpful in decreasing symptoms and personality problems, and that these psychological changes last at 
least for two years after treatment termination. 
Exploratory analyses revealed that gender was a predictor of treatment outcome with respect 
to one of our outcome factors: the post-treatment level of disadaptation and disorganization was 
significantly lower for females compared to male patients. In particular, psychoanalysis was more 
effective for women than for men, even though we found similar levels of this pathology at the start of 
treatment. Interestingly, proportionately more males had been in psychoanalysis compared to 
psychoanalytic psychotherapy (39% vs. 20%). It appears that clinical levels of disadaptation, feelings 
of estrangement, anxiety and disorganized mental states (MMPI-2 clinical scales 4, 7 and 8) in males 
might be a contraindication for psychoanalysis, whereas men with these problems were effectively 
treated with psychoanalytic psychotherapy. Although these findings might be relevant for treatment 
assignment, they still need to be replicated while also investigating potential mechanisms for 
differential reaction to treatment. It might be that women are more motivated to change and more 
likely to benefit from a more intensive treatment like psychoanalysis (e.g., Cottone, Drucker, & Javier, 
2002). Another reason might be that males and females show different drop-out patterns during 
treatment even though they did not differ before treatment. Furthermore, therapist characteristics 
might play a relevant role as a moderator of treatment effects. More research is needed to find out 
whether this finding might be explained by a different reaction of women to treatment setting, by 
certain treatment characteristics, or whether it is a statistical artifact. Furthermore, we should be 
careful in interpreting differential effects, because the patients in the two treatment groups were not 
randomized or systematically matched.  
The present study has several methodological limitations. First of all, with a cross-sectional 
multiple-cohort design it is not possible to draw causal inferences, because of the lack of longitudinal 
data. Individual changes in patients over time were not tested, only differences between patients on a 
group level (e.g., Galatzer-Levy et al., 2000). Therefore, we have to be careful in drawing conclusions 
about treatment effectiveness from the presented data. However, the study did provide strong 
indications for the effectiveness of such a long-term treatment in a relatively short period of time and 
might inspire other researchers to consider a prospective design in a long-term research project. 
Secondly, no data of actual comparison groups were collected, because long-term treatments do not 
lend themselves easily to be tested in a RCT. This lack of control was dealt with by using reported 
data about the average control group effect as a reference point (Leichsenring & Rabung, 2006). A 
third limitation is that in a multiple-cohort design a potential form of confounding involves differences 
in background characteristics and level of pre-treatment psychopathology between the cohorts, so that 
the comparability of the cohorts might be limited (Cogan & Porcerelli, 2005). One cannot be 
absolutely sure that the patients enrolled in the various cohorts were equivalent in terms of baseline 
psychopathology and background characteristics. It could be that patients with more psychopathology 
might be more apt to drop out of treatment, and in selecting subjects for the two post-treatment 
samples (cohort 3 and 4) we may have included more subjects who were relatively higher functioning 
at the start of treatment compared to the other two cohorts. Despite these critiques, the results of our 
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comparison of the four cohorts on pre-treatment DSM-IV-R diagnoses, socio-demographic 
characteristics and clinical decision-making showed no significant differences on most variables, thus 
providing a strong check for the comparability of the four cohorts. Moreover, in our statistical 
analyses of treatment effectiveness we corrected for those pre-treatment variables that did show 
significant differences between the cohorts. Hence, it is less likely that we are dealing with a sampling 
bias. Another limitation concerns the representativeness of our patient samples. The constellation of 
patients in the various cohorts may, on account of self-selection effects (e.g., drop-outs, non-
attainability of patients), be influenced by unknown factors which go undetected in cohort 
comparisons. Also, it is very well possible that we already had a selective sample before the treatment 
started (e.g., as demonstrated in the level of education). We therefore have to keep in mind that this 
sample is not representative of psychotherapy patients in general. Another limitation of the study is 
that no structured interviews were used to diagnose patients. This could possibly have resulted in an 
underestimation of the prevalence of DSM-IV disorders. A final limitation of the study is the lack of 
manualization of the treatments and monitoring of adherence. The psychoanalytically schooled and 
registered therapists participated in frequent case meetings and often received training and supervision 
for years if not acting as supervisor. This may help to buffer for the lack of manualization and 
adherence issues. Also, we did not test nested models even though 47 of our therapists treated 3.9 
patients on average. Furthermore, it might be that treatment assignment produced different groups of 
patients even though this was not visible in the instruments. Future studies would benefit from 
including therapist characteristics, treatment assignment procedures, and treatment adherence 
measures into the research design.  
Although the present study has some limitations, this study can also be seen as unique with 
regard to the multiple-cohort design and the measures we used to assess the treatment outcome. The 
major merits of this study were the large sample size, the high external validity, the inclusion of large 
group of patients who received psychoanalysis and the comprehensive assessment battery. Long-term 
psychoanalytic treatment appeared to be effective in reducing symptomatic distress and improving 
personality functioning for patients with chronic symptoms of depression and personality pathology. 
These treatment effects were not yet visible after one year of treatment, but more so at the end of 
treatment and at two-year follow-up. Our preliminary findings regarding the interaction between 
patient gender and type of treatment on treatment outcome may also have clinical implications, 
although more research is clearly needed. The presence and depth of depression, the level of social 
maladjustment and feelings of alienation, and the level of (social) anxiety and self-doubt were 
substantially and consistently reduced after long-term psychoanalytic treatment. 
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ABSTRACT 
 
The present study evaluated the clinical significance of long-term psychoanalytic treatment in four 
groups of about 60 patients in different phases of treatment (before, during, after, follow-up) with 
normative comparisons on four symptom questionnaires (SCL-90, BDI-II, STAI, IIP-64) and two 
personality assessment instruments (MMPI-2, Rorschach-CS). In each group, the proportion of 
patients with clinically elevated scores was calculated by comparing their scores with clinical and 
nonclinical reference groups for each instrument. The authors also calculated a combined percentage 
of clinically elevated scores based on the six instruments as a conservative estimate of improvement to 
nonclinical levels after long-term psychoanalytic treatment. Compared to pretreatment levels, the 
authors found a significant decrease in the percentage of clinical cases after treatment. For the 
personality assessment, these results became even more evident at follow-up. It appears that long-term 
psychoanalytic treatment was clinically significant for patients with chronic mental disorders. In the 
discussion, the authors point out that the evaluation of clinical significance at group level should be 
followed by an examination of individual changes over a longer period of time. 
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INTRODUCTION 
 
Nowadays, psychotherapy outcome research does not focus solely on the statistical significance of 
treatment effects, but also on the clinical significance of the results by comparing test scores to 
normative samples. Normative comparisons provide evidence for the clinical significance of 
therapeutic interventions (Kendall & Grove, 1988; Kendall & Norton-Ford, 1982). This approach 
differs from studying treatment outcome using traditional pre- versus post-treatment group mean 
comparisons in the sense that normative comparisons focus on whether or not the end-state 
functioning falls within the normative range on relevant outcome measures (Jacobsen, Follette, & 
Revenstorf, 1984; Kendall, Marrs-Garcia, Nath, & Sheldrick, 1999). This way, one can determine 
whether or not the therapeutic change has made a practical, beneficial impact on the patient’s life. The 
assessment of clinical significance represents an important step forward in the evaluation of treatment 
effects (Kazdin, 1999). 
For patients, therapists, and researchers, returning to normal functioning is probably one of the 
most important aspects of treatment outcome. There are numerous ways to assess clinical significance 
(e.g., Atkins, Bedics, McGlinchey, & Beauchaine, 2005; Bauer, Lambert, & Nielsen, 2004; Jacobsen, 
Roberts, Berns, & McGlinchey, 1999; Ogles, Lunnen, & Bonesteel, 2001; Wise, 2004). Outcome 
studies that assess clinical significance can focus on whether or not test scores of a person fall below 
or above a certain threshold (usually referred to as normative comparisons), and/or focus on the actual 
amount of change (usually referred to as reliable change; Jacobsen & Truax, 1991). In this cross-
sectional multicohort study, we used the first method to assess the clinical significance of long-term 
psychoanalytic treatment. 
Normative comparisons tell us how the patient’s level of functioning after treatment relates to 
that of the “functional” population and/or the “dysfunctional” population (Jacobsen et al., 1984; 
Jacobson & Truax, 1991; Kendall et al., 1999). Assessing reliable change is not possible in a cross-
sectional study due to a lack of outcome data on changes within individuals on all instruments. The 
main research question was whether long-term psychoanalytic treatment is effective in returning 
patients to normal functioning and reducing the number of clinical cases by comparing outcomes with 
data from normative samples. 
Evaluating the clinical significance of two forms of long-term psychoanalytic treatment 
(psychoanalysis and psychoanalytic psychotherapy) is particularly interesting because of the high 
intensity of the clinical input provided. In several countries (e.g., Norway, Belgium, Germany, 
Canada, the Netherlands), governments still provide funding for these two forms of treatment, 
although research into its effectiveness has only recently become more substantial. Recent meta-
analyses point out that psychoanalytic treatment has proven to be an effective treatment for depression 
(Leichsenring, 2001) and personality disorders (Leichsenring & Leibing, 2003). Previous results from 
regular clinical practice had already shown that 91% of the patients presented substantial 
psychopathology, with especially high levels of depressive problems and (anxious) personality 
pathology at onset of long-term psychoanalytic treatment (Berghout & Zevalkink, 2008). 
This was in line with findings from other studies. Patients at onset of psychoanalytic treatment 
were found to score significantly higher on general symptomatology (SCL-90-R), depression (BDI-II), 
anxiety (STAI), and interpersonal problems (IIP-64) compared to nonclinical norm groups, although 
not all patients had clinically elevated scores on all instruments (Finland: Knekt & Lindfors, 2004; 
Germany: Brockmann, Schlüter, Brodbeck, & Eckert, 2002; Leichsenring, Biskup, Kreische, & Staats, 
2005; Pushner, Kraft, & Bauer, 2004; Sweden: Blomberg, Lazar, & Sandell, 2001; Sandell et al., 
2000; US: Vaughan et al., 2000). The next question we asked ourselves was whether or not 
psychoanalytic treatment can reduce this high number of clinical cases. 
From the literature, we learned that several research studies reported on improvement rates 
and reduction in percentage of clinical cases. An early review by Bachrach, Galatzer-Levy, 
Skolnikoff, and Waldron (1991) found improvement rates between 60% and 90% in returning patients 
to normal functioning as reported by clinicians. More recently, Leichsenring et al. (2005) reported that 
about 80% of the patients in psychoanalysis showed clinically significant improvements on 
symptomatic functioning at the end of treatment and at a 1-year follow-up. Sandell et al. (2000) 
assessed the proportion of patients that could be identified as “clinical cases” on the basis of three 
outcome measures in different phases of psychoanalysis and psychoanalytic psychotherapy. For 
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psychoanalysis, 88% of their patients were clinical cases before treatment, with a substantial reduction 
to 33% clinical cases 3 years after treatment termination as measured with a composite measure 
consisting of SCL-90, SAS, and SOCS. 
In the psychoanalytic psychotherapy group, there was a more modest decrease in the 
percentage of clinical cases, from 67% before treatment to 45% three years after treatment termination 
(Sandell et al., 2000). Grande et al. (2006) also studied the clinical significance of psychoanalysis and 
psychoanalytic psychotherapy and found significant results after treatment. For general 
psychopathology (SCL-90-R GSI), they found that 61% of the patients in psychoanalysis and 37% of 
the patients in psychoanalytic psychotherapy had posttreatment scores within the nonclinical range. 
With regard to the level of interpersonal problems (IIP-64 total score), 47% of the patients in 
psychoanalysis and 27% of the patients in psychoanalytic psychotherapy were at nonclinical levels 
after treatment. At follow-up, results were in the same direction, but no longer statistically significant 
(Grande et al., 2006). On the basis of these previous findings, we also expected to find a significant 
reduction in the number of patients with clinically elevated scores after psychoanalytic treatment as 
compared to our pretreatment group, and in particular better results for psychoanalysis than for 
psychoanalytic psychotherapy. 
We examined the clinical effectiveness of long-term psychoanalytic treatment by investigating 
the proportion of patients with clinically elevated scores on four symptom measures and two 
personality assessment instruments in different phases of treatment. Because of the diversity and 
complexity of patients’ problems, it is sensible to use multiple outcome measures for evaluating the 
clinical significance of treatment (Hill & Lambert, 2004). The six instruments assess different areas of 
functioning and thus provide a broad perspective on therapy outcome (Kendall et al., 1999). 
Normative data of functional and dysfunctional populations were available for these instruments and 
were usually reported in the test manuals of the outcome measures. These data provide reliable 
estimates of general and/or clinical population parameters.  
First, scores on the symptom measures and personality assessment instruments were analyzed 
separately. After that we calculated a combined index, which provided a conservative estimate of 
improvement after long-term psychoanalytic treatment based on the six instruments taken together. In 
the assessment of clinical cases, we followed other researchers who had shown that it is possible to use 
statistically defined cutoff values and combine different instruments to come to a global assessment of 
the percentage of clinical cases in a certain patient population (Blomberg et al., 2001; Puschner, Kraft, 
Kächele, & Kordy, 2007; Rudd et al., 1996; Sandell et al., 2000). 
 
METHOD 
 
Subjects 
The total sample consisted of 231 subjects from four mental health care organizations (Nederlands 
Psychoanalytisch Instituut, De Gelderse Roos, Mediant, Parnassia/Psy-Q). The majority of our sample 
(73%) were women. The age range of our subjects ranged from 19 to 68 years, with an average age of 
36 years (SD = 8.4). We found that 77% of all subjects had received previous (psycho-)therapeutic 
treatment before applying for long-term psychoanalytic treatment. Further, we found that 44% of the 
subjects were living with a partner, 21% had children, 92% had a Western cultural background, 76% 
had received higher education, and 79% was unemployed. Most frequently diagnosed DSM-IV Axis I 
disorders were mood disorders (47%), particularly dysthymic disorder (30%). With regard to Axis II 
diagnoses, we found that the majority of the patients (73%) were diagnosed with a personality 
disorder. 
In this study, we used a cross-sectional design with four different cohorts. These cohorts were 
representative samples of patients from different phases of treatment. The subjects were not randomly 
assigned to the cohorts or treatments but followed a naturalistic route through the clinical setting. This 
ensures high external validity and generalizabilty of the findings (Leichsenring, 2004; Seligman, 1995; 
for a more extensive description of the methodology, cf. Zevalkink & Berghout, 2006). The advantage 
of such a research design is that we can obtain information about the effects of long-term treatments 
within a relatively short period of time (de Maat, Dekker, Schoevers, & de Jonghe, 2007; Sandell, 
Blomberg, & Lazar, 1997). By investigating the necessary information on patient characteristics and 
controlling for potential pretreatment differences, we intended to make the four cohorts as equivalent 
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as possible regarding baseline characteristics (Bickman & Rog, 1998). The pretreatment cohort (n = 
64) consisted of patients who had just started long-term psychoanalytic treatment; in the during-
treatment cohort (n = 49) patients were 1 year into treatment; the end-of-treatment cohort (n = 67) 
consisted of persons who had just finished (approximately 3 months after treatment termination) long-
term psychoanalytic treatment; and persons in the follow-up cohort (n = 51) had already finished their 
treatment 2 years ago.  
Inclusion criteria for participation were a minimum age of 18 years, having mastery of the 
Dutch language, and assignment for long-term psychoanalytic treatment (>25 sessions or >1 year, with 
a minimum frequency of once a week). Exclusion criteria were the presence of (acute) psychotic 
symptoms. In each cohort, about 40% of the patients received psychoanalysis (PA) and 60% received 
psychoanalytic psychotherapy (PP). There were no significant differences across cohorts regarding the 
PA/PP distribution. Chi-square analyses and ANOVAs revealed no significant differences between the 
four cohorts on pretreatment (sociodemographic) patient characteristics (sex, treatment history, living 
situation, cultural background, educational level, source of income, DSM-IV Axis I diagnosis), except 
for age at intake and DSM-IV Axis II diagnosis. Subjects in the end-of-treatment cohort appeared to be 
somewhat younger at the start of treatment compared to subjects in the other cohorts (F = 3.68, p < 
.05, maximum difference of 3.2 years). The frequencies of Axis II diagnoses were roughly comparable 
across the four cohorts; however, in the pretreatment and during-treatment cohorts, there were 
significantly more patients with a personality disorder diagnosis at the start of treatment compared to 
the other two cohorts (χ² = 16.86, p < .01). 
 
Treatments 
Both psychoanalytic psychotherapy and psychoanalysis are open-ended long-term psychotherapeutic 
treatments, defined as consisting of 25 sessions or more and lasting more than 1 year. These 
psychoanalytic treatments have been described in textbooks (e.g., Etchegoyen, 1991; Greenson, 1967; 
Luborsky, 1984; Mitchell & Black, 1995; Pine, 1990, 1998; Wallerstein, 1995). Efforts have been 
made to manualize psychoanalytic treatment, but so far this work has been complicated by the relative 
long duration of the treatment and the complexity of the technique. In general, psychoanalytic 
treatments share some common theoretical assumptions and intend to influence the working of 
unconscious processes by either focusing on conflicts, object relations, the self, and/or interactional 
processes (Gabbard, 2005; de Wolf, 2002). Psychoanalysis differs from psychoanalytic psychotherapy 
in that patients in psychoanalysis receive three or more sessions per week lying on the couch, while 
patients in psychoanalytic psychotherapy sit face-to-face and the frequency typically is one or two 
times a week. The average length of treatment was 6.5 years for PA (SD = 2.7 yrs.) and 3.9 years for 
PP (SD = 2.5 yrs.). As could be expected, this difference in treatment duration was significant (F = 
29.0, p <.001). All therapists (N = 94) in the project are licensed clinicians (psychiatrists/ 
psychotherapists or psychologists/ psychotherapists) and members of one of the Netherlands 
psychoanalytic societies. 
 
Measures 
In line with methodological recommendations, we used multiple outcome measures and data 
collection methods to enhance validity (Bickman & Rog, 1998). For this project, four symptom 
measures (SCL-90-R, BDI-II, STAI, IIP-64) and two personality instruments (MMPI-2 and 
Rorschach-CS) were selected. 
Symptom measures. The SCL-90-R measures symptoms in nine major areas of the patient’s 
psychological, somatic, and interpersonal functioning. The 90 items are scored on a 5-point Likert 
scale (Derogatis, 1983). In the Netherlands, norms and translations were developed by Arrindell and 
Ettema (2003). The 21-item BDI-II measures depressive symptoms, scored on a 4-point Likert scale 
(Beck, Steer, & Brown, 1996). In the Netherlands, van der Does (2002) translated the BDI-II and 
developed norm scores. The 40-item STAI assesses state and trait anxiety, scored on a 4-point Likert 
scale (Spielberger, 1983). State anxiety reflects a momentary anxiety, and trait anxiety refers to a 
general tendency to respond with anxiety to perceived threats in the environment. The STAI was 
published in the Netherlands and norm scores were developed by van der Ploeg (2000). The IIP 
consists of 64 items, scored on a 5-point Likert scale, that assess perceived interpersonal difficulties on 
eight subscales (Horowitz, Alden, Wiggins, & Pincus, 2000). Clinical norm scores were derived from 
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Horowitz, Strauss, and Kordy (1994). For each of the questionnaires we used only the total or overall 
sum scores. 
Personality assessment. The MMPI-2 (Butcher, Dahlstrom, Graham, Tellegen & Kaemmer, 
1989), a 567-item self-report questionnaire, aims to quantitatively measure an individual’s level of 
emotional adjustment and attitude toward test taking, resulting in clusters of personality variables 
(Groth-Marnat, 1997). In concordance with other research on the MMPI-2, we did not use scale 5-
Masculinity-Femininity (Mf), because this scale is usually not considered as a clinical scale that 
measures psychopathology (e.g., Nieberding et al., 2003; Terlidou et al., 2004). Derksen, de Mey, 
Sloore, and Hellenbosch (2006) translated the MMPI-2 and developed norms for use in the 
Netherlands. 
The Rorschach inkblot test measures different dimensions of personality functioning and has 
been used as a diagnostic tool and outcome instrument in psychoanalytic treatment for quite some time 
(e.g., Ganellen, 1996; Grønnerød, 2004; Viglione, 1999). It assesses clients’ personality structure, with 
particular emphasis on understanding how they respond to and organize their environment. In this 
way, it can also be considered a measure of perception and association (Weiner, 1998). It consists of a 
set of 10 bilaterally symmetrical inkblots on sturdy cards. Three psychologists with extensive training 
and experience in the Comprehensive System (CS) scored the Rorschach (Exner, 2001, 2003). A 
number of variables were selected that were found to be important in assessing differences as a result 
of psychotherapeutic treatment. 
We selected eight variables of the CS (the six Special Indices, EII-2, AdjD) because those are 
assumed to be global measures of personality functioning. Based on age and sex-differentiated norms 
of clinical and nonclinical reference groups, the CS produces aggregate scores on six Special Indices: 
Perceptual-Thinking (PTI), Depression (DEPI), Coping Deficit (CDI), Suicide Constellation (SCON), 
Hypervigilance (HVI), and Obsessive Style (OBS). The Ego Impairment Index (EII-2) is a relatively 
new Rorschach composite and measures psychological impairment and thought disturbance (Viglione, 
Perry, & Meyer, 2003). The Adjusted D score (AdjD) score gives an indication of whether a person 
typically has adequate resources to manage problems. Norm scores for the Rorschach-CS were derived 
from Exner (2001). 
 
Procedure 
All patients who met the inclusion criteria were approached via mail. An informed consent with a 
return envelope was enclosed in the letter as well. In total we approached 383 persons to participate, of 
which 247 (65%) persons said “Yes,” 81 (21%) said “No,” and 55 (14%) never responded. Of the 247 
persons who agreed to participate, 16 eventually did not participate in the study for varying reasons 
(e.g., withdrawal from the study, never started the psychoanalytic treatment). Chi-square analyses and 
ANOVAs showed that these 16 dropouts did not differ significantly (p < .05) on pretreatment 
sociodemographic and diagnostic characteristics from the 231 subjects who actually did participate. 
When subjects returned a positive informed consent, we telephoned them to make an appointment for 
the personality assessment (MMPI-2 and Rorschach-CS). At that time, we also sent them the symptom 
questionnaires by regular mail. They could send these questionnaires back in a stamped envelope. 
Data gathering was done between January 2004 and June 2007. The personality assessments were 
done by researchers, psychologists, clinicians and research assistants trained in administering the 
Rorschach. 
 
Data analyses 
We investigated the raw Rorschach data and evaluated whether the Rorschach protocols in all four 
cohorts were equally complex. After computing z-scores for R (number of responses) and Form% 
(measure of defensiveness), we computed a summary index of complexity by calculating the average 
z-scores after reversing the direction of the Form% variable. We found no significant differences in R, 
Form%, and response complexity. The values indicate that overall we are dealing with high R–low 
Lambda patients, that is, persons who give rich and elaborate responses. In line with Meyer (1992, 
1993), we corrected for the influence of R (number of responses) on the raw scores by dividing all raw 
scores by R and multiplying by 20.25. The multiplier is the average R in the adult outpatient norm 
group (Exner, 2001). With raw scores no longer confounded by variations in R, structural data would 
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be easier to interpret and more suitable for research purposes (Meyer, 1992, 1993). Missing values 
(4.8%) were replaced by the mean group average of the corresponding cohort. 
Next, we calculated the percentages of patients who scored above (or below) a certain cutoff 
on the different assessment instruments. One of the most often used, and perhaps the least arbitrary, is 
a cutoff based on information from both functional and dysfunctional populations (cutoff C) that 
allows precise determination of which population a subject’s score belongs in (Jacobsen et al., 1984; 
Jacobsen & Truax, 1991). According to this definition, a clinically elevated score is defined as a score 
that is closer to the mean of the clinical population than to the nonclinical population. The formula for 
the calculation of this cutoff value is as follows:  
 
  (SD0 × M1) + (SD1 × M0) 
Cut-off = —————————— 
  (SD0 + SD1) 
 
where  
M0  = mean score in the non-clinical reference group 
SD0  = standard deviation in the non-clinical reference group 
M1  = mean score in the clinical reference group 
SD1  = standard deviation in the clinical reference group 
 
The cutoff values of the four symptom measures and the MMPI-2 scales are shown in Table 1. 
In the following, we have reported the chi-square analyses of the differences between the pretreatment 
cohort and the end-of-treatment cohort as well as those between the pretreatment cohort and the 
follow-up cohort. Raw percentage data are reported for all cohorts. Chi-square analyses revealed no 
significant differences between the pretreatment cohort and the during-treatment cohort in the number 
of patients with clinically elevated scores on both the symptom measures and the two personality 
measures. Therefore, the next results will only show proportions for the during-treatment cohort in the 
tables. Chi-square analyses revealed no significant differences between PA and PP patients on initial 
impairment or treatment outcome. Therefore, we report the aggregated results from both patient 
groups together as one large group. 
 
RESULTS 
 
Symptom measures 
Table 2 shows the percentages of patients with clinically elevated scores on the symptom measures in 
the different phases of treatment. Chi-square analyses revealed significant differences on all four 
questionnaires between the pretreatment group and the end-of-treatment and follow-up groups in 
number of patients with clinically elevated scores. 
 
Personality assessment 
Table 3 shows the percentages of patients with clinically elevated scores on the MMPI-2 clinical 
scales in the different phases of treatment. The results show significant decreases in the percentage of 
patients with clinically elevated scores on several MMPI-2 clinical scales, but not on all scales. 
Pretreatment versus end-of-treatment comparisons revealed significant differences in the number of 
patients with elevated scores on the scales for Depression, Hysteria, Psychopathic Deviate, 
Psychasthenia, and Social Inhibition. And with our pretreatment versus follow-up comparisons we 
found significant effects on the scales for Depression, Psychopathic Deviate, and Psychasthenia. 
Table 4 shows the percentages of patients with clinically elevated scores on the Rorschach 
scales in the different phases of treatment. We found a significant decrease in the percentage of 
patients with an elevated score on the Perceptual Thinking Index (PTI). On the other Rorschach scales, 
we did not find significant decreases in the proportion of patients with clinically elevated scores. 
Secondary analyses on the potential differential effect of treatment type revealed that the decrease in 
clinically elevated scores on the PTI was mainly due to patients in psychoanalysis. Post-hoc chi-square 
analyses revealed significant differences in the number of clinically elevated scores on the PTI 
between pretreatment and end-of-treatment (24% vs. 3%, χ² = 5.46, p < .05) and a statistical trend  
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Table 1. Cut-off Values for the Symptom Measures and the MMPI-2 Clinical Scales 
Symptom measures MMPI-2 clinical scales  
SCL-90-R 
GSI 
BDI-II 
total 
STAI 
trait 
IIP-64 
total 
1-Hs 2-D 3-Hy 4-Pd 6-Pa 7-Pt 8-Sc 9-Ma 0-Si 
Cut-off value 0.641 11.34 44.74 81.86 57.3 58.3 58.8 59.9 57.5 58.6 58.3 56.8 54.5 
 
 
Table 2. Percentage of Patients with Scores above the Clinical Cut-off on the Symptom Measures 
Phase of treatment  
Pre During End Follow-up 
Comparison 
 Pre vs. End 
Comparison 
 Pre vs. Follow-up 
Symptom measure % % % % ∆ in % χ²  ∆ in % χ²  
SCL-90-R GSI score 59 47 12 20 -47 32.3 *** -39 18.5 *** 
BDI-II total score 66 53 13 18 -53 37.5 *** -48 26.5 *** 
STAI trait score 77 51 13 24 -64 52.9 *** -53 32.0 *** 
IIP-64 total score 66 71 30 37 -36 16.8 *** -29 9.2 ** 
Note. N = 231. 
** p < .01, *** p < .001. 
 
 
Table 3. Percentage of Patients with Scores above the Clinical Cut-off on the MMPI-2 Clinical Scales and PSY-5 Scales 
Phase of treatment  
Pre During End Follow-up 
Comparison 
Pre vs. End 
Comparison 
Pre vs. Follow-up 
MMPI-2 scale % % % % ∆ in % χ²  ∆ in % χ²  
1-Hypochondriasis 25 33 20 20 -5 0.5  -5 0.4  
2-Depression 63 57 18 30 -45 26.6 *** -33 11.9 ** 
3-Hysteria 44 45 23 30 -21 6.5 * -14 2.3  
4-Psychopathic deviate 73 59 56 46 -17 4.3 * -27 8.9 ** 
6-Paranoia 58 71 58 52 0 0.0  -6 0.4  
7-Psychasthenia 77 67 39 48 -38 18.4 *** -29 9.9 ** 
8-Schizophrenia 53 67 41 40 -12 1.9  -13 1.9  
9-Hypomania 28 25 23 20 -5 0.5  -8 1.0  
0-Social inhibition 48 49 29 38 -19 5.3 * -10 1.2  
Note. N = 229. 
* p < .05, ** p < .01, *** p < .001. 
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between pretreatment and follow-up (24% vs. 5%, χ² = 3.49, p< .10) in the PA-group, but no 
significant differences between the cohorts in the PP group. 
 
Combining instruments: Clinical cases across instruments 
After investigating the percentage of clinical cases for each instrument separately, we combined the 
test scores from the four symptom measures and calculated the percentages of patients who scored 
within the clinical range on at least two symptom measures. In comparison to the pretreatment cohort, 
results showed a significant reduction in the number of patients with clinically elevated scores on at 
least two symptom measures at the end of treatment (75% vs. 18%) and at follow-up (75% vs. 26%) 
(see Table 5). With regard to the MMPI-2, we found a significant reduction in the number of patients 
who had clinically elevated scores on at least two MMPI-2 clinical scales at treatment termination and 
at follow-up. On the Rorschach-CS, we found a significant reduction in the percentage of patients with 
at least two clinically elevated Rorschach indices at follow-up but not at the end of treatment. 
Finally, we combined the results from the symptom measures with the personality assessment 
instruments and we redefined a clinical case as someone who fulfilled at least two of the three 
following criteria: (1) clinically elevated scores on at least two symptom measures; (2) clinically 
elevated scores on at least two MMPI-2 clinical scales; and (3) clinically elevated scores on at least 
two Rorschach indices. Based on this definition, a significant reduction in the percentage of clinical 
cases after psychoanalytic treatment was found both after treatment (84% vs. 41%) and at follow-up 
(84% vs. 40%) compared to the percentage of patients before treatment. The still relatively high 
number of clinical cases after treatment was mainly due to the results of the personality assessments.  
Further, we performed exploratory analyses to identify the characteristics of the subjects with 
the most unfavorable treatment outcome. From the end-of-treatment and follow-up cohorts, we 
distinguished six subjects with clinically elevated scores on the symptom measures and on the MMPI-
2 and on the Rorschach-CS. Sociodemographic characteristics of this small subgroup did not differ 
significantly from those with more favorable treatment outcome. Examination of pretreatment DSM-IV 
diagnoses did show that all six subjects (100%) were diagnosed with a personality disorder at the start 
of treatment, whereas 60% of the patients with a more favorable treatment outcome were diagnosed 
with a personality disorder at the start of treatment (χ² = 3.84, p < .10). 
 
DISCUSSION 
 
In this study, we investigated the clinical significance of long-term psychoanalytic treatment by 
examining the percentage of patients considered to function normally (i.e., at nonclinical levels) in 
different phases of treatment. The vast majority of patients were identified as clinical cases before 
treatment on the basis of six instruments measuring both symptoms and personality functioning. After 
treatment, we found a significant decrease in the number of clinical cases, and these results became 
even more evident at follow-up for the personality assessment. The results of these normative 
comparisons signify clinically meaningful improvements in real life. 
In particular, our results showed large reductions in the number of patients with clinically 
elevated scores on the symptom measures, but also significant improvements on the personality 
measures. These results are in line with other studies on the clinical significance of psychoanalytic 
treatment (Grande et al., 2006; Leichsenring et al., 2005; Perry, Banon, & Ianni, 1999; Sandell et al., 
2000). Thus far, the evaluation of clinical significance in treatment outcome research has mainly 
emphasized symptom reduction (Kazdin, 1999). The current study can be considered a valuable 
addition to the literature because of the comprehensive personality assessment of each patient. 
The long-term effects of psychoanalytic treatment were particularly apparent on the MMPI-2 
scales for Depression, Psychopathic Deviate, and Psychasthenia. This means that the presence and 
depth of depression, the level of social maladjustment and feelings of alienation, and the level of 
(social) anxiety and self-doubt were all substantially reduced after long-term psychoanalytic treatment. 
Furthermore, at 2-year follow-up, we still found significant differences with the pretreatment group on 
these personality variables. Apparently long-term psychoanalytic treatment is especially effective in 
returning patients to normal functioning in these areas and sustaining these improvements over a 
longer period of time. These variables appear to play an important role in treatment monitoring, in the 
sense that improvements in these areas could be expected after being in psychoanalytic treatment. The 
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Table 4. Percentage of Patients with Scores above the Clinical Cut-off on the Rorschach Variables 
Phase of treatment  
Pre During End Follow-up 
Comparison 
Pre vs. End 
Comparison 
Pre vs. Follow-up 
Rorschach variable % % % % ∆ in % χ²  ∆ in % χ²  
Perceptual-Thinking (PTI > 2) 16 6 5 4 -11 4.6 * -12 4.2 * 
Depression (DEPI > 5) 19 14 18 26 -1 0.0  +7 0.8  
Coping Deficit (CDI > 3) 25 25 21 26 -4 0.3  +1 0.0  
Suicide Constellation (S-CON > 7) 11 14 12 20 +1 0.0  +9 1.7  
Hypervigilance (HVI Positive) 28 20 25 14 -3 0.1  -14 3.5 † 
Obsessive Style (OBS Positive) 0 0 2 2 +2 1.0  +2 1.3  
Ego Impairment Index-2 (EII-2 > 0.7) 23 29 25 20 +2 0.1  -3 0.2  
Adjusted D score (AdjD < -1 or AdjD > 1) 31 27 28 20 -3 0.1  -11 2.0  
Note. N = 231. 
† p < .10, * p < .05. 
 
 
Table 5. Percentage of Patients Identified as Clinical Cases after Combining Instruments  
Phase of treatment 
Pre During End Follow-up 
Comparison 
Pre vs. End 
Comparison 
Pre vs. Follow-up 
 
% % % % ∆ in % χ² ∆ in % χ² 
Above cut-off on > 1 symptom measures 75 63 18 26 -57 34.0*** -49 27.9*** 
Above cut-off on > 1 MMPI clinical scales 89 88 73 70 -16 5.6* -19 6.5* 
Above cut-off on > 1 Rorschach scales 52 39 42 31 -10 1.3 -21 4.7* 
‘Clinical case’ 84 71 41 40 -43 26.1*** -44 24.3*** 
Note. N = 229. 
† p < .10, ** p < .01, *** p < .001. 
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other MMPI-2 variables appear to be more stable and therefore less suitable to monitor change in 
psychoanalytic treatment. 
Overall, we found substantial decreases in the number of patients with clinically elevated 
scores on all instruments, but the effects on the Rorschach-CS were the smallest. Perhaps this is 
because the global indices of the Rorschach-CS give us an estimation of our most stable personality 
traits, and on this level of functioning one would obviously expect the least changes. On an 
idiosyncratic level, the Rorschach-CS is an invaluable instrument to identify someone’s strong as well 
as weak points and use this information for thorough clinical decision making before treatment.  
Although several studies have shown that the Rorschach-CS can also be a valuable instrument 
in monitoring treatment outcome (e.g., Ganellen, 1996; Grønnerød, 2004; Viglione, 1999; Weiner & 
Exner, 1991), we found that using the global indices of the Rorschach-CS for measuring treatment 
outcome when comparing groups of patients appeared to be less useful. However, the combined score 
showed a significant decrease in clinical cases—as measured with the Rorschach—at 2-year follow-
up. This might also be interpreted as a postponed sleeper effect of the psychoanalytic treatment on 
structural personality aspects, such as reduction of distrust in others (HVI) and better reality testing 
(PTI).  
Although we found encouraging results about the clinical significance of psychoanalytic 
treatment effects, there was still a sizable proportion of patients with clinically elevated scores on our 
assessment instruments after treatment. For instance, 18% of the patients still had clinically elevated 
scores on the MMPI-2 Depression scale at the end of treatment, for the BDI-II this percentage was 
13%; and on the Depression scale of the Rorschach-CS this percentage was 18%. These results are in 
line with findings from a review of psychotherapy for depression, which suggested that most treated 
patients did show progress but were still more depressed than normative samples (Robinson, Berman, 
& Neimeyer, 1990). As Wise (2004) also pointed out, a complete return to normal functioning might 
not be realistic for intensive outpatient treatments. It could be that certain patients went through 
substantial change but at the end of treatment were still not functioning in the normative range. 
In the literature, these cases are normally referred to as improved, in contrast to recovered 
(Jacobsen & Truax, 1991). However, with our cross-sectional research design we were not able to 
examine these individual changes. Our exploratory analyses showed that the subjects with the most 
unfavorable treatment outcome were all diagnosed with a personality disorder at the start of treatment, 
while in the subgroup of patients with a more favorable treatment outcome, 60% were diagnosed with 
a personality disorder at the start of treatment. This could mean that the presence of a personality 
disorder can have a detrimental effect on treatment outcome; however, it does not necessarily mean 
that all patients with a personality disorder will have an unfavorable treatment outcome.  
In the research literature there is a growing body of evidence that patients with a personality 
disorder have worse treatment outcome compared to those without a personality disorder (e.g., Diguer, 
Barber, & Luborsky, 1993; Newton-Howes, Tyrer, & Johnson, 2006; Reich, 2003; Shea, Widiger, & 
Klein, 1992). Our exploratory findings are in line with these results, but further research is needed to 
identify exactly which patient/therapist/treatment characteristics are reliable predictors of an 
unfavorable treatment outcome, so that the treatment may be contraindicated in the future for certain 
subgroups or subtypes of patients. 
Another noteworthy finding was that the number of clinical cases after 1 year of treatment was 
comparable to that before treatment. In contrast to often found symptom decreases within the first year 
of (short-term) psychotherapy (Howard, Kopta, Krause, & Orlinsky, 1986; Kopta, Howard, Lowry, & 
Beutler, 1994), the current study shows that in this particular patient population the level of symptoms 
and personality problems does not decrease rapidly, justifying a longer treatment process. Moreover, 
we found that 77% of the patients had already tried a previous (short-term) treatment, which 
strengthens our belief that we are dealing with a patient population with chronic symptoms/problems 
that are perhaps more resistant to change and require a more intensive form of therapy, such as long-
term psychoanalytic treatment. It appears that patients in psychoanalytic treatment follow a different 
(and slower) pattern of change compared to those in short-term therapies, which are primarily focused 
on symptom reduction. This hypothesis could be further investigated by performing growth curve 
analyses to study the exact trajectories of symptoms and personality functioning in long-term 
psychoanalytic treatment. 
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The definition of clinical significance and the selection of instruments are crucial in this 
discussion. Because there is a lack of consensus regarding what measures are the most appropriate in 
assessing the clinical significance of treatment effects, it is recommended that multiple measures be 
used simultaneously. In this we followed other studies (Blomberg et al., 2001; Derogatis & Lazarus, 
1994; Puschner et al., 2007; Rudd et al., 1996; Sandell et al., 2000) and tried to make an even more 
conservative estimate of the number of clinical cases. Of course, clinical significance also depends on 
the goals of treatment and the nature of the problems of the patient population (Foster & Mash, 1999; 
Kazdin, 1999). Because the goals of long-term psychoanalytic treatment are both structural and 
symptomatic change, we used personality assessment instruments as well as symptom questionnaires. 
Another essential issue is the selection of normative data. Tingey, Lambert, Burlingame, and 
Hansen (1996) pointed out that although identifying normative reference groups is essential in 
evaluating clinical significance, here too there is a lack of consensus or guidelines for selecting these 
groups. As an addition to the clinical significance literature, they proposed a four-group distinction 
(asymptomatic, mildly symptomatic, moderately symptomatic, severely symptomatic) instead of a 
two-group (clinical and nonclinical) distinction for a more sensitive analysis of clinical significance. 
However, in practice, most measures only have established norms for a functional and a dysfunctional 
population and not for groups that are somewhere in between. Tingey et al. (1996) do touch on an 
important issue however, because the selection of the reference groups determines the cutoffs directly 
and therefore can significantly influence the results. So in this, we are dependent on the availability, 
quality, and representativeness of the reference groups that are mentioned in the manuals of the 
assessment instruments. For the MMPI-2, we used a clinical sample of outpatients patients with 
relatively mild distress. Consequently, the means of the MMPI-2 scales in the nonclinical and clinical 
norm groups were located fairly close to each other. This could perhaps explain why we still found a 
lot of clinically elevated scores on the MMPI-2 scales after treatment, because the cutoff values that 
distinguish between nonclinical and clinical were relatively low. More research is needed to evaluate 
alternative cutoff points and their utility in distinguishing between clinical and nonclinical groups. 
In multiple-cohort designs a potential form of confounding involves differences in background 
characteristics and level of pretreatment psychopathology between the cohorts (Cogan & Porcerelli, 
2005). One cannot be sure that the patients enrolled in the various cohorts were exactly equivalent in 
terms of baseline psychopathology and background characteristics. It could be that patients with more 
psychopathology might be more apt to drop out of treatment and, in selecting subjects for the two 
posttreatment samples, we may have included more subjects who were relatively higher-functioning at 
the start of treatment compared to the other two cohorts. This could potentially influence the results of 
our cohort comparisons. In the present study, we compared the four cohorts on pretreatment DSM-IV-
R diagnoses and sociodemographic characteristics. We found no significant differences on most 
variables, thus providing a strong check for the comparability of the four cohorts. 
Another issue to keep in mind is that age and treatment effects could have occurred. Age 
effects are those associated with personal maturation that persons would presumably experience 
during any period of time (Raudenbush & Chan, 1992). With regard to treatment effects, one could 
argue that it is impossible to know whether the improvements we found are actually attributable to the 
treatment given. It is not possible to draw causal inferences from the presented data. We have to be 
careful in drawing conclusions about the clinical significance of both treatments. A related issue is that 
in cross-sectional studies, ideas about changes within individuals cannot be tested. We are only able to 
talk about differences between patients on a group level and not of individual changes in patients over 
time. Therefore, we encourage further studies on the clinical significance of long-term psychoanalytic 
treatment effects that also investigate reliable changes on an individual level. 
Although the present study has certain limitations, we think the results of our study make a 
valuable contribution to the evidence about the clinical significance of long-term psychoanalytic 
treatments. The major merits of this study were the large sample size, the high external validity, and 
the comprehensive personality assessment. A large proportion of patients with chronic symptoms of 
depression and personality pathology appeared to profit from long-term psychoanalytic treatment. 
These effects were not yet visible after 1 year of treatment, but more so at the end of treatment and at 
2-year follow-up. Psychoanalytic treatment has made a practical, beneficial, and clinically relevant 
impact on the patients’ lives, given our findings that the presence and depth of depression, the clinical 
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level of social maladjustment and feelings of alienation, and the clinical level of (social) anxiety and 
self-doubt were all substantially reduced after long-term psychoanalytic treatment. 
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ABSTRACT 
 
Objectives. Longitudinal measurements can provide important information regarding varieties in 
developmental trajectories of patients in long-term treatment. The present study investigated changes 
in general symptoms, depression, anxiety, and interpersonal problems during the first two years of 
long-term psychoanalytic psychotherapy (PP) and psychoanalysis (PA). It was expected that 
interpersonal problems diminish more slowly compared to symptomatic dysfunctioning.  
Design. To obtain information about changes over a longer period within a relatively short period of 
time, an accelerated longitudinal design with five consecutive measurement points across two cohorts 
of patients was used. 
Methods. Changes on the SCL-90-R, BDI-II, STAI, and IIP-64 were investigated during the first two 
years of long-term psychoanalytic psychotherapy (n = 73) and psychoanalysis (n = 40). Linear 
regression analysis was performed to model the courses of improvement. 
Results. After two years of treatment patients in both groups still presented moderate to high levels of 
symptoms and interpersonal problems compared to non-clinical populations. As expected, 
interpersonal problems changed less rapidly. PP-patients changed both with regard to symptomatic 
and interpersonal problems, whereas the only significant change in the PA-group was on one of the 
symptomatic subscales. Slopes in the PA-group and in the PP-group did not differ significantly from 
each other, except for the IIP-64 scale Intrusive, with PP-patients showing significantly more 
improvement than PA-patients. The height of intake values of the outcome variables appeared to 
predict the speed of symptomatic recovery. 
Conclusions. Symptoms and interpersonal problems did not decrease notably within the first two 
years of psychoanalytic treatment. This confirms the belief that significant change takes time for 
patients with chronic mental disorders and personality pathology. In regular practice, it is advisable to 
monitor changes routinely in order to identify fast responders quicker and change the treatment plan 
accordingly.  
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INTRODUCTION 
 
In recent years psychoanalytically oriented researchers have invested in outcome studies to provide 
empirical evidence for the effectiveness of their treatments. This has led to a considerable (and still 
growing) body of research about the clinical effectiveness of long-term ambulatory psychoanalytic 
treatment (e.g., Bateman & Fonagy, 2009; Berghout & Zevalkink, 2009; Leichsenring & Rabung, 
2008; de Maat, de Jonghe, Schoevers, & Dekker, 2009). Besides studying treatment outcome, it is also 
relevant to study changes in psychiatric and psychological symptoms during long-term treatment. The 
main reason for such a study is that longitudinal measurements provide information regarding varieties 
in developmental trajectories of patients in long-term treatment that might help clinical decision 
making and provide feedback to the therapist about the patient’s progress or deterioration at both a 
group and individual level (Anstey & Hofer, 2004; Miller, Duncan, Brown, Sorrell, & Chalk, 2006). A 
meta-analysis by Lambert and colleagues (2003) showed that monitoring patient treatment responses 
and providing feedback to the therapists significantly improved psychotherapy outcome compared to 
providing no information about the patient’s progress during treatment. Especially the recognition of 
potential treatment failure seemed to improve outcome by decreasing further deterioration and guiding 
patients back on track again. The fluctuations of patient improvement and deterioration provide 
independent patient information that may prompt psychotherapists to modify their treatment approach 
and, for instance, change the treatment intensity or refer the patient to other health care providers 
(Lambert, 2007; Percevic, Lambert, & Kordy, 2006). Lambert (2007) pointed out that clinical decision 
making will be more accurate and efficient when therapists can see in a graph whether their patient 
responds well to treatment and is on track (‘green light’), shows slower progress than expected 
(‘yellow flag’), or even has deteriorated (‘red flag’). But before making use of such a system, it is 
necessary to establish how the expected developmental trajectories look like for particular groups of 
patients in a certain treatment. The areas of improvement and the developmental trajectories of 
patients entering long-term psychoanalytic treatment might be different from those of patients entering 
shorter forms of treatment. This requires systematically monitoring changes in psychiatric symptoms – 
such as anxiety and depressive symptoms – during treatment to identify in what stage of treatment, in 
which areas of symptomatic functioning, and to what extent improvements are being achieved. 
Interpersonal problems are among the most frequent complaints brought into psychotherapy by 
patients (Horowitz, 2004; Horowitz, Rosenberg, Baer, Ureño, & Villaseñor, 1988; Monsen, Odland, 
Faugli, Daae, & Eilertsen, 1995; Ruiz et al., 2004). Therefore, monitoring the patient’s state in the 
interpersonal domain is also clinically relevant. The phase model of therapeutic change developed by 
Howard, Lueger, Maling, and Martinovich (1993) states that changes in interpersonal functioning are 
mostly achieved in later stages of treatment than changes in symptoms. Empirical studies on the 
effects of psychoanalytic treatment give support to this differential timing in therapeutic effect (e.g., 
Haase et al., 2008). The literature also reveals that some types of interpersonal problems improve more 
readily than others. For example, problems related to a dependent personality style (submissiveness, 
nonassertiveness) are more likely to improve than problems related to antisocial behavior (hostility, 
dominance) in psychoanalytic treatment (Horowitz, Rosenberg, & Bartholomew, 1993; Huber, 
Henrich, & Klug, 2007).  
Previous studies on improvements during long-term psychoanalytic treatments have generated 
diverse results. Blomberg, Lazar, & Sandell (2001) studied growth/decay curves of symptomatic 
distress and social relations for patients in psychoanalysis or psychoanalytic psychotherapy. Both 
groups of patients started treatment at about the same level of symptomatic distress as measured by the 
Global Severity Index (GSI) of the Symptom Checklist-90-R (SCL-90-R GSI; Derogatis, 1983) and 
followed similar paths during treatment. The patterns of improvement on social adjustment as 
measured with the Social Adjustment Scale (SAS; Weissman & Bothwell, 1976) were somewhat 
different. The psychoanalytic psychotherapy group started off at a significantly higher level (i.e., more 
social problems) than the psychoanalysis group, and the groups improved at roughly the same 
moderate rate. However, in both groups there was a remarkable increase in social problems in the 
beginning of treatment, before significant improvement started to happen (Blomberg et al., 2001). In a 
longitudinal study by Puschner, Kraft, Kächele, and Kordy (2007) the course of symptomatic 
improvement of patients in psychoanalysis and psychodynamic psychotherapy was tracked over a two 
year period. In both forms of treatment the course of improvement could be adequately fitted by a 
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linear model. Symptom distress (SCL-90-R GSI) decreased notably within two years. No significant 
differences between forms of treatment as to level or pace of symptom improvement were observed. 
Leichsenring, Biskup, Kreische, and Staats (2005) also studied treatment effects at different time-
points, but only for patients in psychoanalytic therapy. They found relatively small effects (d = 0.38) 
after 50 sessions (= approximately 7 months) on the Inventory of Interpersonal Problems-64 (IIP-64; 
Horowitz, Alden, Wiggins, & Pincus, 2000), and moderate effects (d = 0.57) on the SCL-90-R GSI. 
After 160 sessions (= approximately 24 months) these effects had increased substantially; the effect 
size on the IIP-64 was moderate (d = 0.66), and on the SCL-90-R GSI they found a large effect size (d 
= 0.87) after two years of treatment. Knekt et al. (2008) compared the effectiveness of long-term 
psychodynamic psychotherapy (up to 3 years) with two forms of short-term therapy (5 to 8 months). 
They collected data over a 3-year period. All three interventions were associated with significant 
reductions in anxiety symptoms as measured by the SCL-90-Anxiety scale and the Hamilton Anxiety 
Rating Scale (HAM-A; Hamilton, 1959) and depressive symptoms as measured by the Beck 
Depression Inventory (BDI; Beck, Steer, & Brown, 1996) and the Hamilton Depression Rating Scale 
(HAM-D; Hamilton, 1960). Patients who received short-term treatment showed an early response and 
presented significantly more symptom improvement within the first 12 months of the study period 
compared to patients in long-term psychotherapy. During the second year of follow-up no significant 
differences were found between the short-term and long-term therapies. However, in the third year 
long-term psychotherapy was found to be significantly more effective in reducing anxiety and 
depressive symptoms than both short-term treatments. Apparently, symptomatic improvement in the 
long-term psychotherapy group started slowly but increased considerably in the long run. Brockmann, 
Schlütter, Brodbeck, and Eckert (2002) also followed patients in long-term psychoanalytic 
psychotherapy in the first years of treatment, with measurement points at intake, 1 year, 2.5 years, and 
at 3.5 years. After 1 year of treatment they found only small improvements on interpersonal problems 
(IIP-64) and already quite large improvements in general symptoms (SCL-90-R GSI). At 2.5 years and 
at 3.5 years large effects were achieved for both outcome measures. These results show that response 
patterns may differ between treatment groups but also within groups with some patients responding 
faster to treatment than others. 
The present study investigated changes in general symptoms, depression, anxiety, and 
interpersonal problems during the first two years of long-term psychoanalytic psychotherapy and 
psychoanalysis. It was predicted that interpersonal problems (as measured with the IIP-64) and 
psychological symptoms (as measured with the SCL-90-R, BDI-II, STAI) would decrease 
significantly within the first two years of treatment. Based on results of previous studies it was 
predicted that interpersonal problems (especially hostility and dominance) diminish more slowly 
compared to symptomatic dysfunctioning (Brockmann et al., 2002; Horowitz et al., 1993; Huber et al., 
2007; Leichsenring et al., 2005). Linear regression analysis was performed for all subscales and total 
scales of the instruments to model the courses of improvement in both treatment groups. No 
significant differences in course of improvement between psychoanalysis and psychoanalytic 
psychotherapy were expected (Blomberg et al, 2001; Puschner et al., 2007). Finally, in line with 
suggestions by Lambert (2007), subsamples of patients responding either fast or slow to treatment 
were identified. The current study investigated whether certain pretreatment characteristics might act 
as predictors of a fast treatment response. No hypotheses about predictors of treatment response were 
proposed, therefore these analyses were considered to be exploratory.  
 
METHOD 
 
Participants 
The total sample consisted of 113 participants from four mental health care organisations in the 
Netherlands, who received either psychoanalysis (PA; n = 40) or psychoanalytic psychotherapy (PP; n 
= 73). Before the study started ethical approval was obtained from a medical ethical committee 
(METC). This was obligatory for receiving the grant that was provided by the Netherlands 
government. The study followed the progress of adults who had come into treatment via the usual 
pathways in each of the mental health settings. At two points in time, participants were approached: 
before treatment and at one year in treatment. This means that the first cohort (PA: n = 25; PP: n = 39) 
consisted of patients who had just started long-term psychoanalytic treatment and the second cohort 
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(PA: n = 15; PP: n = 34) consisted of patients who were already one year in treatment. Patients in 
these two cohorts were assessed three times over a one-year period. The third measurement point in 
the first cohort overlapped with the first measurement in the second cohort. In this way, there were 
five consecutive measurement points in the first two years of treatment. This is called an ‘accelerated 
longitudinal design’ with two cohorts (Bell, 1953). Such a design allows for estimating a single 
developmental curve by linking together smaller, overlapping segments of data from different groups 
to study changes over a longer period within a relatively short period of time (Anderson, 1995; Bell, 
1953; Duncan, Duncan, & Hops, 1996; Sandell, Blomberg, & Lazar, 1997).  
Inclusion criteria for participation were a minimum age of 18 years, having mastery of the 
Dutch language, having been assigned to long-term psychoanalytic treatment (> 25 sessions or > 1 
year, with a minimum frequency of once a week) by a team of clinicians. Previous research had shown 
that complex emotional problems, chronic depressive symptoms, interpersonal difficulties, and other 
personality problems were distinctive of patients assigned to long-term psychoanalytic treatment 
(Zevalkink & Berghout, 2008). Exclusion criteria were the presence of (acute) psychotic symptoms, 
because this would heavily influence test administration. There were no significant differences 
between cohorts regarding the PA/PP distribution. Sociodemographic and psychiatric pretreatment 
data for participants in both cohorts were available and analysed using chi-square analyses and one-
way ANOVAs. This revealed no significant differences between the two cohorts at the start of 
treatment for the following variables: gender, age, treatment history, living situation, cultural 
background, educational level, employment status, DSM-IV Axis I, II and V diagnosis. The majority 
of the sample (71%) consisted of women. The age range of the participants ranged from 19 to 62 
years, with an average age of 34 years (SD = 8.0), 48% of the participants were living with a partner, 
27% had children, 92% had a Dutch cultural background, 75% had received higher education, and 
85% had a paid job. Furthermore, 78% of the participants had received previous (psycho)therapeutic 
treatment. Before treatment, the most frequently diagnosed DSM-IV Axis I disorders were mood 
disorders (50%), in particular dysthymic disorder (31%), followed by anxiety disorders (12%). With 
regard to Axis II diagnoses, the majority of the patients (85%) were diagnosed with a personality 
disorder, in particular personality disorder not otherwise specified (PDNOS; 39%), dependent 
personality disorder (15%) and avoidant personality disorder (12%).  
Statistical modelling of longitudinal studies ideally involves three or more assessments 
(Anstey & Hofer, 2004). All longitudinal studies suffer from missing data and participant drop-out. 
One possible methodological problem in longitudinal studies is selective drop-out or attrition. This 
means that individuals with poorer mental health or less motivation are more likely to discontinue the 
study (Anstey & Hofer, 2004). Response rates across measurement points were as follows: Cohort 1: 
t0 = 100%, t1 = 84%, t2 = 91%, and in Cohort 2: t0 = 100%, t1 = 86%, t2 = 71%. No significant 
differences in initial pathology or sociodemographic characteristics were found between drop-outs and 
patients who did finish the study.  
 
Treatments 
Both psychoanalytic psychotherapy and psychoanalysis are open-ended long-term psychotherapeutic 
treatments, defined as consisting of 25 sessions or more and lasting more than one year. These 
psychoanalytic treatments have been described in textbooks (e.g., Gabbard, 2005, 2009; Greenson, 
1967; Person, Cooper, & Gabbard, 2005; Wallerstein, 1995). In general, psychoanalytic treatments 
share some common theoretical assumptions and intend to influence the working of unconscious 
processes by either focusing on conflicts, object relations, the self, and/or interactional processes. 
Psychoanalysis differs from psychoanalytic psychotherapy in several ways. Patients in psychoanalysis 
typically receive three to five sessions per week for a period of several years (4 patients received 3 
sessions per week, 25 patients received 4 sessions per week, and 11 patients received 5 sessions per 
week). The setting of psychoanalysis encourages regression, due to the couch position and the greater 
neutrality and abstinence of the analyst (Gabbard, 2005; de Wolf, 2002). Patients in psychoanalytic 
psychotherapy sit face-to-face and the treatment is less frequent with one or two sessions a week (61 
patients received 1 session per week, and 12 patients received 2 sessions per week). On average, 
psychoanalytic psychotherapy has shorter treatment duration than psychoanalysis (3.9 years vs. 6.5 
years; Berghout & Zevalkink, 2009). Treatment assignment is based on therapeutic judgments about 
patients’ ego strength, affect tolerance, capacity for reflection and insight, but also on practical 
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considerations such as distance to the treatment facility, patient motivation and availability of 
therapists. Both treatment forms are covered by health insurance in the Netherlands. More patients are 
assigned to psychoanalytic psychotherapy for practical reasons, such as its lower intensity and higher 
availability. All therapists (N = 50) in the project are licensed clinicians (psychiatrists/psychotherapists 
or psychologists/psychotherapists) and member of one of the Netherlands psychoanalytic societies. On 
average, the therapists had 22.8 years (SD = 7.9) of experience. The mean age of the therapists was 
53.1 years (SD = 7.1). 
 
Instruments 
In this study, the SCL-90-R, BDI-II, STAI, and IIP-64 were used, which are four of the most widely 
utilized self-report measures to assess therapeutic improvement (Hill & Lambert, 2004). The SCL-90-
R measures symptoms in eight major areas of the patient’s psychological, somatic, and interpersonal 
functioning (Phobic Anxiety, Anxiety, Depression, Hostility, Obsessive-Compulsive, Interpersonal 
Sensitivity, Sleeping Problems, and Somatic Complaints). The 90 items are scored on a 5-point Likert 
scale ranging from “not at all” to “extremely” (Derogatis, 1983). In the Netherlands, norms and 
translations were developed by Arrindell and Ettema (2003) who also studied the psychometric 
properties. Their study showed that the subscales of the SCL-90-R had a good internal consistency, a 
high stability and possessed discriminant and convergent validity (Arrindell & Ettema, 2003). The 21-
item BDI-II measures depressive symptoms, scored on a 4-point Likert scale (Beck et al., 1996). The 
BDI-II consists of three subscales (Affective, Cognitive, and Somatic). In the Netherlands, Van der 
Does (2002) translated the BDI-II and developed norm scores. Their research showed that the 
reliability (internal consistency) of the Dutch version of the BDI-II was high. Also the convergent 
validity of the BDI-II Total score with other measures of depression appeared to be high (Van der 
Does, 2002). The 40-item STAI assesses state and trait anxiety, scored on a 4-point Likert scale 
ranging from “not at all” to “very much so” (Spielberger, 1983). State anxiety reflects a momentary 
anxiety, and trait anxiety refers to a general tendency to respond with anxiety to perceived threats in 
the environment. The STAI was published in the Netherlands and norm scores were developed by Van 
der Ploeg (2000). Psychometric research showed that both scales of the STAI were homogenous, 
reliable, and correlated highly with other measures of anxiety, supporting the validity of the STAI 
(Van der Ploeg, 2000). The IIP consists of 64 items, scored on a 5-point Likert scale ranging from “not 
at all” to “extremely”, that assess perceived interpersonal difficulties on eight subscales (Domineering, 
Vindictive, Cold, Socially Inhibited, Nonassertive, Overly Accommodating, Self-sacrificing, and 
Intrusive; Horowitz et al., 2000). The internal consistency of the Dutch version of the IIP-64 was 
investigated in clinical and non-clinical populations (Vanheule, Desmet & Rosseel, 2006; Zevalkink, 
Katzko, Berghout, & Riksen-Walraven, 2008). All Cronbachs alphas were found to be satisfactory, 
except for the subscale ‘Intrusive’ in the Vanheule et al. study. 
 
Procedure 
All patients who met the inclusion criteria were approached via regular mail. Participants were given 
extensive written information about the research project and an informed consent with a return 
envelope was also enclosed in the letter. When participants returned a positive informed consent, the 
questionnaires were sent by regular mail. They could send these questionnaires back in a stamped 
envelope. Data gathering was completed in the period of January 2005 to June 2007. 
 
RESULTS 
 
Pretreatment differences 
First, pretreatment differences between the two treatment groups were examined within the first 
cohort. No significant pretreatment differences between PA- and PP-patients were found on any of the 
subscales of the SCL-90-R, BDI-II, STAI, and IIP-64. In addition, no significant differences between 
patients in PA and PP were found regarding pretreatment sociodemographic characteristics or clinical 
diagnoses (DSM-IV), except that there appeared to be relatively more women in PP (80%) than in PA 
(55%), χ2(1, N = 113) = 7.47, p = 0.006. Gender did not appear to be significantly related to the scores 
on the questionnaires on any measurement point (as tested with one-way ANOVAs using an alpha of 
0.01), therefore no correction for gender was needed in subsequent analyses. 
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Patterns and rates of change 
To examine the course of improvement, test scores were averaged across all respondents at the same 
measurement point and in the same treatment modality. The means were plotted across time as growth 
curves to visualize the average course of improvement in each of the two treatment groups. Figures 1 
through 4 show the average means of the SCL-90-R GSI score, BDI-II total score, STAI Trait score, 
and IIP-64 total score at each point of measurement, as well as the estimated slopes based on the 
regression analyses. In order to have a point of reference the means of the non-clinical norm groups 
were plotted in each figure. As can be seen from the figures, after two years of treatment the mean 
scores on all four instruments were still above the non-clinical norm.  
 
Figure 1. Average means and estimated slopes of the SCL-90-R GSI in PA and PP 
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Note. Mean score of the non-clinical norm group for the Symptom Checklist-90-R (SCL-90-R) Global Severity 
Index (GSI) was derived from Arrindell and Ettema (2003).  
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Figure 2. Average means and estimated slopes of the BDI-II Total score in PA and PP 
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Note. Mean score of the non-clinical norm group for the Beck Depression Inventory-II (BDI-II) Total score was 
derived from Van der Does (2002).  
 
 
Figure 3. Average means and estimated slopes of the STAI Trait score in PA and PP 
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Note. Mean score of the non-clinical norm group for the State-Trait Anxiety Inventory (STAI) Trait score was 
derived from Van der Ploeg (2000).  
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Figure 4. Average means and estimated slopes of the IIP-64 Total score in PA and PP 
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Note. Mean score of the non-clinical norm group for the Inventory of Interpersonal Problems-64 (IIP-64) Total 
score was derived from Zevalkink, Katzko, Berghout, and Riksen-Walraven (2008).  
 
Linear regression analysis was used to model the symptom courses and to examine patterns 
and rates of change over the two year period. The measures that were used provide continuous scores, 
with parametric statistical properties, which allows for analysis of growth curves and rates of change 
(Anstey & Hofer, 2004). Change rates were estimated in each group by the linear trend 
(unstandardized b) found when the means were regressed on the time scale. Regression parameters for 
all subscale scores and total scores are presented in Table 1. In the PA-group a statistically significant 
improvement was found on the SCL-90-R subscale Interpersonal sensitivity (b = -2.78, p = 0.021). In 
the PP-group statistically significant improvements were found on the SCL-90-R Global Severity 
Index (b = -0.10, p = 0.039) and subscales Depression (b = -3.93, p = 0.001) and Hostility (b = -0.79, p 
= 0.006); the BDI-II Total score (b = -2.29, p = 0.031) and Cognitive scale (b = -1.34, p = 0.002); the 
STAI Trait anxiety scale (b = -2.48, p = 0.023); and the IIP-64 subscales Domineering (b = -1.35, p = 
0.020) and Intrusive (b = -1.62, p = 0.004). Differences in regression coefficients between PA and PP 
were tested using General Linear Modelling (GLM). The comparisons between the regression 
coefficients in the PA-group and those in the PP-group showed that most slopes did not differ 
significantly from each other. The only difference was on the IIP-64 subscale Intrusive, with PP-
patients showing significantly more improvement than PA-patients in the first two years of treatment 
(F = 5.17, p = 0.024). 
 
Identifying fast responders 
In order to investigate whether predictors of rapid symptom progress could be elicited, patients with 
complete data sets in the first cohort (n = 58) were analyzed. In that subgroup ‘fast responders’ were 
identified, i.e. patients whose symptom scores (SCL-90-R GSI) reached non-clinical levels after one 
year of treatment (≤ 0.31), and were compared with ‘slow responders’, i.e. patients whose GSI scores 
were still above the non-clinical norm (> 0.31) at one year of treatment. The number of patients in 
each subgroup was small, therefore these analyses were exploratory. Chi-square analyses and one-way 
ANOVAs were used to compare fast responders to slow responders regarding pretreatment test scores 
and sociodemographic and diagnostic characteristics (gender, age, treatment history, living situation, 
cultural background, educational level, employment status, DSM-IV diagnoses). Based on the GSI 
cut-off (0.31) 15 slow-responders and 7 fast responders were identified in the PA group, and 17 slow  
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Table 1. Regression parameters for psychoanalysis and psychoanalytic psychotherapy and comparison of regression coefficients 
Psychoanalysis 
(103 observations of 40 patients) 
 Psychoanalytic psychotherapy 
(199 observations of 73 patients) 
  
Intercept  Slope  Intercept  Slope   
Comparison 
slopes PA vs. PP 
Scale M SE  b SE p   M SE  b SE p   F p  
Symptom Checklist-90-R (SCL-90-R)                
Global Severity Index (GSI) 0.70 0.06  -0.10 0.06 .082   0.68 0.05  -0.10 0.05 .039 *  0.00 .995  
Phobic Anxiety 1.85 0.35  -0.64 0.34 .059   1.46 0.32  -0.19 0.28 .506   0.93 .335  
Anxiety  6.26 0.84  -0.69 0.81 .396   6.11 0.62  -0.94 0.56 .095   0.07 .796  
Depression  17.51 1.57  -2.95 1.51 .053   17.49 1.28  -3.93 1.15 .001 **  0.25 .617  
Hostility 2.94 0.34  -0.38 0.33 .251   2.93 0.32  -0.79 0.28 .006 **  0.79 .374  
Obsessive-Compulsive  8.43 0.92  -0.95 0.89 .289   7.97 0.75  -0.68 0.67 .315   0.06 .811  
Interpersonal Sensitivity  13.99 1.23  -2.78 1.19 .021 *  12.34 1.03  -1.78 0.93 .056   0.42 .520  
Sleeping Problems  2.01 0.35  0.36 0.34 .284   2.60 0.33  -0.28 0.29 .341   1.82 .179  
Somatic Complaints  4.02 0.66  0.61 0.63 .339   4.78 0.70  0.53 0.63 .404   0.01 .936  
Beck Depression Inventory-II (BDI-II)                
Total score 14.41 1.38  -2.05 1.30 .119   13.90 1.17  -2.29 1.05 .031 *  0.02 .888  
Affective 2.94 0.36  -0.62 0.34 .067   2.50 0.29  -0.45 0.26 .084   0.17 .683  
Cognitive 5.40 0.62  -0.95 0.59 .109   5.34 0.47  -1.34 0.43 .002 **  0.28 .595  
Somatic 6.07 0.60  -0.47 0.57 .410   6.06 0.56  -0.51 0.51 .320   0.00 .967  
State-Trait Anxiety Inventory (STAI)                
State anxiety 42.61 1.66  -0.39 1.58 .806   42.01 1.38  -1.32 1.24 .290   0.20 .652  
Trait anxiety 47.87 1.75  -1.55 1.66 .352   47.74 1.22  -2.48 1.08 .023 *  0.23 .630  
Inventory of Interpersonal Problems-64 (IIP-64)                
Total score 91.01 4.65  1.58 4.45 .724   89.08 3.97  -4.69 3.59 .194   1.10 .295  
Domineering (PA) 7.54 0.70  -0.78 0.67 .250   7.74 0.64  -1.35 0.58 .020 *  0.37 .545  
Vindictive (BC) 7.61 0.69  -0.24 0.66 .717   6.30 0.58  -0.38 0.53 .470   0.03 .870  
Cold (DE) 9.51 0.95  0.62 0.91 .498   8.19 0.72  -0.57 0.65 .387   1.11 .292  
Socially Inhibited (FG) 12.28 1.04  0.58 1.00 .561   12.02 0.84  -0.83 0.76 .280   1.20 .274  
Nonassertive (HI) 16.13 0.97  0.08 0.93 .930   15.25 0.83  0.58 0.75 .438   0.16 .687  
Overly Accommodating (JK) 15.24 0.89  0.33 0.85 .702   14.78 0.72  0.30 0.65 .644   0.00 .980  
Self-sacrificing (LM) 14.37 0.94  0.43 0.90 .635   15.17 0.80  -0.83 0.72 .255   1.09 .298  
Intrusive (NO) 8.33 0.80  0.56 0.76 .469   9.63 0.62  -1.62 0.56 .004 **  5.17 .024 * 
* p < .05, ** p < .01. 
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Table 2. Intake values of slow responders and fast responders in the first cohort 
Psychoanalysis Psychoanalytic psychotherapy 
Slow responders 
(n = 15) 
Fast responders 
(n = 7) Slow vs. fast 
 Slow responders 
(n = 17) 
Fast responders 
(n = 19) Slow vs. fast 
Predictor (intake value) M SD M SD F p  M SD  M SD  F p  
Symptom Checklist-90-R (SCL-90-R)                 
Global Severity Index (GSI) 0.81 0.30 0.50 0.26 5.37 .031*  0.91 0.31  0.56 0.30  11.32 .002 ** 
Phobic Anxiety 1.93 3.33 1.86 3.34 0.00 .961  1.29 1.45  1.11 2.03  0.10 .752  
Anxiety  7.00 7.70 5.29 4.39 0.30 .592  9.35 5.41  4.42 3.34  11.10 .002 ** 
Depression  19.93 7.95 12.86 7.08 4.03 .058  24.76 10.05  14.26 8.12  12.01 .001 ** 
Hostility 3.47 2.53 1.86 1.07 2.56 .125  3.65 3.64  2.42 1.90  1.66 .207  
Obsessive-Compulsive  9.00 3.46 6.29 4.96 2.23 .151  10.47 4.89  7.00 5.04  4.37 .044 * 
Interpersonal Sensitivity  16.33 8.21 8.29 6.40 5.20 .034*  14.82 4.93  10.00 6.68  5.96 .020 * 
Sleeping Problems  2.60 2.17 1.71 1.25 1.00 .330  3.65 3.61  2.53 2.67  1.14 .294  
Somatic Complaints  4.67 3.66 3.29 2.14 0.85 .368  6.24 4.92  4.58 4.03  1.23 .275  
Beck Depression Inventory-II (BDI-II)                 
Total score 18.48 8.82 8.86 6.18 6.71 .018*  20.04 6.66  12.21 7.13  11.49 .002 ** 
Affective 3.72 2.58 1.86 1.57 3.06 .096  3.93 1.57  1.84 1.61  15.58 .000 *** 
Cognitive 7.27 4.35 2.71 3.04 6.20 .022*  7.47 3.57  5.05 3.91  3.73 .062  
Somatic 7.49 3.47 4.29 3.15 4.30 .051  8.63 4.41  5.32 2.98  7.11 .012 * 
State-Trait Anxiety Inventory (STAI)                 
State anxiety 47.60 11.24 38.86 6.74 3.58 .073  50.56 11.73  38.84 7.07  13.50 .001 ** 
Trait anxiety 50.86 10.69 45.71 8.64 1.23 .280  52.70 5.80  45.84 9.13  7.05 .012 * 
Inventory of Interpersonal Problems-64 
(IIP-64) 
                
Total score 102.72 24.40 67.86 24.83 9.64 .006**  93.78 30.62  83.53 33.11  0.92 .343  
Domineering (PA) 8.62 4.81 6.29 3.59 1.29 .270  9.28 7.36  5.89 3.76  3.12 .086  
Vindictive (BC) 10.03 4.68 5.57 3.05 5.24 .033*  8.05 6.43  4.00 3.28  5.84 .021 * 
Cold (DE) 12.49 6.38 4.71 3.30 9.09 .007**  9.40 6.34  6.63 5.23  2.06 .161  
Socially Inhibited (FG) 13.99 4.46 8.00 5.03 7.96 .011*  13.19 5.00  10.74 6.50  1.59 .216  
Nonassertive (HI) 17.22 4.72 14.00 4.28 2.35 .141  14.30 6.32  16.58 6.67  1.10 .302  
Overly Accommodating (JK) 16.90 4.32 12.43 5.68 4.19 .054  14.38 6.87  15.58 6.31  0.30 .589  
Self-sacrificing (LM) 14.58 4.05 10.57 7.02 2.92 .103  15.05 7.37  15.32 7.49  0.01 .916  
Intrusive (NO) 8.90 5.35 6.29 4.46 1.26 .276  10.13 7.59  8.79 3.88  0.46 .503  
* p < .05, ** p < .01, *** p < .001. 
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responders and 19 fast responders in the PP-group. In both treatment groups no significant differences 
between slow responders and fast responders were found on pretreatment sociodemographic and 
diagnostic characteristics. However, significant differences were found between the slow responders 
and fast responders with regard to pretreatment values on the outcome measures (see Table 2). In the 
PA-group slow responders differed from fast responders in that they had higher pretreatment scores on 
the SCL-90-R (GSI, Interpersonal sensitivity), BDI (Total score, Cognitive), and IIP-64 (Total score, 
Vindictive, Cold, and Socially Inhibited). In the PP-group slow responders differed from fast 
responders in that they had higher pretreatment scores on the SCL-90-R (GSI, Anxiety, Depression, 
Obsessive-Compulsive, Interpersonal sensitivity), BDI (Total score, Somatic, Affective), IIP-64 
(Vindictive), and STAI Trait and State Anxiety. In sum, slow responders in both treatment groups 
tended to have higher scores on pretreatment symptoms and interpersonal problems as compared to 
fast responders. 
  
DISCUSSION 
 
The present study investigated changes in symptoms and interpersonal problems in the first two years 
of long-term psychoanalytic psychotherapy and psychoanalysis. Four main conclusions can be drawn. 
First of all, the rates of change were much lower than expected because patients in both treatment 
groups still presented moderate to high levels of symptoms and interpersonal problems after two years 
of treatment compared to non-clinical populations. Secondly, patients in psychoanalytic psychotherapy 
improved with regard to both symptomatic and interpersonal problems. In contrast, the only 
significant improvement in the psychoanalysis group was on one of the symptomatic subscales. This 
might indicate that perhaps the expectation that interpersonal problems would diminish more slowly 
was especially true for this particular group of patients. Third, the slopes of change were similar in 
both treatment groups, with the exception of the IIP-64 scale Intrusive where PP-patients showed 
significantly more improvement than PA-patients in the first two years of treatment. Fourth, 
exploratory analyses revealed that interesting differences could be found between patients responding 
fast to treatment and patients responding slow to treatment. In particular, fast responders in both 
treatment groups seemed to start with a much lower level of symptoms and interpersonal problems 
compared to slow responders.  
A meta-analytic study into dose-effect relationships in psychotherapy reported that 50% of the 
patients with chronic distress symptoms showed clinically significant improvement after 16 sessions, 
whereas characterological recovery was obtained for 50% of the patients after more than 104 sessions 
(Howard, Kopta, Krause, & Orlinsky, 1986; Kopta, Howard, Lowry, & Beutler, 1994). In studies with 
patients in psychoanalytic treatment smaller improvement rates were found for interpersonal problems 
than for (general/depressive/anxiety) symptoms (Blomberg et al., 2001; Brockmann et al., 2002; Haase 
et al., 2008; Leichsenring et al., 2005). The longitudinal data in the present study confirm that the rates 
of symptomatic change – as measured with the SCL-90-R-GSI, BDI-II, and STAI-Trait – were larger 
than those of personality problems (IIP-64). One would indeed expect changes in interpersonal 
problems to take longer than symptomatic recovery, because the former are more characterological in 
nature and can be seen as more closely resembling personality traits (Barkham et al., 1996; Howard et 
al., 1993; Huber et al., 2007). Nevertheless, the present study also showed that these rates of change 
did not come close to non-clinical scores in this group of patients in psychoanalytic treatment. This 
finding, in combination with the fact that 78% of the patients had already tried previous (short-term) 
treatment, might justify substantially more sessions than 104 to obtain 50% of the patients being 
recovered. A previous study with different patients had shown that patients assigned to psychoanalytic 
treatment had complex emotional and personality problems (Zevalkink & Berghout, 2008). 
Furthermore, the improvement rates might not only depend on the nature of the problem (e.g., acute 
distress vs. characterological issues), but also on other variables, such as therapist variables (e.g., level 
of experience), the quality of the therapeutic relationship, patient variables (e.g., psychological 
mindedness) or characteristics of the treatment. Future studies that include longitudinal data gathered 
using Routine Outcome Monitoring (ROM) will shed more light on the issue (Lambert, 2007). 
The present study revealed some differences between rates of change for patients in 
psychoanalysis versus patients in psychoanalytic psychotherapy. Significant changes in symptomatic 
distress (SCL-90-R GSI) were found during the first two years of psychoanalytic psychotherapy, but 
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not in the psychoanalysis group. The findings with regard to psychoanalysis are in contrast those of 
Blomberg et al. (2001) and Puschner et al. (2007). These studies reported a significant decrease in 
symptom distress within the first two years of both psychoanalysis and psychoanalytic psychotherapy. 
A possible and methodological explanation for the discrepant findings is that the present study had a 
lower number of patients in the psychoanalysis group compared to the number of participants in these 
two studies. This might be substantiated by the finding that the slopes of change between patients in 
psychoanalysis and patients in psychoanalytic psychotherapy did not differ significantly from each 
other. Compared to the hypothetical situation of ‘no change’ (regression coefficient = 0), several 
slopes of change in the psychoanalytic psychotherapy group were significantly different. This was not 
true in the psychoanalysis group. It appears that changes in the psychoanalysis group were neither 
distinctive from ‘no change’ nor dissimilar from the slopes of the patients in psychoanalytic 
psychotherapy. An alternative explanation for the difference between psychoanalysis and 
psychoanalytic psychotherapy in this study is that it reveals a theoretically justifiable difference 
between both treatments that is related to the setting and techniques. For instance, in psychoanalysis 
the use of the couch is intended to encourage regression (Gabbard, 2005; de Wolf, 2002). In 
psychoanalytic psychotherapy, the face-to-face arrangement might more easily invite the patient to 
discuss and focus on current symptoms and complaints. Perhaps, the setting does indeed induce slower 
change in psychoanalysis in symptoms compared to psychoanalytic psychotherapy. The present study 
has shown that change is only relatively slower in the group of patients in psychoanalysis compared to 
patients in psychoanalytic psychotherapy. A more thorough study is warranted to establish whether the 
observed differences are a methodological artefact or theoretically relevant.  
Another difference is that patients in psychoanalytic psychotherapy showed more 
interpersonal improvement compared patients in psychoanalysis, who even seemed to deteriorate in 
the first two years of treatment in this respect. The course of improvement for patients in 
psychoanalysis might differ from that of patients in psychoanalytic psychotherapy in that interpersonal 
problems first tend to increase, before they will eventually decrease to non-clinical levels at treatment 
termination and at follow-up (Berghout & Zevalkink, 2009). A possible explanation is the previously 
mentioned differences in treatment characteristics. For instance, the couch might encourage even more 
regression with respect to interpersonal problems than symptomatic functioning for patients in 
psychoanalysis. An intensive treatment with four to five sessions a week might entice the development 
of a different kind of relationship with the therapist in psychoanalysis as compared to psychoanalytic 
psychotherapy with the attachment history of the patient more fully in focus. Alternatively, the 
relatively low intensity and face-to-face arrangement of psychoanalytic psychotherapy might 
accelerate the treatment process and reduce the potential iatrogenic effects of treatment through 
regression.  
The improvement rates of the interpersonal problems were also investigated in more detail. 
Based on previous research, it was expected that problems related to a dependent personality style 
(submissiveness, nonassertiveness) would improve faster than problems related to antisocial behaviour 
(hostility, dominance) (Horowitz et al., 1993; Huber et al., 2007). Contrary to expectation, the findings 
showed that in both treatment groups no significant reductions were found on the subscales for Social 
Inhibition, Overly Accommodating, and Nonassertiveness after two years of treatment, whereas 
problems related to antisocial behaviour (Intrusiveness) did decrease significantly in the first two years 
of psychoanalytic psychotherapy. Perhaps the discrepancy in findings might be explained by two 
major differences between the present study and the studies of Horowitz et al. (1993) and Huber et al. 
(2007). First, they reported on pre-post treatment effects, whereas the present study reports on effects 
in the first two years on long-term psychoanalytic treatment. Second, the studies differed in the 
duration of treatment: Horowitz et al. (1993) studied the outcome of brief dynamic psychotherapy (up 
to 20 sessions once per week); Huber et al. (2007) studied the outcome of psychoanalytic 
psychotherapy with a mean duration of 32 months; and in the present study treatments were much 
longer (psychoanalytic psychotherapy: 3.9 years, psychoanalysis: 6.5 years; Berghout & Zevalkink, 
2009). Only by following the patients in both treatment groups longitudinally for their whole treatment 
length (plus follow-up period), complete developmental paths of the different types of interpersonal 
problems will become clear. It might be particularly interesting to study differences in dependency and 
antisocial pathways across treatments.  
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While patients in psychoanalysis and psychoanalytic psychotherapy did not appear to differ on 
the magnitude of symptoms and interpersonal problems at start of treatment, the intake values 
nonetheless appeared to be important predictors of the trajectory of progress of the treatment. A faster 
return to normal functioning is more likely among patients with relatively low initial symptom scores. 
Patients with more symptomatic impairment at intake require longer treatment to achieve similar 
results. Thus, the level of psychopathology at intake could be a key predictor for the time required to 
get to non-clinical levels with regard to symptomatic distress. These results are in line with findings 
from Puschner et al. (2007), who also found that initial symptom distress was the strongest predictor 
of the speed of symptom improvement. 
The current research focused on changes in symptoms and interpersonal problems, which can 
be seen as common goals in any psychotherapeutic treatment. However, especially in the case of long-
term psychoanalytic treatment, therapeutic goals may also include changes on a deeper personality 
level, such as attachment representation, reality testing or emotion regulation. Therefore, further 
research is needed to investigate the course of improvement of these elements of personality 
functioning during and after long-term psychoanalytic treatment. 
 In accelerated longitudinal designs the results could be confounded when differences between 
the cohorts regarding background characteristics and/or level of pretreatment psychopathology are 
present (Cogan & Porcerelli, 2005). Large pretreatment differences between the two patient groups 
might increase variability in test scores and decrease the reliability of the estimations of the group 
mean averages. In the present study, the two cohorts were compared on pretreatment DSM-IV-R 
diagnoses and sociodemographic characteristics. No significant differences were found on any 
variable, thus providing a strong check for the comparability of the two cohorts. However, piecing 
together segmented growth curve information from accelerated longitudinal designs can never replace 
information from truly longitudinal studies conducted over extended periods of time (Willet, Singer, & 
Martin, 1998). The major limitation of an accelerated longitudinal design is that it limits the inferences 
one can draw about the effects during a two-year period on individuals, as only within-individual 
development is measured over a one-year period. Therefore, psychoanalytic researchers are 
encouraged to also perform true longitudinal studies that investigate individual changes throughout the 
whole treatment. With the availability of growth curves for a large sample of patients, a single 
patient’s course of treatment might be predicted as soon as intake information is available (Lutz, 
Lowry, Kopta, Einstein, & Howard, 2001). Another issue to keep in mind is the co-occurrence of age 
and treatment effects. Age effects are those associated with personal maturation that persons would 
presumably experience during any period of time (Raudenbush & Chan, 1992). With regard to 
treatment effects, one could argue that it is impossible to know whether the improvements are actually 
attributable to the treatment given. Because no control group was included, it is not possible to draw 
causal inferences from the presented data. Furthermore, results should be interpreted carefully as there 
is the potential for Type I error in conducting multiple statistical tests. Also, the reliance on self-report 
measures limits the scope of investigation, as many interesting components of personality functioning 
can not be captured fully by self-report measures. Another limitation of the study is the lack of 
manualisation of the treatments and monitoring of adherence. However, the strong and unique 
psychoanalytic identity of the participating mental health institutes, with its accompanying training 
and supervision, may help to buffer the lack of manualisation and adherence issues. Every therapist in 
this study was psychoanalytically trained and/or was under supervision of an experienced 
psychoanalyst. Future studies would benefit from including treatment adherence measures into the 
research design as well as other process measures to study the mechanisms of change during 
psychoanalytic treatment.  
On average, patients with chronic mental disorders and personality pathology did not reach 
non-clinical levels after two years of treatment regarding symptoms and interpersonal problems and 
appeared to require further intensive long-term treatment in order to achieve significant improvements. 
Research has shown that after an average of five years of long-term psychoanalytic treatment 
(psychoanalysis or psychoanalytic psychotherapy) symptoms and interpersonal problems are 
effectively reduced, although complete remission could not be expected for all patients (Berghout & 
Zevalkink, 2009). The longitudinal data of this study pointed out that not much symptomatic and 
interpersonal improvement is to be expected in the first two years of psychoanalytic treatment. This 
appears to hold true especially for patients in psychoanalysis and less for those in psychoanalytic 
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psychotherapy. Apparently, the patterns of change across time differ for each type of treatment. The 
present data confirm the belief of therapists that significant change takes time in this particular patient 
population. In regular practice, it might be advisable to monitor changes routinely in order to identify 
fast responders quicker and change the treatment plan accordingly.  
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ABSTRACT 
 
Long-term psychoanalytic treatment is perceived as an expensive ambulatory treatment for mental 
illnesses. However, there are indications that psychoanalytic treatment can result in cost savings in the 
long term. In this study, we investigated the effect of long-term psychoanalytic treatment on health 
care utilization and work impairment and also calculated the associated societal costs. We assessed 
health care utilization and work impairment of patients before, during, and after long-term 
psychoanalytic treatment (N = 231). Our results show that the total difference in costs associated with 
health care utilization and work impairment between pre- and post-treatment was € 2.444 per person 
per year. Two years after treatment termination these cost savings had increased to € 3.632 per person 
per year. This indicates that we can expect decreased medical consumption and higher work 
productivity right after psychoanalytic treatment, but also that long-term psychoanalytic treatment can 
generate economical benefits in the long run. However, we can not conclude that all invested costs 
will be earned back eventually. More research is needed on the cost-effectiveness of psychoanalytic 
treatment. 
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INTRODUCTION 
 
Despite the considerable and growing body of research about the clinical effectiveness of long-term 
psychoanalytic treatment (Leichsenring & Rabung 2008; de Maat, de Jonghe, Schoevers, & Dekker 
2009), relatively little attention has been paid to economical evaluations, particularly with reference to 
the broader range of societal effects. If untreated, persons with personality disorders and/or depression 
often pose a heavy economic burden on the general health care system (Bateman & Fonagy 2003; 
Bender et al. 2001; Luppa, Heinrich, Angermeyer, König, & Riedel-Heller 2007; Smit, Bohlmeijer, & 
Cuijpers 2003; Soeteman, Hakkaart-van Roijen, Verheul, & Busschbach 2008). A recent study showed 
that patients applying for long-term psychoanalytic treatment present substantial levels of chronic 
depressive symptoms, interpersonal difficulties and personality pathology (Berghout & Zevalkink 
2008; Zevalkink & Berghout 2008). Long-term psychoanalytic treatments such as psychoanalysis and 
psychoanalytic psychotherapy are perceived as expensive ambulatory treatments for mental illnesses, 
because they often cover a relatively long period of time. These treatments are still covered by 
national health insurance plans in Canada, Australia and several European countries, including the 
Netherlands. When psychoanalysis is no longer part of the national health insurance plan, its 
availability tends to become limited as happened in the United Kingdom. However, when it is still part 
of the national health insurance plan clinicians are pushed to make decisions about inclusion that in 
effect constitute rationing (Willock, Balzert, Fayek, & Abraham 1999). In other words, these 
treatments are available only to patients for whom there are strong indications that they need it. For 
instance, in The Netherlands professionals follow government approved guidelines for treatment 
assignment to long-term psychoanalytic treatments (Zevalkink 2004). Here, psychoanalytic treatment 
is indicated to patients with complex emotional disorders, chronic mood and/or personality pathology 
and will only be determined after multiple intake sessions, screening questionnaires and a 
comprehensive personality assessment. Economic considerations encourage policy makers and health 
insurance companies to only fund evidence-based treatments, which are of minimal burden to patients 
and that can be provided in the shortest possible period of time. In that regard a study into the costs 
and effects of psychoanalytic treatment from a societal point of view seems justifiable.  
Fortunately, more and more cost-effectiveness data are available regarding these long-term 
treatments. A recent review suggests that long-term psychoanalytic therapies may result in cost 
savings in the long term, primarily through reductions in absenteeism from work, but also through 
reductions in health care utilization (de Maat, Philipszoon, Schoevers, Dekker, & de Jonghe 2007). 
However, not all studies on cost and benefits of psychoanalytic treatments show similar positive 
results. For example, Lazar, Sandell, & Grant (2006) found significant improvements in self-rated 
general health state, but no reductions in terms of absence from work and health care utilization for 
patients who received long-term psychoanalytic treatment. In contrast, they found that the average 
number of consultations with psychologists, social workers, and other paramedics increased 
significantly after psychoanalytic psychotherapy. Results from a prospective, naturalistic longitudinal 
study on medical utilization in mid- and long-term outpatient psychotherapy by Kraft, Puschner, 
Lambert, and Kordy (2006) showed an impressive reduction in the number of hospital days (about 
80%), and also a substantial reduction in medical health care costs (about 25%) from pre-treatment to 
two years after the start of treatment. In a retrospective long-term follow-up study by Beutel, Rasting, 
Stuhr, Rüger, and Leuzinger-Bohleber (2004) work loss and hospitalization days were assessed before, 
during, and after psychoanalytic treatment. On the basis of health insurance records they found that 
absenteeism from work declined strongly from pre-treatment to the end of treatment (66% less days of 
sick leave) and remained fairly stable throughout the 7-year follow-up period. They also found a large 
reduction in ambulatory medical consultations and of psychotropic medication use. The mean number 
of hospital days was rather low initially and remained low throughout treatment and follow-up.  
In studying the effects of treatment on societal costs, it might be relevant to adopt a broad 
societal perspective by considering both direct and indirect costs such as medical costs outside the 
treatment site and costs due to work impairment (Drummond, Sculpher, Torrance, O’Brien, & 
Stoddart 2005; Krupnick & Pincus 1992; Soeteman et al. 2008). In Germany, health insurance records 
provide independent data about these costs, including sick leave, hospitalization days, and medical 
consultations, although it appeared difficult to obtain complete datasets for a large number of patients 
(Beutel et al. 2004). Their research showed that patients’ self-reports were significantly correlated to 
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the health insurance records. In most other countries, however, patients’ self-reports are the only 
available data source for health costs outside the psychotherapy setting. An advantage of patients’ self-
reports is that it can include more information and also that it can assess disability for persons who did 
not have a paid job throughout the assessment period, like students or homemakers, who would 
otherwise not be included if only data from health insurance records were to be considered. 
 Most cost related studies in psychotherapy have focused on reductions in health care use 
and/or reductions in absenteeism from work (e.g., Bateman & Fonagy 2003; Chiles, Lambert, & Hatch 
1999; Gabbard, Lazar, Hornberger, & Spiegel 1997; de Maat, et al. 2007). However, there is evidence 
that not just absenteeism from work, but also reduced productivity at work might take up a substantial 
proportion of indirect costs (Hakkaart-van Roijen & Bouwmans 2007). The aim of this study was to 
investigate the direct and indirect costs of patients before, during, and after long-term government-
sponsored psychoanalytic treatment from a broad societal perspective. In this study we used a quasi-
experimental, cross-sectional design with four cohorts of patients in different phases of treatment. 
These cohorts were representative samples of patients from different phases of treatment who 
followed a naturalistic route through the mental health clinic to ensure high external validity and 
generalizabilty of the findings (Leichsenring 2004; Sandell, Blomberg, & Lazar 1997; Seligman 
1995). The advantage of such a research design is that we can obtain information about the effects of 
long-term treatments within a relatively short period of time. Cohort studies provide the best available 
evidence when randomized controlled trials (RCTs) are not feasible (Centre of Evidence Based 
Medicine Oxford 2009). We expected high costs associated with associated with health care utilization 
and work impairment in the group of patients entering psychoanalytic treatment due to their earlier 
attempts to receive psychotherapy (Zevalkink & Berghout 2008) and their low quality of life 
(Berghout, Zevalkink, & Hakkaart-van Roijen 2010), and expected significantly less costs in the group 
of patients after long-term psychoanalytic treatment.  
 
METHOD 
 
Subjects  
The total sample consisted of 231 subjects from four mental health care organisations (Nederlands 
Psychoanalytisch Instituut, De Gelderse Roos, Mediant, Parnassia/Psy-Q) divided over four cohorts. 
The pre-treatment cohort (n = 64) consisted of patients who just started long-term psychoanalytic 
treatment, in the during-treatment cohort (n = 49) patients were one year in treatment, the post-
treatment cohort (n = 67) consisted of persons who had just finished (approximately 3 months after) 
long-term psychoanalytic treatment, and persons in the follow-up cohort (n = 51) had already finished 
their treatment two years ago (follow-up).  
Inclusion criteria for participation were a minimum age of 18 years, having mastery of the 
Dutch language, having received or being assigned to long-term psychoanalytic treatment (> 25 
sessions, with a minimum frequency of once a week). Exclusion criteria were the presence of acute 
psychotic symptoms. In total we had approached 383 persons, of which 247 (65%) persons said “Yes”, 
81 (21%) said “No”, and 55 (14%) never responded. Of the 247 persons who agreed to participate, 16 
eventually did not participate in the study due to various reasons (withdrawal from the study, never 
started the psychoanalytic treatment). No significant demographic differences between responders and 
early drop-out/non-responders were found. All therapists (N = 94) in the project were licensed 
clinicians (psychiatrists/ psychotherapists or psychologists/psychotherapists) and member of one of the 
Netherlands psychoanalytic societies. Frequencies of treatment were as follows: 115 patients (50%) 
had one session per week, 23 patients (10%) were seen twice a week, 4 patients (2%) three times a 
week, 43 patients (18%) four times a week, and 46 patients (20%) were seen five times per week. 
Twenty-four subjects (10%) received medication in addition to their psychotherapy. 
The majority of our sample (73%) were women. The age range of our subjects ranged from 19 
to 68 years, with an average age of 36 years (SD = 8.4). We found that 77% of all subject had received 
previous (psycho)therapeutic treatment before applying for long-term psychoanalytic treatment. 
Further, we found that 44% of the subjects were living with a partner, 21% had children, 92% had a 
Dutch cultural background, 76% had received higher education, and 79% was employed. Chi-square 
analyses revealed no significant differences between the cohorts on pre-treatment sociodemographic 
patient characteristics (gender, treatment history, living situation, cultural background, educational 
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level, employment status), except for age at intake. Subjects in the post-treatment cohort were 
somewhat younger at the start of treatment compared to subjects in the other cohorts. Chi-square 
analysis on pre-treatment DSM-IV-R Axis I diagnoses did not show significant differences between 
the cohorts. Most frequently diagnosed across all cohorts were mood disorders (47%), in particular 
dysthymic disorder (30%). The frequencies of Axis II diagnoses were also roughly comparable across 
the four cohorts, except for the two cohorts after treatment in which significantly more patients were 
diagnosed with no personality disorder. Pre-treatment Global Assessment of Functioning (GAF) 
scores (Axis V) of patients in the follow-up cohort were significantly higher compared to those of 
patients in the other cohorts. This, however, might be due to the tendency among mental health 
professionals in recent years to estimate the GAF score lower in light of the threat of budget cuts. An 
additional study in a random subsample confirmed that it was a temporally influenced structural 
adjustment of the GAF score instead of a selection bias. In this subsample we investigated whether the 
four cohorts had experienced similar processes with regard to treatment assignment over time and 
across mental health clinic. Three experienced clinicians independently and retrospectively assessed 
the pre-treatment GAF and treatment assignment (PP versus PA) from patient files in which all 
information regarding cohort status, mental health organization, pre-treatment psychiatric 
classification, and treatment assignment was removed and edited in a similar format. The results from 
this additional study showed that clinical decision making did not change significantly over time 
(cohorts) nor differed across the four mental health organizations, thus providing a strong check for 
the comparability of the cohorts (data are available on request). 
 
Instruments 
Societal costs consist of both treatment costs—as directly assessed at the mental health clinics—and 
costs associated with health care utilization and work impairment—as measured with a questionnaire.  
Treatment costs. The estimation of treatment costs involves two steps: the measurement of the 
quantities of resource use and the assignment of unit costs or prices (Drummond et al. 2005). Total 
quantities of resource use could be calculated for patients who had finished their long-term 
psychoanalytic treatment. Three resource units were of importance here: the pre-treatment diagnostic 
assessment, the number of realized sessions, and the number of cancelled sessions for which costs 
were already made. Data on quantities of resource use were obtained from administrative records kept 
by the mental health care organizations. At one of the research sites there was no exact session 
administration before 2001, so for those patients whose treatments started before 2001, the number of 
sessions was calculated assuming an equal distribution of sessions over time (e.g., 138 sessions in 
2001-2003 was extrapolated to 276 sessions for the period 1999-2003). 
For the valuation of resource use we did not use existing market prices, because these may not 
accurately reflect the real costs. Instead, unit costs were based on data of actual personnel costs of all 
psychotherapists and psychiatrists who delivered psychoanalysis or psychoanalytic psychotherapy in 
2006, including material and overhead costs. This calculation led to an average cost per session wereof 
€ 115.22. The costs for the pre-treatment diagnostic assessment were estimated at € 3128.20. These 
unit costs were then multiplied by the quantities of resource use which resulted in an estimation of the 
total direct treatment costs. A discount rate of 4% was applied to account for differential timing of 
costs (Oostenbrink, Bouwmans, Koopmanschap, & Rutten 2004).  
Costs associated with health care utilization and work impairment. In line with an earlier 
study, direct costs were defined as the monetary valuation of the resources used to detect and treat 
medical problems and indirect costs as the costs associated with productivity loss due to absence from 
work and reduced efficiency at work (Hakkaart-van Roijen et al. 2004). Direct medical costs and 
indirect costs were measured with the 'Trimbos and iMTA questionnaire for Costs associated with 
Psychiatric illness' (TiC-P) developed by Hakkaart-van Roijen, van Straten, Donker, and Tiemens 
(2002). The TiC-P measures costs of relevant utilization of health care other than the psychoanalytic 
treatment and indirect costs due to production losses. The price of medication was not considered in 
the costs analyses because of the relatively low costs associated with it. We used the HLQ approach to 
estimate costs associated with productivity loss at work (Hakkaart-van Roijen & Bouwmans 2007). 
With this approach, respondents are asked to estimate the number of additional hours they should have 
worked to compensate for production losses due to illness and reduced efficiency on working days. 
For the analysis of long-term absence from work we applied the friction-cost method (Oostenbrink et 
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al. 2004). This limits the indirect costs of productivity losses to the period it takes to replace someone 
who becomes disabled. This friction period is estimated at 154 days (Hakkaart-van Roijen & 
Bouwmans 2007). The recall period of the TiC-P was 4 weeks, so the mean costs were multiplied by 
13 to calculate the annual costs. Missing values (4%) were replaced using the group mean imputation 
method, where the means were calculated per cohort and treatment modality.  
 
Procedure 
All patients who met the inclusion criteria (see Subjects) were approached via mail. When subjects 
returned a positive informed consent, they received a package of questionnaires, including the TiC-P, 
by regular mail with a stamped addressed envelope. Data gathering was done in the period of January 
2004 to June 2007. DSM-IV diagnoses were collected in a consensus meeting of psychiatrists, 
psychotherapists and test-psychologists at the start of treatment after a comprehensive personality 
screening. 
 
Data analyses 
Statistical comparisons of costs associated with health care utilization and work impairment between 
the cohorts were done using ANOVAs in SPSS (version 17.0). Pearson correlation was used to 
investigate the relation between dosage of treatment and indirect cost savings. 
 
RESULTS 
 
Health care utilization 
The top part of Table 1 shows the mean direct costs per person per year for patients in psychoanalytic 
treatment in each of the four cohorts. We found that the pre- vs. post-treatment difference for total 
direct costs was € 704 per year, which was a difference of 45%. Investigation of the separate 
categories revealed that the biggest contributor to costs associated with health care utilization was the 
use of ambulatory mental health care elsewhere. The pre-treatment vs. two-year follow-up difference 
was € 832 per year, which was a cost difference of 53%.  
 
Work impairment 
The bottom part of Table 1 presents the mean annual indirect costs that are associated with 
productivity loss in each phase of treatment. The data point to several findings. First, the pre- vs. post-
treatment difference in indirect costs was € 1.740 per person per year, which was a difference of 44%. 
Second, the biggest difference in costs associated with work impairment was in the category: absence 
of work. Third, at follow-up the difference in indirect costs was € 2.800 per person per year, which 
was a difference of 71% compared to pre-treatment. Fourth, standard deviations were high. This might 
be explained by the fact that cost data were skewed, which is a common finding in cost-related studies.  
 
Costs of long-term psychoanalytic treatment and indirect cost savings 
The average treatment duration was 61 months (= 5.1 years). Total costs of treatment were calculated 
by adding the costs of the pre-treatment assessment, the realized treatment sessions, and the cancelled 
treatment sessions. The average total costs of the treatments were estimated at € 64.717. Our results 
show that—after adding up cost savings due to a less health care utilization and work impairment—the 
total difference in societal costs between pre- and post-treatment was € 2.444 per person per year. Two 
years after treatment termination these cost savings had increased to € 3.632 per person per year. We 
found no significant correlation between dosage of treatment and indirect cost savings.  
 
DISCUSSION 
 
In this study we investigated the effect of long-term psychoanalytic treatment on health care utilization 
and work impairment. We adopted a broad societal perspective and found a substantial difference (€ 
2.444 per person per year) in societal costs between pre- and post-treatment. The total cost savings 
even increased after a two-year follow-up period (€ 3.632 per person per year). This indicates that we 
can expect decreased medical consumption and higher work productivity immediately after 
psychoanalytic treatment and increased economical gains two years after the treatment has ended. The 
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Table 1. Mean direct and indirect costs per year (in €) of patients in different phases of long-term psychoanalytic treatment 
Phase of treatment 
 Pre-treatment 
During-
treatment Post-treatment Follow-up ANOVA 
Health care utilization M (SD) M (SD) M (SD) M (SD) F  
General practitioner 111 (211) 79 (136) 54 (108) 64 (140) 1.62  
Ambulatory mental health care — center 655 (2.564) 169 (772) 75 (615) 99 (705) 2.15 † 
Ambulatory mental health care — private 594 (1.508) 300 (628) 529 (1.531) 262 (792) 1.01  
Company doctor 22 (74) 11 (55) 22 (110) 11 (54) 0.35  
Medical specialist 83 (285) 109 (322) 146 (515) 166 (573) 0.42  
Physiotherapist 72 (358) 108 (329) 10 (53) 72 (357) 1.14  
Social worker 23 (128) 30 (209) 0 (0) 14 (102) 0.61  
Alternative health practitioner 10 (80) 26 (184) 10 (79) 50 (283) 0.72  
Self-help group 0 (0) 14 (93) 20 (158) 0 (0) 0.70  
Total direct medical costs 1.570 (2.875) 846 (1.107) 866 (1.697) 738 (1.485) 2.27 † 
           
Work impairment           
Absence from work 2.435 (5.380) 1.133 (3.256) 1.255 (4.017) 595 (1.986) 2.24 † 
Reduced efficiency at work 1.355 (3.211) 1.303 (2.240) 918 (2.616) 500 (1.349) 1.35  
Unpaid labour 142 (597) 38 (172) 19 (97) 37 (198) 1.71  
Total indirect costs 3.932 (6.637) 2.474 (4.190) 2.192 (6.200) 1.132 (2.363) 2.74 * 
           
Total direct and indirect costs 5.502 (7.746) 3.320 (4.548) 3.058 (6.474) 1.870 (2.878) 3.87 * 
Note. npre-treatment = 64, nduring-treatment = 49, npost-treatment = 67, nfollow-up = 51. 
† p < .10, * p < .05. 
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benefits that were observed at treatment termination were maintained at two-year follow-up, 
suggesting a continuous benefit of psychoanalytic treatment. An explanation for this potential sleeper 
effect might be that long-term psychoanalytic treatment reduces people’s vulnerability to become 
psychologically distressed when faced with challenges in a way that protects from relapse after 
treatment.  
The results of our study were somewhat less optimistic as those reported in a recent review on 
the costs and benefits of long-term psychoanalytic treatment (de Maat et al. 2007). Unlike this review, 
we can not conclude that all invested costs will eventually be earned back due to savings in areas like 
health care utilization and work productivity. Also, we found no significant correlation between 
dosage of treatment and indirect cost savings. Apparently, costs savings (as a result of reduced health 
care use and work impairment) do not increase with more investments (increased frequency or longer 
duration). This would suggest that the costs-savings ratio for high-frequency psychoanalytic 
treatments is less favorable than that for low-frequency treatments.  
We have found that indirect costs represented the major part of the total costs. This is in line 
with findings from cost-of-illness studies of patients seeking psychotherapy (e.g., Luppa et al. 2007). 
Improved efficiency at work made a large, although not significant, contribution to the total indirect 
cost savings. Absence from work appeared to be the biggest contributor to indirect costs savings. 
Before treatment, patients pose a considerable economic burden on society mainly due to absenteeism 
from work. After psychoanalytic treatment we found substantially lower costs related to absence from 
work. This fact becomes even more compelling if we take into account that, according to national 
health statistics, the mean number of days of sick leave naturally increases with age (van der Linden & 
de Rijk 2008). The subjects who had already finished their treatment were significantly older at the 
time of assessment than the subjects before and during treatment (F = 6.71, p < .001). Considering this 
naturalistic course, one would expect higher levels of absenteeism from work in the post-treatment and 
follow-up groups. Our results show that the opposite was the case.  
The present study has some methodological limitations. First, the use of the cross-sectional 
cohort design limits the strength of our conclusions and mainly shows that the data strongly suggest 
that psychoanalytic treatment reduces costs associated with health care utilization and work 
impairment. A longitudinal RCT design can provide more conclusive answers. Relatedly, in multiple-
cohort designs a potential form of confounding involves differences in background characteristics and 
level of pre-treatment psychopathology between the cohorts (Cogan & Porcerelli 2005). One cannot be 
sure that the patients enrolled in the various cohorts were equivalent in terms of baseline 
psychopathology and background characteristics. We compared the four cohorts on pre-treatment 
DSM-IV-R diagnoses, sociodemographic characteristics and clinical decision making and found no 
significant differences on most variables. This provided support for the comparability of the four 
cohorts. Longitudinal research is certainly needed for more conclusive evidence. Also, we decided not 
to consider costs of medication use, because of the immense diversity in medications used and 
relatively low costs of the medication but we included as much relevant societal costs as possible. 
Also, we are dealing with imperfect estimates of true overall costs for society. As Lazar et al. (2006) 
pointed out, remote savings such as reduced health care consumption and increased productivity of the 
patient’s family members, should ideally be included, but are obviously difficult to measure. We 
encourage future research to also attempt to assess these remote cost savings. Besides the limitations, 
the major methodological merits of our study were the large sample size and the state-of-the-art 
assessment of direct and indirect costs.  
The present study has shown that costs associated with health care utilization and work 
impairment were significantly lower after long-term ambulatory psychoanalytic treatment compared to 
before treatment. Furthermore, these economical gains were again found at two-year follow-up. Of 
course, long-term psychoanalytic treatment should not only be considered beneficial because it can 
reduce costs associated with health care utilization and work impairment. The primary goal of 
psychotherapy is to improve a patient’s psychological state with reductions in societal costs as 
secondary goals (Lazar et al. 2006). We recommend to conduct state-of-the-art cost-effectiveness 
analyses for future studies.  
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A cost-utility analysis of psychoanalysis 
versus psychoanalytic psychotherapy 
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ABSTRACT 
 
Objectives: Despite the considerable and growing body of research about the clinical effectiveness of 
long-term psychoanalytic treatment, relatively little attention has been paid to economic evaluations,  
particularly with reference to the broader range of societal effects. In this cost-utility study, we 
examined the incremental cost-effectiveness ratio (ICER) of psychoanalysis versus psychoanalytic 
psychotherapy.  
Methods: Incremental costs and effects were estimated by means of cross-sectional measurements in 
a cohort design (psychoanalysis, n = 78; psychoanalytic psychotherapy, n = 104). Quality-adjusted 
life-years (QALYs) were estimated for each treatment strategy using the SF-6D. Total costs were 
calculated from a societal perspective (treatment costs plus other societal costs) and discounted at 4 
percent. 
Results: Psychoanalysis was more costly than psychoanalytic psychotherapy, but also more effective 
from a health-related quality of life perspective. The ICER—that is, the extra costs to gain one 
additional QALY by delivering psychoanalysis instead of psychoanalytic psychotherapy—was 
estimated at €52,384 per QALY gained.  
Conclusions: Our findings show that the cost-utility ratio of psychoanalysis relative to psychoanalytic 
psychotherapy is within an acceptable range. More research is needed to find out whether cost-utility 
ratios vary with different types of patients. We also encourage cost-utility analyses comparing 
psychoanalytic treatment to other forms of (long-term) treatment. 
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Psychoanalysis is perceived as an expensive ambulatory treatment for mental illnesses. This high 
intensity treatment is still covered by national health insurance in Canada, Australia, and several 
European countries, including the Netherlands. Economic considerations encourage policy makers and 
health insurance companies to only fund evidence-based treatments, which are of minimal burden to 
patients and that can be provided in the shortest possible period of time. In that light, psychoanalysis is 
on the brink of extinction if no evidence can be provided of its effectiveness in curing particular 
groups of patients. Perhaps shorter or less intensive treatments, such as psychoanalytic psychotherapy, 
are more cost-effective compared with psychoanalysis. Despite the considerable and growing body of 
research about the clinical effectiveness of long-term psychoanalytic treatment (e.g., Leichsenring and 
Rabung) (15), relatively little attention has been paid to economic evaluations, particularly with 
reference to the broader range of societal effects. Although state-of-the-art cost-effectiveness data are 
still scarce for long-term psychotherapy in the Netherlands, the first studies show promising results 
(e.g., Bartak et al. and van Asselt et al.) (3;22). In this light, a study into the cost-effectiveness of 
psychoanalysis might be particularly interesting because this is one of the most expensive ambulatory 
psychotherapeutic treatments with four to five sessions a week during an average of 4 to 5 years. 
Long-term psychoanalytic psychotherapy has a lower dosage with one to two sessions a week during 
an average of 2 to 3 years. A previous study showed that these two psychoanalytic treatments are 
commonly assigned to patients with serious, but roughly comparable, mental health problems, in 
particular chronic depression and personality problems (25). Because of the similarity of the mental 
health problems at the start of treatment, a comparison of the cost-effectiveness between the two long-
term psychoanalytic treatments seems reasonable. The general aim of this study is to investigate how 
the costs and consequences of psychoanalysis relate to those of psychoanalytic psychotherapy. 
Cost-utility analysis is generally recommended as the preferred economic evaluation method, 
especially when the health effects are measured in quality-adjusted life-years (QALYs; 10). The 
quality adjustment is based on a set of weights, called utilities, which reflects the desirability of the 
health states. A systematic review on cost-utility analysis studies of depression treatment showed that 
psychotherapy had lower costs per QALY than (primary physician) usual care (19). In addition, data 
on cost-effectiveness of psychotherapy for personality disorders suggest that treatment for patients 
with a high burden of disease may eventually lead to cost-savings (3). In cost-utility analyses, health 
improvement is commonly measured with instruments that describe and value health-related quality of 
life over a range of different health states. Such generic instruments can be used to assess the quality 
of life within a certain clinical setting and relate it to reported health states in other settings without 
having to gather that information in the project itself. Furthermore, state-of-the-art economic 
evaluations always include two different types of costs: (i) direct treatment costs and (ii) indirect costs 
associated with healthcare use and lost productivity related to health problems (21).  
The objective of this study was to investigate the estimated cost-effectiveness of 
psychoanalysis delivered by mental health workers in ambulatory mental health clinics for patients 
with chronic depression and/or personality problems in comparison with a lower intensity 
psychoanalytic psychotherapy. Earlier reports have shown that both forms of psychoanalytic treatment 
were effective with regard to reducing mental health symptoms and personality problems (4; 
Berghout, Zevalkink, & de Jong, unpublished data, 2009). In this cost-utility study, we examined the 
incremental cost-effectiveness ratio (ICER) of high-dosage versus lower-dosage psychoanalytic 
treatment which estimates the additional costs that need to be invested to achieve an extra QALY 
when choosing psychoanalysis over psychoanalytic psychotherapy. 
 
METHOD 
 
Participants 
This multicenter study included 182 subjects from four mental healthcare organizations (Nederlands 
Psychoanalytisch Instituut, De Gelderse Roos, Mediant, Parnassia/Psy-Q) who received either 
psychoanalysis (PA; n = 78) or psychoanalytic psychotherapy (PP; n = 104). In this study, we used a 
quasi-experimental, cross-sectional design with three different cohorts (20). These cohorts were 
representative samples of patients from different phases of treatment. The subjects followed a 
naturalistic route through the clinical setting with treatment assignment performed in teams of 
experienced therapists who followed professional guidelines for government sponsored long-term 
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ambulatory psychoanalytic treatment. The pretreatment cohort consisted of patients who just started 
long-term psychoanalytic treatment (nPA = 25, nPP = 39), the posttreatment cohort consisted of persons 
who had just finished long-term psychoanalytic treatment (approximately 3months after treatment 
termination; nPA =31, nPP = 36), and persons in the follow-up cohort had already finished their 
treatment 2 years ago (nPA = 22, nPP = 29). The PA/PP distribution did not significantly differ between 
cohorts.  
The comparability of the patients in the cohorts was investigated in two ways. First, we 
examined pretreatment differences between cohorts with regard to sociodemographic characteristics 
(gender, age at intake, treatment history, cultural background, educational level, employment status, 
and living situation) and psychiatric diagnoses within each treatment group to identify potential 
confounds (5). For patients in the PA-group Chi-squared analyses and ANOVA revealed no significant 
differences between the three cohorts on pretreatment sociodemographic patient characteristics. In the 
PP-group, we found cohort differences regarding age at intake and living situation: subjects in the 
posttreatment cohort were somewhat younger at the start of treatment compared with subjects in the 
other two cohorts (F = 3.39; p < .05), and there were significantly fewer subjects in the posttreatment 
cohort who lived with a partner (χ2 = 8.37; p < .05).  
Psychiatric diagnoses were assessed following the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-IV-R) (2) of which three axes are relevant for research: Axis I (symptoms), 
Axis II (personality), and Axis IV (general functioning). For DSM-IV-R Axis I, no significant 
pretreatment differences between cohorts were found. Most frequently diagnosed across all cohorts 
were mood disorders (44 percent), in particular dysthymic disorder (30 percent) followed by anxiety 
disorders (13 percent). The frequencies of Axis II diagnoses were roughly comparable across the 
cohorts, however, in the pretreatment PP-cohort there were significantly more patients with a 
diagnosis for a personality disorder (χ2 = 9.44; p < .01) compared to the other two cohorts. The 
majority of the patients (71 percent) was diagnosed with a personality disorder, in particular 
personality disorder not otherwise specified (29 percent), narcissistic personality disorder (13 percent), 
dependent personality disorder (12 percent), and avoidant personality disorder (12 percent). On Axis 
V, the average Global Assessment of Functioning (GAF) score was 64.0 (SD = 7.9). Pretreatment 
GAF scores of patients at follow-up were significantly higher compared with those of patients before 
and at end of treatment in both treatment groups (PA: F = 3.77, p < .05; PP: F = 4.38, p < .05). Maybe 
it has become customary to estimate the GAF score lower in light of the threat of budget cuts in recent 
years (see also Doidge et al.) (8).  
Second, in a random subsample (n = 58), we investigated whether the cohorts had experienced 
similar processes with regard to treatment assignment over time and mental health clinic with the aid 
of three independent clinicians who retrospectively assessed the pretreatment GAF and treatment 
assignment (PP versus PA) from patient files in which all information regarding cohort status, mental 
health organization, pretreatment psychiatric classification, and treatment assignment was removed 
and edited in a similar format. No significant GAF differences were found. The results showed that 
clinical decision making did not change significantly over time (cohorts) nor differed across the four 
organizations (for details, see Berghout et al., unpublished data, 2009). This supports the hypothesis 
that a higher GAF in the follow-up might be a temporally influenced structural adjustment of the GAF 
score instead of a selection bias. 
 
Treatments 
Both psychoanalytic psychotherapy and psychoanalysis are open-ended long-term psychotherapeutic 
treatments, defined as consisting of at least 25 sessions or lasting at least 1 year. These psychoanalytic 
treatments have been described in textbooks (e.g., 10;11;18). In general, psychoanalytic treatments 
share some common theoretical assumptions and intend to influence the working of unconscious 
processes by either focusing on conflicts, object relations, the self, and/or interactional processes (11). 
Psychoanalysis differs from psychoanalytic psychotherapy in that patients in psychoanalysis receive 
three or more sessions per week lying on the couch, while patients in psychoanalytic psychotherapy sit 
face-to-face and the frequency typically is one or two times a week. The average length of treatment 
was 6.46 years for PA (SD = 2.68 yr) and 3.94 years for PP (SD = 2.50 yr). As could be expected, this 
difference in treatment duration was significant (F = 29.0; p < .001). All therapists (n = 87) in the 
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project were licensed clinicians (psychiatrists/psychotherapists or psychologists/psychotherapists) and 
a member of one of the Netherlands psychoanalytic societies. 
 
Procedure 
Inclusion criteria for participation were a minimum age of 18 years, having mastery of the Dutch 
language, and having received or being assigned to long-term psychoanalytic treatment (>25 sessions, 
with a minimum frequency of once a week). Exclusion criteria were the presence of (acute) psychotic 
symptoms. All participants who met these criteria were approached by means of mail. When subjects 
returned a positive informed consent, they received a package of questionnaires by regular mail with a 
stamped return envelope. Data gathering was done in the period of January 2005 to June 2007. The set 
of questionnaires we used in the first months of the study did not include the SF-36. The number of 
patients with missing SF-36 data was highest in the pretreatment cohort, because we started relatively 
early with data collection in this cohort. DSM-IV-R diagnoses were assessed in a consensus meeting 
of psychiatrists, psychotherapists, and test-psychologists at the start of treatment after a comprehensive 
personality screening. 
 
Instruments 
Health-Related Quality of Life. The Short-Form Health Survey (SF-36) (24) is a generic self-
report measure of health-related quality of life. The Dutch version of the SF-36 was used (1), which 
consists of thirty-six items and generates scores across eight dimensions of physical and mental health. 
In an extensive validation study, the mean coefficient alpha (internal consistency) of the SF-36 scales 
across scales and samples was found to be 0.84 (1). From a sample of eleven items of the SF-36, 
Brazier et al. (6) estimated a preference-based single index measure, resulting in the SF-6D index. The 
SF-6D index can be regarded as a continuous outcome scored on a 0.29 to 1.00 scale, with 1.00 
indicating “full health.” This index introduces preference weights into the scoring of descriptive data 
to generate health state utility values needed to construct QALYs and conduct cost-utility analyses (6). 
Missing values (22 percent) were replaced by using the group mean imputation method. QALYs were 
estimated by calculating the average utility scores (SF-6D index) between the pretreatment and 
posttreatment measurements as well as the average scores between the posttreatment and follow-up 
measurements and multiplying it by the time between these measurement points. We assumed that 
health status changes between two measurement points were gradual over time so that changes in 
utility scores could be approximated by a straight line (9). Sample sizes were not considered to be too 
discrepant to consider alternative statistical methods.  
Direct Treatment Costs. The estimation of direct treatment costs involves two steps: the 
measurement of the quantities of resource use and the assignment of unit costs or prices (9). Total 
quantities of resource use could be calculated for patients who had finished their long-term 
psychoanalytic treatment. Three resource units were of importance here: the pretreatment diagnostic 
assessment, the number of realized sessions, and the number of cancelled sessions for which costs 
were already made. Data on quantities of resource use were obtained from administrative records kept 
by the mental healthcare organizations. At one of the research sites, there was no exact session 
administration before 2001, so for those patients whose treatments started before 2001, the number of 
sessions was calculated assuming an equal distribution of sessions over time (e.g., 138 sessions in 
2001–2003 was extrapolated to 276 sessions for the period 1999–2003).  
For the valuation of resource use, unit costs were based on data of actual personnel costs of all 
psychotherapists and psychiatrists who delivered psychoanalysis or psychoanalytic psychotherapy in 
2006, including material and overhead costs. The average session costs were calculated at €115.22, 
and the costs associated with the whole pretreatment diagnostic assessment (intake sessions, 
personality assessment, clinical decision making) were calculated at €3,128. These unit costs were 
then multiplied by the quantities of resource use which resulted in an estimation of the total direct 
treatment costs. A discount rate of 4 percent was applied to account for differential timing of costs 
(17). 
Other Societal Costs. In addition, direct medical costs and indirect costs were measured with 
the “Trimbos and iMTA questionnaire for Costs associated with Psychiatric illness” (TiC-P) (13). The 
TiC-P measures costs of relevant utilization of health care other than the psychoanalytic treatment and 
indirect costs due to production losses in paid work. We used the Health and Labor Questionnaire 
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(HLQ) approach to estimate costs associated with productivity loss at work (12). With this approach, 
respondents are asked to estimate the number of additional hours they should have worked to 
compensate for production losses due to illness and reduced efficiency on working days. For the 
analysis of long-term absence from work, we applied the friction-cost method (17). This limits the 
indirect costs of productivity losses to the period it takes to replace someone who becomes disabled. 
This friction period is estimated at 154 days (12). Missing values (4 percent) were replaced by using 
the group mean imputation method. The total societal costs were estimated by calculating the averages 
between the pretreatment and posttreatment measurements as well as the averages between the 
posttreatment and follow-up measurements and multiplying it by the time between these measurement 
points. We assumed that changes in societal costs between two measurement points were gradual over 
time. A discount rate of 4 percent was applied to account for differential timing of costs (17). 
 
Sensitivity Analyses 
The usual approach to handling uncertainty in economic evaluations is to conduct sensitivity analyses 
(9). Robustness of the results was assessed by using three-way sensitivity analyses. We recalculated 
ICERs by varying discount rates of treatment costs and other societal costs between 0 percent and 8 
percent, by using the lower confidence limit or the upper confidence limit (95 percent confidence 
interval) of the incremental effects in QALYs, and by using mean imputation or no imputation to deal 
with missing data. 
 
RESULTS 
 
Pretreatment Assessment 
For each treatment group, baseline sociodemographic and diagnostic characteristics of the patients are 
presented in Table 1. Chi-squared analyses and ANOVA revealed no significant differences between 
patients in PA and patients in PP on pretreatment sociodemographic or diagnostic characteristics, 
except for the distribution of gender. There were significantly more women in the PP-group than in the 
PA-group (80 percent versus 62 percent; χ2 = 7.38;  p< .01). Before the start of treatment, patients in 
PA did not differ significantly from patients in PP with regard to the SF-6D utility score and direct and 
indirect healthcare utilization. 
 
Table 1. Baseline characteristics of study participants in psychoanalysis (PA) and psychoanalytic 
psychotherapy (PP) 
 PA (n = 78) PP (n = 104)  
Age, years: M (SD) 33.2 (7.9) 31.6 (7.9)  
Gender     
Female 62% 80% ** 
Received previous treatment 79% 72%  
Education    
Middle 21% 24%  
Higher 79% 76%  
Western cultural background 90% 91%  
Living with partner 48% 44%  
Living with children 22% 18%  
Employed 84% 73%  
DSM-IV-R diagnoses    
Diagnosed with Axis-I disorder 99% 100%  
Diagnosed with Axis-II disorder 72% 69%  
Global Assessment of Functioning: M (SD) 65.0 (7.3) 63.3 (8.3)  
** p < .01. 
 
Incremental Cost-Effectiveness Ratio 
Table 2 presents the mean SF-6D utility scores for each cohort. A 2 (treatment group) × 3 (phase of 
treatment) independent groups analysis of variance was performed to examine main and interaction 
effects between treatment groups and phase of treatment. We found a significant main effect for phase 
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of treatment, which means that there were significant differences between the cohorts on the SF-6D 
index. These differences were in the expected direction, that is, better health status after treatment 
compared with before treatment. We did not find a main effect for treatment group nor an interaction 
effect. 
 
Table 2. SF-6D means and standard deviations for a two × three ANOVA 
 Phase of treatment 
 Pre-treatment Post-treatment Follow-up 
Treatment group M SD M SD M SD 
Psychoanalysis (PA) 0.704 (0.05) 0.793 (0.09) 0.757 (0.09) 
Psychoanalytic psychotherapy (PP) 0.713 (0.07) 0.767 (0.10) 0.776 (0.09) 
 Between-Subjects effects 
 df F  η2 p  
Phase of treatment  2 12.17 *** 0.12 .000  
Treatment group 1 0.00  0.00 .955  
Phase of treatment × Treatment group 2 1.20  0.01 .305  
Within group error 176 (0.01)     
Note. Value enclosed in parentheses represents mean square error. PA: npre-treatment = 25, npost-treatment = 31, nfollow-up 
= 22; PP: npre-treatment = 39, npost-treatment = 36, nfollow-up = 29. 
*** p < .001. 
ANOVA = analysis of variance. 
 
Table 3 presents the average treatment costs and other societal costs as well as the total costs 
of PA and PP. The total treatment costs for PA and PP were calculated by multiplying the average 
number of sessions by the basic session cost and adding the costs associated with the whole 
pretreatment diagnostic assessment (intake sessions, personality assessment, clinical decision making). 
The average number of sessions (including cancelled sessions) in PA was 971, and the average 
number of sessions for PP was 180. As expected, psychoanalysis was more expensive than 
psychoanalytic psychotherapy. Next, we calculated the number of QALYs achieved. Table 3 shows 
that more QALYs were achieved after PA as compared with PP (6.4 versus 4.5, respectively), but that 
the average costs per QALY was also higher. The ICER was estimated by dividing the difference in 
overall costs by the difference in QALYs between PA and PP. Table 3 shows that the extra costs to 
gain one additional QALY by delivering psychoanalysis instead of psychoanalytic psychotherapy was 
€52,384. 
 
Table 3. Total costs, QALYs and average costs per QALY for psychoanalysis (PA) and 
psychoanalytic psychotherapy (PP) and Incremental Cost-Effectiveness Ratio 
 PA PP 
Incremental 
values 
Treatment costs (€)  103,507 22,576  
Other societal costs (€) 35,593 15,580  
Total overall costs (treatment + societal; €)  139,100 38,156 100,944 
    QALYs  6.384 4.457 1.927 
Average costs per QALY (€ / QALY) 21,789 8,561  
    Incremental Cost-Effectiveness Ratio   52,384 
Note. QALYs = Quality Adjusted Life Years. NPA = 78, NPP = 104. 
 
Sensitivity Analyses 
The lower bound estimation of incremental QALYs was estimated at 1.857, and the upper bound 
estimation of incremental QALYs was estimated at 1.997. Incremental costs at a discount rate of 0 
percent were estimated at €114,864, and incremental costs at a discount rate of 8 percent were 
estimated at €89,540. Table 4 shows the recalculated ICERs across varying discount rates and varying 
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estimations of QALY differences. We found a small to moderate degree of variation in ICER 
estimations, supporting the robustness of the results. 
 
Table 4. ICER estimations based on three-way sensitivity analyses 
Discount rate  ∆ QALYs  Dealing with missing data  ICER estimation 
0%  Lower confidence limit  Mean imputation €61,854/ QALY 
0%  Upper confidence limit  Mean imputation €57,518/ QALY 
0%  Lower confidence limit  No imputation €64,098/ QALY 
0%  Upper confidence limit  No imputation €55,678/ QALY 
8%  Lower confidence limit  Mean imputation €48,217/ QALY 
8%  Upper confidence limit  Mean imputation €44,837/ QALY 
8%  Lower confidence limit  No imputation €49,967/ QALY 
8%  Upper confidence limit  No imputation €43,403/ QALY 
Note. ICER = Incremental Cost-Effectiveness Ratio. QALYs = Quality Adjusted Life Years. 
 
DISCUSSION 
 
In this study, we presented a cost-utility analysis to address the relative effectiveness and costs of two 
forms of long-term ambulatory psychoanalytic treatment using a cross-sectional cohort design. We 
combined pretreatment, posttreatment, and follow-up estimates of health-related quality of life and 
costs to provide incremental cost-effectiveness ratios and the average cost per QALY. The results 
showed that psychoanalysis was more expensive than psychoanalytic psychotherapy, but also more 
effective in terms of QALYs gained. The ICER of psychoanalysis compared with psychoanalytic 
psychotherapy showed that the cost of one QALY gained was just over €52,000. Whether or not 
psychoanalysis provides good value for money compared with psychoanalytic psychotherapy depends 
on the threshold of the ICER as is acceptable in the society at hand. From the literature, it becomes 
clear that estimates of this threshold vary from €12,000 to €73,000 per extra QALY in the Netherlands 
(7). The literature also reveals that estimates of acceptable threshold values tend to increase in patient 
populations with life-threatening diseases and higher burden of disease. Our results suggest that the 
cost-utility ratio of psychoanalysis relative to psychoanalytic psychotherapy appears to be within the 
acceptable range when lenient threshold values are applied, but it becomes less cost-effective when 
stricter threshold values are used. The results should be interpreted with caution due to the design, 
which brings biases from both sampling and timing differences. 
We used state-of-the-art instruments to assess health-related quality of life and direct and 
indirect societal costs. With the SF-6D, it is possible to examine whether a treatment has a clinically 
relevant effect on health-related quality of life, as the minimally important difference (MID) for the 
SF-6D utility scores has been estimated to be 0.033 points (23). Utility scores for patients receiving 
psychoanalysis increased with 0.089 from pretreatment to posttreatment. For patients in 
psychoanalytic psychotherapy, the increase in utility scores from pretreatment to posttreatment was 
0.054. From this, we can conclude that both treatments had a clinically relevant effect on health-
related quality of life as it exceeds 0.033. The SF-36 is a generic measure and not so much targets the 
specific areas in which our patients experience problems. In this way, it is possible to compare patient 
populations. Although not relevant for cost-utility analysis, we tentatively examined the SF-36 
subscales. It appeared that our patient population showed significantly worse health-related quality of 
life scores in several areas (mainly mental problems) before treatment as compared to the age- and 
sex-adjusted reference scores from the Dutch general population (1).However, our patients did not 
report many physical problems and were actually functioning quite well in these areas at the start of 
treatment. With the TiC-P, we generated data on direct medical costs following a standard procedure. 
It included costs associated with productivity loss at work, which was particularly relevant to our 
study population. As advised by the developers of the instrument, we decided not to consider costs of 
medication use, because of the immense diversity in medications used and relatively low costs 
associated with it. By including the TiC-P, we tried to adopt a broad societal perspective. Nonetheless, 
we are aware that we are still dealing with imperfect estimates of true overall costs for society. As 
Lazar et al. (14) pointed out, remote savings such as reduced healthcare consumption and increased 
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productivity of the patient’s family members, should ideally be included, but are obviously difficult to 
measure.  
Even in the most carefully designed study, data for all patients are unlikely to be complete. 
Group mean imputation generates ‘replacement’ values for missing data that will permit complete case 
analysis using the whole data set. While mean imputation is one of the most commonly used methods 
to deal with missing data in economic evaluations, Oostenbrink and Al (16) state that one should be 
cautious to apply relatively simple methods such as mean imputation to deal with missing data, 
because it can often lead to biased estimates. We had to deal with a fairly large amount of missing SF-
6D data, so these estimations were associated with the most uncertainty. The sensitivity analyses 
revealed, however, that this uncertainty impacted the estimations of the cost-effectiveness ratios only 
to a moderate extent.  
In cross-sectional cohort designs, a potential form of confounding involves differences in 
background characteristics and level of pretreatment psychopathology between the cohorts. One 
cannot be sure that the patients enrolled in the various cohorts were entirely equivalent in terms of 
baseline psychopathology and background characteristics. Pretreatment differences could potentially 
influence the results of our cohort comparisons. To investigate bias, we compared the three cohorts on 
pretreatment DSM-IV-R diagnoses, sociodemographic characteristics and clinical decision making 
and found very few significant differences. Although we realize that there might be other variables—
which we did not measure—that could have relevance to potential confounds, we have checked the 
comparability of the cohorts on several variables and found no significant sampling bias. The present 
cross-sectional cohort design was set up to gather data about costs and effects of long-term treatments 
within a relatively short period of time. We encourage future studies on the cost-utility of long-term 
psychoanalytic treatment to also include true longitudinal research designs. In addition, we encourage 
cost-utility analyses of psychoanalytic treatment compared with other forms of (long-term) treatment. 
Our study has shown that psychoanalysis is indeed more costly compared with psychoanalytic 
psychotherapy, but also more effective from a health-related quality of life perspective. The cost-
utility ratio of psychoanalysis relative to psychoanalytic psychotherapy appeared to be within the 
acceptable range, however, when one uses stricter thresholds psychoanalysis becomes less cost-
effective than psychoanalytic psychotherapy. More research is needed to find out which types of 
patients have benefited more from psychoanalysis as compared to psychoanalytic psychotherapy. 
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The general aim of this thesis was to provide data on the effectiveness of long-term psychoanalytic 
treatment. We focused on the characteristics of the patient population, the clinical effectiveness of 
psychoanalytic treatment, the course of improvement during treatment, and the cost-effectiveness of 
psychoanalysis compared to psychoanalytic psychotherapy. This chapter describes the findings and 
conclusions of these studies followed by a discussion of the present research. In this chapter, we will 
only include additional references that were not part of the discussion sections of the empirical 
chapters, with some notable exceptions, in order to avoid too much duplicity.  
 
GENERAL SUMMARY 
 
Chapters 2 and 3 described results of a pilot study on the characteristics (e.g., level of 
psychopathology) of patients assigned to long-term psychoanalytic treatment in order to investigate 
the feasibility of doing effectiveness research in this setting. The study (N = 170) intended to provide a 
detailed description of the patient population in regular clinical practice. Results showed that 
psychoanalytic treatment is not for the ‘worried well’: the overwhelming majority of patients were 
identified as clinical cases, characterized by high levels of depression, hypervigilance, trait anxiety, 
and interpersonal problems. The pilot study also showed that patients assigned to psychoanalysis 
reported higher pre-treatment levels of interpersonal problems and avoidance, and less problems with 
reality testing, information processing and instrumental aggression compared with patients assigned to 
psychoanalytic psychotherapy. 
The following five chapters described results of our multiple cohort study into long-term 
psychoanalytic treatment (N = 231). We have summarized our study under three subsections: 
effectiveness, longitudinal measurements, and cost-effectiveness. The effectiveness results of the 
multiple cohort study showed that long-term psychoanalytic treatment appeared to be highly effective 
in reducing the level of psychopathology (d = 1.19 – 1.27) and moderately effective in improving 
personality functioning (d = 0.52 – 0.79). Patient gender was found to moderate treatment outcome 
after psychoanalysis, in that women appeared to have better treatment outcome than men. We found 
that psychoanalytic treatment also led to clinically significant changes in patients’ lives, although 
complete remission should not be expected for all patients. The longitudinal results showed that most 
symptoms and interpersonal problems did not decrease notably within the first two years of 
psychoanalytic treatment; the significant effects were found at treatment termination (which was after 
3.9 years in the psychoanalytic psychotherapy group and after 6.5 years in the psychoanalysis group) 
and also at follow-up two years after treatment termination. With regard to cost-effectiveness, we 
found that long-term psychoanalytic treatment led to indirect cost savings due to reduced health care 
utilization (pre vs. post: -45%, pre vs. follow-up: -53%) and work impairment (pre vs. post: -44%, pre 
vs. follow-up: -71%). These cost savings were still lower than the direct treatment costs. Our cost-
utility analysis revealed that psychoanalysis was more costly than psychoanalytic psychotherapy, but 
also more effective from a health related quality of life perspective. The cost-utility ratio of 
psychoanalysis relative to psychoanalytic psychotherapy was estimated at about €52.000 which 
appeared to be within the acceptable range.  
 
GENERAL CONCLUSIONS AND DISCUSSION 
 
Four general conclusions can be drawn, which will be discussed in light of the relevant literature. 
First, our detailed analyses of patient characteristics revealed that we are dealing with a special and 
complex patient population. To begin with, similar to findings in the U.S., Canada, and Australia 
(Doidge et al., 2002) the great majority of the patients had previously received treatment of some kind. 
This finding is important, because apparently these patients had already tried the road to less intensive 
treatments. The stereotype of patients in psychoanalytic treatment is that they are ‘YAVIS’ patients 
(Young, Attractive, Verbal, Intelligent, and Social). Sociodemographically, many of the patients in 
psychoanalytic treatment can indeed be described as young, female, and highly-educated. However, 
these characteristics are not uncommon for patients in regular ambulatory psychotherapeutic practice 
in the Netherlands (GGZ Nederland, 2009). More distinctive is their psychopathology profile. Patients 
assigned to psychoanalytic treatment reported fewer symptoms and complaints compared to other 
psychotherapy patients. In this regard their pathology appeared to be less severe than other 
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psychotherapy patients. However, we did find that the majority of the patients assigned to 
psychoanalytic treatment were in fact clinical cases, albeit in less easily detectable areas of social and 
emotional functioning (e.g., Rorschach-CS Special Indices were significantly higher than psychiatric 
outpatients). For instance, Exner (2001) reported normative cut-off scores for psychiatric outpatients 
with 20% having clinically elevated scores on the Depression Index, and 11% having clinically 
elevated scores on the Hypervigilance Index. In our sample, we found that 53% of the patients had a 
clinically elevated Depression Index and 26% on the Hypervigilance Index. This illustrates that 
patients who are assigned to psychoanalytic treatment suffer from problems that exist on a deeper 
personality level and are more distressed than is commonly assumed. Also, the fact that most 
symptoms and interpersonal problems did not readily decrease within the first two year of treatment, 
illustrates the persistence and chronic nature of the mental health problems these patients are 
struggling with. Therefore, we can conclude that patients entering ambulatory long-term 
psychoanalytic treatment can be characterized by complex emotional disorders, chronic mood and/or 
personality pathology, and so it seems reasonable that they have occupied their own niche within 
ambulatory mental health care.  
The second general conclusion which can be drawn from this research study is that long-term 
psychoanalytic treatment is highly effective in reducing the level of psychopathology and moderately 
effective in improving personality functioning. These findings are in line with those of recent meta-
analyses (Leichsenring & Rabung, 2008; de Maat, de Jonghe, Schoevers, & Dekker, 2009). In this 
study we used symptom questionnaires as well as personality assessment instruments to study the 
effectiveness of long-term psychoanalytic treatment. Although symptom reduction may be seen as an 
important target of long-term psychoanalytic treatment, the broader goal is to achieve fundamental 
character change and change in vulnerabilities inherent in the patient’s personality (Gabbard, 2009; 
Shedler, 2010). Our results give support to the notion that change after psychoanalytic treatment goes 
further than symptom alleviation and behavioral change, in that personality change is also achieved. 
We consider this a major merit of our study. We found that the presence and depth of depression, the 
level of social maladjustment and feelings of alienation, and the high levels of anxiety and self-doubt 
that characterize patients who apply for psychoanalytic treatment could be effectively reduced after 
long-term treatment, and for the most part remain stable in the long run. Long-term psychoanalytic 
treatment also appeared to have a clinically significance impact on patients’ lives, as demonstrated by 
the large number of patients whose end-state functioning was in the normative range on most outcome 
measures. These treatment effects were not yet visible after one year of treatment, but more so at the 
end of treatment and at two-year follow-up. It is important to emphasize that most treatment effects 
were sustained after a two-year follow-up period, because this follow-up effect is not commonly found 
after short-term psychotherapy or pharmacotherapy (Hughes & Cohen, 2009; de Maat, Dekker, 
Schoevers, & de Jonghe, 2006). Therefore, a tentative conclusion is that long-term psychoanalytic 
treatment is suitable and effective for patients with complex emotional problems, chronic mood 
disorders and/or personality pathology. We emphasize that the results from our cohort study regarding 
the effectiveness of long-term psychoanalytic treatment are based on cross-sectional cohort 
comparisons. Individual changes in patients across the complete duration of treatment were not tested, 
only differences between patients on a group level. Therefore, we need to be careful in drawing 
definite conclusions about treatment effectiveness from the presented data. 
The third general conclusion of this research study concerns the findings regarding 
characteristics of patients in psychoanalysis and psychoanalytic psychotherapy. First of all, it is 
remarkable that we found many similarities between patients in psychoanalysis and those in 
psychoanalytic psychotherapy. For instance, patients in psychoanalysis and psychoanalytic 
psychotherapy did not differ in the level of symptoms and complaints before treatment as measured 
with three symptom questionnaires (SCL-90-R, BDI-II, STAI). Apparently these instruments mainly 
function as screening instruments and are not sensitive enough to detect more subtle differences 
between groups of patients. Another similarity we found was that the pre-post effect sizes of 
psychoanalysis and psychoanalytic psychotherapy were fairly comparable. Although patients in 
psychoanalysis had a significant longer treatment with higher frequency of sessions compared to 
patients in psychoanalytic psychotherapy, the end of treatment was signaled by a similar level of 
change in symptoms and personality problems. In other words, therapists and patients generally appear 
to end treatment when clinical significant change is obtained, albeit that psychoanalytic psychotherapy 
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achieved this effect after 3.9 years, and psychoanalysis after 6.5 years. This level of clinical change is 
a more common finding, because other forms of treatment aimed at other types of patients report 
similar effect sizes (e.g., Lambert & Ogles, 2004). Besides similarities, we also found differences 
between the two treatment groups. The first difference was related to pre-treatment levels of 
personality problems, as measured with the MMPI-2, Rorschach-CS and IIP-64. In the pilot study, 
patients assigned to psychoanalysis reported higher pre-treatment levels of interpersonal problems and 
avoidance and fewer problems with reality testing, conceptual thinking and instrumental aggression 
compared with patients assigned to psychoanalytic psychotherapy (Zevalkink & Berghout, 2008). 
However, this was not replicated in the pre-treatment group of the multiple cohort study (Berghout, 
Zevalkink, & de Jong, 2009). Perhaps the personality differences are too subtle to detect in a relatively 
smaller sample. Another possible explanation for this discrepancy is that in the first study we 
investigated intended treatment, and in the second study we investigated realized treatment. This 
might suggest that therapeutic decision making does not always relate to the actual treatment delivery 
(see also Caligor et al. 2009). In this, we have to keep in mind that we only looked at a certain 
selection of patient variables, and did not assess other variables that might be important in treatment 
assignment, such as therapist availability, therapist-patient matching, and life circumstances of the 
patient. Another difference between the two patient groups was found in the longitudinal study. 
Although changes in symptoms and interpersonal problems within the first two years of 
psychoanalytic treatment were fairly limited, we did find more significant changes during the first two 
years of psychoanalytic psychotherapy compared to psychoanalysis. This might suggest that patients 
in psychoanalysis follow a different (and slower) pattern of change than patients in psychoanalytic 
psychotherapy. Perhaps the setting of psychoanalysis –which encourages regression– may in some 
cases cause an initial increase in anxiety and generate psychological symptoms. Therefore the overall 
changes in the psychoanalysis group might have been smaller than those in the psychoanalytic 
psychotherapy group. A final difference was found in the follow-up effect sizes with those of 
psychoanalysis being somewhat higher than those of psychoanalytic psychotherapy. It seems that the 
slow rate of improvement during psychoanalysis enables patients to maintain their therapeutic gains 
more than patients in the lower intensity psychoanalytic treatment. Perhaps the claim that 
psychoanalysis achieves longer lasting change contains a grain of truth. Our study has tentatively 
investigated similarities and differences between the two treatment groups and reported some 
interesting findings, but more research is certainly needed. 
And fourth, our cost-effectiveness results showed that long-term psychoanalytic treatment is 
indeed an expensive ambulatory treatment, but cost savings can be achieved in the long run by 
reducing health care utilization and work impairment. Nonetheless, we can not conclude that all 
invested costs will be earned back eventually in contrast to the findings of a recent review on the costs 
and benefits of long-term psychoanalytic treatment (de Maat, Philipszoon, Schoevers, Dekker, & de 
Jonghe 2007). Also, we found that costs savings (as a result of reduced health care use and work 
impairment) did not increase with more investments (increased frequency or longer duration). This 
would suggest that the costs-savings ratio for high-frequency psychoanalytic treatments is less 
favorable than that for low-frequency treatments. Our cost-utility analyses (CUA) showed that 
psychoanalysis was indeed more costly than psychoanalytic psychotherapy, but also more effective 
from a health related quality of life perspective (QALYs). The Incremental Cost-Effectiveness Ratio 
(ICER) –i.e. the extra costs to gain one additional QALY by delivering psychoanalysis instead of 
psychoanalytic psychotherapy– was estimated at about €52.000 which appeared to be within the 
acceptable range. This means that psychoanalysis has an added value over psychoanalytic 
psychotherapy which makes the difference in treatment costs a worthwhile consideration for policy 
makers and insurance companies. However, the cost-effectiveness ratio does not follow a one-on-one 
relationship. Our analyses showed that psychoanalysis is four to five times more expensive than 
psychoanalytic psychotherapy, but the effectiveness of psychoanalysis is not four to five times bigger 
than that of psychoanalytic psychotherapy. In order to assess whether or not psychoanalysis still 
provides good value for money compared to psychoanalytic psychotherapy one can investigate 
whether the ICER falls below or above a certain agreed upon threshold. So far, there is no clear 
consensus yet on what ICER value could function as a threshold when comparing the costs and effects 
of two treatments. Estimates of such a threshold vary substantially (from €12.000 to €73.000; Brouwer 
& Rutten, 2006) and can depend on many variables, such as societal and cultural factors. Our results 
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suggest that the Incremental Cost-Effectiveness Ratio of psychoanalysis relative to psychoanalytic 
psychotherapy appears to be within the acceptable range when lenient threshold values are applied, but 
it becomes less cost-effective when stricter threshold values are employed. Future research is needed 
to make more accurate estimates of cost-effectiveness ratios and ICER thresholds. In this regard, one 
also needs to take into account that the choice of instrument to measure health-related quality of life 
may influence ICER estimations as well (Sach et al., 2009). Therefore, careful consideration needs to 
be paid to the methodology of future cost-effectiveness studies.  
 
CLINICAL AND ECONOMICAL IMPLICATIONS 
 
The outcome measures in our research project were selected on the basis of theoretical significance, 
empirical research, clinical utility, and psychometric qualities. Most of the instruments we selected are 
widely used measures to assess therapeutic improvement and are also relevant for clinical decision 
making regarding treatment selection (Hill & Lambert, 2004). The relatively short self-report 
measures (SCL-90-R, BDI-II, STAI, IIP-64, and SF-36) are also suitable for monitoring progress 
during treatment, also known as routine outcome monitoring (ROM). This will ultimately improve the 
quality of care and therapeutic decision making (Lambert, 2007). Effectiveness research and routine 
outcome monitoring are tremendously valuable in identifying which patients improve, when they 
improve, and –perhaps even more important– which patients do not improve. This constant monitoring 
of treatment progress and treatment outcome can eventually help to improve treatment assignment and 
treatment delivery. We want to emphasize that we recognize that such data collection can be a big 
burden for treatment professionals; therefore it is vital that this process is organized independently 
from the treatment process (Oudejans, 2009). Two important benefits of routinely monitoring 
treatment progress and outcome can be identified.  
First of all, patients and therapists will be able to use the results about progress regarding 
symptoms and personality to identify which treatments can be terminated. When enough progress has 
been achieved and the patient is again functioning on an acceptable level, the therapist can see this in 
the ROM reports and may suggest terminating the treatment. The systematic monitoring of treatment 
progress can also identify patients who do not improve in treatment. In those cases the reports may 
serve as primers to evaluate whether or not it is sensible to continue treatment. And if so, reflect on 
why the therapy is not working, and discuss what should be modified in order to make the treatment 
more effective. The more therapists become familiar with results from effectiveness research and 
routine outcome monitoring the more they will become able to interpret and use results from 
questionnaires and personality assessment instruments, which can eventually improve their treatments. 
Patients will also experience that they are being taken seriously. Process and outcome measurement 
gives patients a moment to reflect on how they are doing, and how they were feeling a while ago. This 
moment of evaluation also allows them to reflect on the process of therapy, and whether or not they 
feel they have made enough progress in the therapy.  
The second important advantage of outcome monitoring treatment progress and outcome is 
that it will improve transparency towards third party payers. Policy makers and insurance companies 
are putting more and more pressure on mental health care providers to demonstrate the quality and 
effectiveness of their treatments. By providing feedback about treatment progress and outcome on an 
aggregated level, these third party payers will be provided with the best evidence available.  
Before commenting on the cost-effectiveness of psychoanalytic treatment, it is important to 
note that the patient population receiving psychoanalytic treatment in the Netherlands is very small (± 
150 new patients each year and ± 400 patients in treatment). Indeed, long-term psychoanalytic 
treatments (especially psychoanalysis) are relatively expensive ambulatory treatments, but relatively 
cheap compared to clinical or day-clinical treatments. Nonetheless, we believe it is important to not 
waste public money and know when to stop. Perhaps some psychoanalyses can be terminated quicker. 
A suggestion could be to consider treatment termination after four years, give the patient a break, 
monitor how the patient is doing for a year or two, and if necessary resume treatment. This might 
prevent patients and therapists to get stuck in seemingly endless psychoanalyses. 
If we think of the adagio: “short if possible, long if necessary”, does this mean that we should 
always start with short-term treatment and only assign patients to long-term psychoanalytic treatment 
when previous treatment has failed? From a cost-effectiveness point of view it would be advisable to 
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start with a short-term treatment if possible, and if that is not sufficient suggest long-term treatment. 
This is called stepped care. The majority of patients assigned to long-term psychoanalytic treatment 
have already received previous treatment. This seems to be characteristic of this patient population, 
and fits in the stepped-care way of thinking that long-term treatment is indicated when short-term 
treatment(s) failed. Of course, in clinical practice it should still be possible that in some cases 
clinicians decide to offer a patient long-term psychoanalytic treatment regardless whether the patient 
has received previous treatment or not. 
The answer to the question when patients should be assigned to psychoanalysis and when to 
psychoanalysis is not solved in our study and remains a complicated one. Our cost-effectiveness data 
suggest that both treatments are viable options to improve the quality of life. Our longitudinal data 
showed that progress in psychoanalysis goes slower than in psychoanalytic psychotherapy, and the 
effectiveness data revealed that psychoanalysis might have longer lasting effects compared to 
psychoanalytic psychotherapy. In sum, the results of our study sketch a complicated picture. There 
might also be other considerations that play a role in choosing one treatment over the other. For 
instance, recent theoretical and empirical insights into the development of interpersonal problems have 
shown that patients with an internal working model of relationships that reflect a defensive, avoiding 
style needed higher intensity psychoanalytic treatment in order to change compared with those with a 
more preoccupied internal working model (Blatt & Shahar, 2004; Fonagy et al., 1996; Horowitz, 
Rosenberg, & Bartholomew, 1993). Further research is needed to look more closely into this issue.  
 
METHODOLOGICAL COMMENTS 
 
We are well aware of the fact that the internal validity of a RCT is better than that of a cross-sectional 
cohort study. However, we believe that the great advantage of cohort studies is that they use an 
effectiveness design, i.e. investigate treatments the way they are delivered in daily practice, whereas 
RCTs use an efficacy design and investigate treatments in experimental circumstances with artificially 
created patient groups, thus having less clinical representativeness than naturalistic research studies. 
To elaborate more on the limitations of cross-sectional cohort studies, two mayor limitations can be 
identified. First, the use of cross-sectional measurements increases threats to validity because the 
cohorts may not be fully comparable. The comparison of results between cohorts regarding symptoms 
and personality may have been distorted by any possible unmeasured differences between the cohorts. 
The second limitation is that the absence of a control group and the limited number of assessments 
over time makes causal interpretations uncertain. One cannot be absolutely sure that the improvements 
found could be attributed to the treatments, because to some degree they could also be caused by other 
(unknown) factors.  
 However, we have performed several cohort comparisons to minimize the distortion that 
possible differences might have caused. The results of our comparison of the cohorts regarding pre-
treatment DSM-IV-R diagnoses, socio-demographic characteristics and clinical decision-making 
showed no significant differences on most variables, thus providing a strong check for the 
comparability of the four cohorts. Moreover, in our statistical analyses of treatment effectiveness we 
corrected for those pre-treatment variables that did show significant differences between the cohorts. 
With regard to the lack of an actual control group, we tried to deal with this by using data from clinical 
and non-clinical reference groups as well as reported data about the average control group effect 
(Leichsenring & Rabung, 2006). This way, we did have some reference points regarding the level of 
symptoms and personality pathology of our patients.  
We used a relatively comprehensive assessment battery that showed that change is consistent 
across different methods. The validity and reliability of the instruments we used in this study appeared 
to be very good, although some might argue that the MMPI-2 and Rorschach-CS have less favorable 
psychometric properties. According to the COTAN (Commissie Testaangelegenheden Nederland: the 
Dutch Test Evaluation Authority) the MMPI-2 has adequate reliability but inadequate validity, and the 
Rorschach has both inadequate reliability and validity (Evers, Vliet-Mulder, & Groot, 2000). It 
therefore seems reasonable to be more careful in interpreting the test results of these instruments.  
 In principle, self-report instruments are vulnerable to distortions. Patients may exaggerate their 
distress before treatment or exaggerate their improvements after treatment (Stiles, Barkham, Mellor-
Clark, & Connell, 2008). This is a restriction inherent to research using self-report measures. 
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However, the MMPI-2 does make some corrections in cases of over- of underreporting of complaints. 
Because we did not want to rely solely on self-report measures we also included personality 
assessment instruments that are less vulnerable to conscious over- of underreporting, such as the 
Rorschach-CS and the Adult Attachment Interview (AAI). At the time of writing this thesis, the 
manuscripts with the complete results of these instruments were not yet ready for publication.  
 Overall, we were very pleased with the participation rate of our study. Out of the 383 eligible 
patients 231 patients participated in the study, yielding a response rate of 65%. We consider this a very 
satisfactory response rate, as it is comparable to or even higher than that in other psychotherapy 
research. All patients were assessed at least once. The attrition rate –regarding the longitudinal 
measurements– was 15% after 6 months and 18% after 12 months. In the process of data collection we 
received many positive responses from patients about the study; patients very much appreciated the 
interest that was being shown in them. We believe that the prospect of being given personal feedback 
about their test results had a positive effect on the response rate. Patients felt that they were being 
taken seriously and valued our approach of assessing the effectiveness of the treatment from the 
patients’ perspective. This strengthens our belief that effectiveness studies and routine outcome 
monitoring are feasible, acceptable and appreciated. 
 
NEXT STEPS OF THIS RESEARCH STUDY 
 
Psychotherapy research needs to differentiate more among patients and to examine systematically the 
patient’s contributions to the treatment process. Different types of patients may respond more 
effectively to different types of treatment or respond to the same type of treatment in divergent ways 
(Blatt & Felsen, 1993). We identified patient characteristics that might be associated with treatment 
outcome. For instance, it appeared that female patients have better prospects when entering long-term 
psychoanalytic treatment, and in particular psychoanalysis, compared to male patients. More 
specifically, psychoanalysis was more effective in reducing personality problems regarding social 
disadaptation and disorganization for women than for men, even though we found similar levels of this 
type of pathology at the start of treatment. In addition, male patients with high levels of social 
disadaptation, feelings of alienation, anxiety and disorganized mental states were more likely to be 
effectively treated with psychoanalytic psychotherapy compared to psychoanalysis. Of course, these 
findings still need to be replicated before they can be used in treatment assignment. They do, however, 
stimulate our curiosity about other possible moderators. In this regard, it might be interesting to 
investigate the influence of patient/therapist gender matching on treatment outcome.  
The implementation of routine outcome monitoring (ROM) will eventually enable us to draw 
stronger conclusions about the effectiveness of psychoanalysis and psychoanalytic psychotherapy, 
because each patient entering treatment will be followed longitudinally during the whole treatment 
process. This way we will also be better able to identify developmental paths within certain subgroups 
of patients. Certain variables –such as patient or treatment characteristics– can possibly be moderating 
factors in treatment outcome. These characteristics might influence the benefit derived from treatment. 
A possible research project for the near-future would be to identify a group of male patients with high 
scores on social disadaptation (MMPI-2 scales 4, 7, and 8) and assign these patients randomly to either 
psychoanalysis or psychoanalytic psychotherapy. In this way, we can test the hypothesis that 
psychoanalytic psychotherapy is more effective than psychoanalysis for this particular group of 
patients. This is just one example of future research steps. On the whole these results will eventually 
facilitate and improve therapeutic decision making, and enable us to formulate and sharpen criteria for 
treatment assignment as well as improve the quality of treatments delivered. Therefore, it is essential 
to do more research and perform additional longitudinal analyses. 
In this study we also used the Adult Attachment Interview (AAI) as an outcome measure. The 
AAI is a 1-hour semi-structured interview about childhood attachment relationships and the present 
evaluation of these experiences. The AAI assesses state of mind with respect to attachment. The 
discourse characteristics of the interviews can be coded systematically, and will eventually yield three 
main classifications: autonomous, dismissing, and preoccupied. Furthermore, interviews can be 
categorized as unresolved with respect to loss or trauma. Unfortunately, at the time of finishing this 
PhD thesis, the AAI data were not yet complete, because transcribing and scoring the AAI is very time 
consuming. Preliminary analyses on 70% of the data show very encouraging results. For instance, first 
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data showed that before treatment about 80% of the patients had insecure attachment representations 
and after treatment only 20% had insecure attachment representations (Zevalkink, 2009). The 
complete AAI data will be presented in future reports.  
In this thesis we focused on characteristics related to the patient. However, therapist variables 
(e.g., adherence, years of experience) as well as patient-therapist variables (e.g., therapeutic alliance), 
might also play a role in explaining the different treatment outcomes. Therefore, we also sent the 
Therapeutic Identity questionnaire (ThId; Sandell et al., 2004) to all therapists to measure therapeutic 
attitudes, styles and beliefs. These results were not included in this thesis, because data-analyses are 
still in progress. For the same reason we also have not included a detailed variable analyses of the 
Rorschach-CS (Exner, 2003) in this thesis, and only reported the general results regarding the Special 
Indices. These results showed some significant treatment effects, but less than expected based on the 
results of the other personality measures (MMPI-2 and IIP-64). Perhaps the detailed analyses of 
Rorschach-CS variables would reveal more or larger effects in certain clusters of variables or certain 
subgroups of patients.  
 
SUGGESTIONS FOR FUTURE RESEARCH 
 
There is a growing and encouraging evidence base for psychoanalytic treatments. Nevertheless, this 
evidence base is relatively small compared to that for other treatments such as Cognitive Behavior 
Therapy (CBT) or Interpersonal Psychotherapy (IPT). The suggestion to also compare long-term 
open-ended psychoanalytic treatment (such as psychoanalysis and psychoanalytic psychotherapy) with 
other forms of psychological treatment is an interesting line of inquiry. As mentioned before, 
comparative research is complicated when it concerns long-term treatments. So far, there have been 
few RCTs which studied psychoanalytic treatments, and most of these efficacy studies concerned 
time-limited psychoanalytic treatment (Busch, Milrod, & Sandberg, 2009; Clarkin et al., 2007; 
Leichsenring, Rabung, & Leibing, 2004; Leichsenring et al, 2009; Svartberg, Stiles, & Seltzer, 2004). 
One notable exception is the Helsinki Psychotherapy Study which is a randomized trial on the 
differential effectiveness of long-term psychodynamic psychotherapy, short-term psychodynamic 
psychotherapy, and short-term solution-focused therapy (Knekt & Lindfors, 2004). They found that 
the two short-term therapies produced benefits more quickly than long-term psychodynamic 
psychotherapy, but in the long run long-term psychodynamic psychotherapy was found to be superior 
to short-term therapies (Knekt et al., 2008). These researchers showed that it is possible to successfully 
apply a RCT design to the study of long-term psychoanalytic psychotherapy. Interestingly, this did not 
apply to their fourth treatment group –the psychoanalysis group– which was studied separately in a 
quasi-experimental design. These patients were self-selected and assessed as suitable for 
psychoanalysis, thus were not randomized to psychoanalysis. Apparently, the researchers found it 
unacceptable to randomize patients to such an intensive and long-term treatment, and therefore chose 
to follow a naturalistic study design to study the effectiveness of psychoanalysis. 
The design of the multiple cohort study was partly cross-sectional and partly longitudinal. The 
longitudinal component of this study was limited to a 12-month period with three measurements in 
that year. By linking the cohorts together we created an ‘accelerated longitudinal design’ which is a 
close approximation of a longitudinal study. The advantage of an accelerated longitudinal design is 
that we can obtain information about therapeutic changes over a longer period within a relatively short 
period of time. However, such approximations of longitudinal studies are always less accurate than 
real longitudinal studies. We therefore encourage future studies on the (cost-) effectiveness of long-
term psychoanalytic treatment to also include true longitudinal research designs.  
Future research should also be focused on identifying mechanisms of change within 
psychoanalytic treatment. It would be interesting to investigate what goes on in treatment that is 
helpful, or what is helpful to different kinds of patients. In this regard we encourage future researchers 
to include process measures such as the Analytic Process Scales (APS; Waldron, Scharf, Hurst, 
Firestein, & Burton, 2004) or the Psychoanalytic Process Rating Scale (PPRS; Beenen & Stoker, 
2001) to establish links between processes and outcomes. Including process measures would 
strengthen the conclusions of an outcome study and would increase also our knowledge of which 
aspects of the treatment seemed to be helpful and which did not.  
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CONCLUDING REMARKS 
 
Fortunately, psychoanalytic treatments are still covered by national health insurance plans in Canada, 
Australia and several European countries including the Netherlands. We believe that it is crucial for 
the ‘survival’ of psychoanalysis and psychoanalytic psychotherapy to stimulate and promote empirical 
research. That does not mean that every psychoanalyst has to do research, or that one should 
immediately be swayed by the results of any study or trend, but we definitely believe the 
(psychoanalytic) community should be informed by it. It is therefore important to stimulate graduate 
students, scholars, university professors, psychotherapists and psychiatrists to become more involved 
in doing psychoanalytic research. Without empirical research supporting the effectiveness of 
psychoanalytic treatment, it will become very hard to maintain the credit from the public as well as 
coverage from health insurance companies. 
The results of the studies in this thesis give support that long-term psychoanalytic 
psychotherapy and psychoanalysis are effective treatments for patients with complex and chronic 
mental health problems. The presence and depth of depression, the level of social maladjustment and 
feelings of alienation, (social) anxiety and self-doubt can be substantially and consistently reduced 
after long-term psychoanalytic treatment. Furthermore, long-term psychoanalytic treatment will lead 
to indirect cost savings due to reduced health care utilization and work impairment. It is clear that 
more work remains to be done, but we think that the present findings are helpful in adding to thinking 
about the effectiveness and cost-effectiveness of long-term psychoanalytic treatment.  
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SUMMARY 
 
 
A cohort study into the effectiveness of long-term psychoanalytic treatment for patients with 
personality disorders and/or chronic depression 
 
Research into the effectiveness and cost-effectiveness of long-term psychoanalytic treatments, in 
specific psychoanalysis and psychoanalytic psychotherapy, is still relatively scarce and is the central 
topic of this PhD thesis. First, we performed a pilot study to investigate pre-treatment mental health 
characteristics of patients assigned to psychoanalysis and psychoanalytic psychotherapy. This pilot 
study was also meant to examine the feasibility of doing effectiveness research in this setting. Next, 
we performed a large multicentre study which aimed to investigate the effectiveness and cost-
effectiveness of long-term ambulatory psychoanalytic treatment in the Netherlands. 
 
Chapter 1 presents an introduction to the subject, which aims to explain the choice of theoretical 
framework, instruments, and design of our study into the effectiveness of psychoanalytic treatment 
 
Chapter 2 offers a description of patients prior to long-term psychoanalytic treatment. The main 
question in this chapter is how the pre-treatment psychopathology levels of patients assigned to long-
term psychoanalytic treatment relate to those of other ambulatory patient groups. For each patient we 
calculated whether the level of symptoms, interpersonal problems and personality pathology were 
above or below a statistically defined cut-off. The results showed that patients assigned to long-term 
psychoanalytic treatment presented less symptoms and complaints than other ambulatory patients. 
However, with regard to personality pathology they scored similar – and in some areas even higher – 
in comparison to other ambulatory patient groups. Next, we combined this information to come to a 
global estimation of the number of ‘clinical cases’ in our patient population. From the combined test 
results it appeared that the overwhelming majority of patients were identified as clinical cases, 
characterized by high levels of chronic depression, hypervigilance, trait anxiety, and interpersonal 
problems. Thirty-five percent of the patients was diagnosed with dystymic disorder. Long-term 
psychoanalytic treatment appears to be assigned to patients with complex and chronic mental health 
problems, most of whom have already received short-term therapy. They present problems that exist 
on a deeper (and less easily detectable) personality level. We conclude that patients assigned to long-
term psychoanalytic treatment are more distressed than is commonly assumed.  
 
Chapter 3 discusses the differences between patients assigned to psychoanalysis (PA) and patients 
assigned to psychoanalysis psychoanalytic psychotherapy (PP). We found a great number of 
similarities, but also some interesting differences between the two patient groups. The results showed 
that patients assigned to psychoanalysis reported higher pre-treatment levels of interpersonal problems 
and avoidance, and less problems with reality testing, information processing and instrumental 
aggression compared with patients assigned to psychoanalytic psychotherapy. These results seem to 
suggest that social inhibition and avoidance are important aspects in the therapists’ decision making 
process regarding treatment assignment. Avoidant patients appear to be more likely to be assigned to a 
longer and more intensive treatment than less avoidant patients. We conclude that there appears to be a 
large ‘grey area’ concerning assignment to psychoanalysis or psychoanalytic psychotherapy, and that 
perhaps other factors (which we did not measure) can also play an important role in therapists’ 
decision making process. 
 
Chapter 4 reports on the results of the multiple-cohort effectiveness study. We compared patients in 
four different phases of treatment (pre, during, post, follow-up) with regard to symptoms and 
personality functioning. Differences in raw scores between patients in the different phases of treatment 
were investigated. We performed factor analyses to reduce the number of outcome variables, and with 
these outcome factors we investigated potential predictors of treatment outcome. Also we compared 
the effect sizes with natural remission data. The results showed that long-term psychoanalytic 
treatment was highly effective in reducing symptomatic distress (d = 1.19 – 1.27) and moderately 
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effective in improving personality functioning (d = 0.52 – 0.79). The effect sizes of psychoanalytic 
treatment were several times bigger that the average control group effect. Patient gender appeared to 
moderate treatment outcome, with women having a better treatment outcome with regard to 
disadaptation and disorganization compared to men, in particular in the psychoanalysis group. Our 
results showed that the presence and depth of depression, the level of social maladjustment and 
feelings of alienation, and the level of (social) anxiety and self-doubt were substantially and 
consistently reduced after long-term psychoanalytic treatment.  
 
Chapter 5 investigates the clinical significance of long-term psychoanalytic treatment. Normative 
comparisons were done to investigate how the patient’s level of functioning related to that of the 
‘functional’ population and the ‘dysfunctional’ population. This way, we got an estimation of the 
proportion of ‘normal functioning’ people in each phase of treatment. The results showed that after 
long-term psychoanalytic treatment the majority of the participants appeared to function within the 
normal range on most instruments. We conclude that psychoanalytic treatment led to clinically 
significant changes in patients’ lives, although complete remission should not be expected for all 
patients.  
 
Chapter 6 discusses the results of the longitudinal measurements we performed within the multiple 
cohort effectiveness study. We investigated changes in symptoms and interpersonal problems during 
the first two years of long-term psychoanalytic psychotherapy and psychoanalysis. The results showed 
less improvement in the first two years with regard to interpersonal problems compared to 
symptomatic improvement. Secondly, patients in psychoanalytic psychotherapy showed clear 
improvements on both symptomatic and interpersonal functioning, while patients in psychoanalysis 
only showed symptomatic improvement within the first two years of treatment. On the whole, the rates 
of change were lower than expected because patients in both treatment groups still presented moderate 
to high levels of symptoms and interpersonal problems after two years of treatment compared to non-
clinical populations. Also, exploratory analyses revealed that interesting differences could be found 
between patients responding fast to treatment and patients responding slow to treatment. We found 
that fast responders in both treatment groups seemed to start with a much lower level of symptoms and 
interpersonal problems compared to slow responders.  
 
Chapter 7 investigates the societal costs and savings of long-term psychoanalytic treatment. Long-
term psychoanalytic treatments are relatively expensive treatments within the ambulatory segment. We 
investigated the effects of long-term psychoanalytic treatment on health care utilization and work 
impairment. From the results of our study it appears that after long-term psychoanalytic treatment 
health care utilization decreases, absenteeism reduces and work productivity increases. Long-term 
psychoanalytic treatment appears to generate economical benefits in the long run. We found that part 
of the treatment costs will be earned back because of these indirect costs savings. However, not all 
invested costs will be earned back eventually.  
 
Chapter 8 reports on the cost-utility analysis where the differences in costs and effects of 
psychoanalysis and psychoanalytic psychotherapy were investigated. The analyses were done from a 
societal perspective. We examined the incremental cost-effectiveness ratio of high-dosage versus 
lower-dosage psychoanalytic treatment which estimates the additional costs that need to be invested to 
achieve an extra quality-adjusted life year (QALY) when choosing psychoanalysis over 
psychoanalytic psychotherapy. Our cost-utility analysis revealed that psychoanalysis is more costly 
than psychoanalytic psychotherapy, but also more effective from a health related quality of life 
perspective. The cost-utility ratio of psychoanalysis relative to psychoanalytic psychotherapy was 
estimated at about €52.000. Whether or not psychoanalysis provides good value for money compared 
to psychoanalytic psychotherapy depends on the threshold of the ICER as is acceptable in the society. 
No clear consensus exists on which ICER value is still acceptable, but estimates of this threshold vary 
from €12,000 to €73,000 per extra QALY. Our results suggest that the cost-utility ratio of 
psychoanalysis relative to psychoanalytic psychotherapy appears to be within the acceptable range 
when lenient threshold values are applied, but it becomes less cost-effective when stricter threshold 
values are used. 
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Chapter 9 summarizes the main findings from the previous chapters of this thesis, and presents a 
general discussion of the results. Merits and limitations of the chosen research design are discussed, 
and implications and recommendations are made for clinical practice, policy making, and future 
research. Finally, we discuss the importance of doing empirical research for the survival of long-term 
psychoanalytic treatments within the health care system.  
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SAMENVATTING 
 
 
Een cohort studie naar de effectiviteit van langdurige psychoanalytische behandelingen voor 
patiënten met persoonlijkheidsstoornissen en/of chronische depressies 
 
Onderzoek naar de behandel-effectiviteit en kosten-effectiviteit van langdurige psychoanalytische 
behandelingen, in het bijzonder psychoanalyse en psychoanalytische psychotherapie, is nog relatief 
weinig uitgevoerd en staat in dit proefschrift centraal. Als eerste is een pilot-studie uitgevoerd om de 
intake karakteristieken (bv. de mate van psychopathologie) van patiënten die verwezen worden naar 
psychoanalyse en psychoanalytische psychotherapie systematisch in kaart te brengen. Deze pilot-
studie was ook bedoeld om de haalbaarheid van een effectiviteitsstudie te onderzoeken. Vervolgens 
hebben we een grootschalig effectiviteitsonderzoek uitgevoerd. Dit project was een samenwerking van 
vier ggz-instellingen met als doel de behandel- en kosten-effectiviteit van langdurige ambulante 
psychoanalytische behandelingen in Nederland te onderzoeken. 
 
Hoofdstuk 1 geeft een introductie op het onderwerp, waarbij de keuzes voor het theoretische 
raamwerk, de gebruikte instrumenten, en de opzet van het onderzoeksproject worden toegelicht.  
 
Hoofdstuk 2 geeft een beschrijving van patiënten voorafgaand aan langdurige psychoanalytische 
behandeling. De centrale vraag in dit hoofdstuk is in hoeverre patiënten voorafgaande aan een 
langdurige psychoanalytische behandeling niveaus van pathologie presenteren die vergelijkbaar zijn 
met andere patiënten binnen de reguliere ambulante GGZ. Op basis van de normgegevens hebben we 
per patiënt berekend of de ernst van de van symptomen, interpersoonlijke problemen en 
persoonlijkheidspathologie boven of onder een statistisch bepaalde afkapwaarde viel. Uit de resultaten 
bleek dat patiënten voorafgaand aan een psychoanalytische behandeling op symptoomniveau minder 
klachten rapporteerden in vergelijking met ambulante psychiatrische vergelijkingsgroepen. Echter, wat 
betreft persoonlijkheidspathologie scoorden zij grotendeels overeenkomstig – en op sommige 
gebieden zelfs hoger – in vergelijking met ambulante psychiatrische vergelijkingsgroepen. Vervolgens 
hebben we deze informatie gecombineerd om tot een globale schatting te komen van het percentage 
patiënten dat als een ‘klinisch geval’ beschouwd kan worden. Uit de gecombineerde testresultaten 
bleek dat de overgrote meerderheid van de patiënten voorafgaand aan psychoanalytische behandeling 
getypeerd kon worden als een ‘klinisch geval’ waarbij een hoge mate van ernstige chronische 
depressiviteit optrad. Zo wordt 35% van de patiënten gediagnosticeerd met een dysthyme stoornis. 
Bovendien waren waakzaamheid, structurele angst en interpersoonlijke problemen kenmerkend voor 
deze patiëntenpopulatie. We concluderen dat de indicatie voor langdurige psychoanalytische 
behandelingen betrekking heeft op een complexe patiëntengroep waarvan het grootste gedeelte 
bovendien al eerder kortdurende therapie heeft gehad met onvoldoende blijvend resultaat. Het blijkt 
dat patiënten die verwezen worden naar langdurige psychoanalytische behandeling vaak problemen 
hebben die op een dieper (en minder zichtbaar) niveau liggen. Zij hebben dus meer lijdensdruk dan op 
het eerste gezicht lijkt of dan soms voetstoots wordt aangenomen.  
 
Hoofdstuk 3 gaat over verschillen tussen patiënten die zijn geïndiceerd voor psychoanalyse (PA) en 
patiënten die zijn geïndiceerd voor psychoanalytische psychotherapie (PP). Naast een groot aantal 
overeenkomsten vonden we enkele interessante verschillen tussen de twee patiëntengroepen. Zo 
vonden we dat PA-patiënten bij aanvang van de behandeling significant meer interpersoonlijke 
problemen rapporteerden en vaker een vermijdende coping-stijl hadden vergeleken met PP-patiënten. 
Ook vonden we dat PA-patiënten lager scoorden op instrumentele agressie en minder problemen met 
informatieverwerking en realiteitstoetsing leken te hebben dan PP-patiënten. Deze resultaten lijken aan 
te tonen dat sociale geremdheid en vermijding belangrijk zijn bij de indicatiestelling voor een 
psychoanalyse en dat therapeuten vaker een langduriger en intensiever behandeling indiceren voor 
meer vermijdende patiënten. Dit neemt niet weg dat er een groot grijs gebied bestaat bij de 
indicatiestelling voor psychoanalyse dan wel psychoanalytische psychotherapie en dat ook andere 
(niet gemeten) factoren meespelen bij de indicatiebeslissing. 
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Hoofdstuk 4 beschrijft de resultaten van het multiple-cohort effectiviteitsonderzoek. Patiënten in 
verschillende fasen van behandeling (vóór, tijdens, na, follow-up) werden met elkaar vergeleken op 
klacht- en op persoonlijkheidsniveau. We onderzochten of er verschillen waren in de ruwe scores op 
de instrumenten tussen de patiënten in verschillende fasen van de behandeling. Vervolgens hebben we 
met behulp van samengestelde factoren onderzocht of wij voorspellers voor de gevonden 
behandeluitkomsten konden identificeren. Ook vergeleken we de effectgroottes van deze 
samengestelde variabelen met gegevens over het natuurlijk beloop. Uit de resultaten blijkt dat 
langdurige psychoanalytische behandelingen zeer effectief zijn in het reduceren van psychische 
symptomen, interpersoonlijke problemen, andere uitingen van actuele psychische stress (d = 1.19 – 
1.27) en ook effectief zijn in het verbeteren van persoonlijkheidsfunctioneren (d = 0.52 – 0.79). De 
effectgroottes van psychoanalytische behandeling blijken vele malen groter te zijn dan die van 
natuurlijk herstel. Daarnaast blijkt het geslacht van de patiënt van invloed te zijn op de 
behandeluitkomst in de psychoanalyse-groep. Vrouwelijke patiënten vertonen hierbij een betere 
behandeluitkomst dan mannen wat betreft sociale aanpassing. Onze resultaten laten zien dat de 
aanwezigheid en de ernst van depressieve pathologie, de mate van sociale angst, onaangepastheid en 
gevoelens van vervreemding allen significant verminderen na langdurige psychoanalytische 
behandeling, en dat deze effecten ook op de langere termijn behouden blijven. 
 
Hoofdstuk 5 bekijkt de effectiviteitsgegevens vanuit de invalshoek van de klinische significantie. 
Normatieve vergelijkingen zijn uitgevoerd om zo een schatting te krijgen van het aantal mensen dat 
‘normaal’ functioneert in verschillende fases van de behandeling. De scores van de patiënten zijn 
vergeleken met scores van normgroepen. Uit de resultaten blijkt dat een groot deel van de patiënten na 
behandeling op de meeste instrumenten in het niet-klinische bereik functioneert. We concluderen dat 
een psychoanalytische behandeling kan zorgen voor klinisch relevante verbeteringen in iemands leven, 
hoewel een compleet herstel naar normaal functioneren niet verwacht kan worden voor alle patiënten.  
 
Hoofdstuk 6 beschrijft de resultaten van de longitudinale metingen die zijn uitgevoerd binnen de 
multiple-cohort effectiviteitsstudie. We onderzochten het verloop van symptomen en interpersoonlijke 
problemen binnen de eerste twee jaar van psychoanalyse en psychoanalytische psychotherapie. Uit de 
resultaten blijkt dat er minder verbetering in interpersoonlijke problemen te zien is vergeleken met 
symptoomverbetering. Bovendien blijkt dat in de PP-groep zowel een duidelijke symptoomverbetering 
als een vermindering van interpersoonlijke problemen had plaatsgevonden, terwijl in de PA-groep er 
slechts significante verbetering werd gevonden op symptoomniveau. In de eerste twee jaar van 
behandeling vonden we dus meer significante verbeteringen in de PP-groep dan in de PA-groep. Over 
het geheel genomen blijkt de ernst van de symptomen en interpersoonlijke problemen na twee jaar 
behandeling nog steeds binnen het klinische bereik te liggen. Verder is gebleken dat de ernst van de 
pathologie bij aanvang van de behandeling voorspellend kan zijn voor de snelheid waarmee 
symptomen af zullen nemen tijdens de behandeling. Hoe meer klachten iemand bij aanvang van de 
behandeling heeft, hoe langer het herstel naar niet-klinisch functioneren zal duren.  
 
Hoofdstuk 7 gaat over de maatschappelijke kosten en besparingen van langdurige psychoanalytische 
behandelingen. We onderzochten of psychoanalytische behandelingen op de lange termijn ook kunnen 
leiden tot een vermindering van zorgconsumptie, ziekteverzuim en productiviteitsverlies. Langdurige 
psychoanalytische behandelingen zijn relatief dure ambulante therapieën. Uit de resultaten blijkt dat 
patiënten na behandeling inderdaad een minder groot beroep doen op de gezondheidszorg, minder 
ziekteverzuim hebben, en ook productiever op het werk zijn. Uitgedrukt in maatschappelijke kosten, 
blijkt dat een deel van de geïnvesteerde kosten (behandelkosten) terugverdiend kan worden als gevolg 
van indirecte kostenbesparingen (vermindering in zorgconsumptie, ziekteverzuim en 
productiviteitsverlies). Echter, niet alle geïnvesteerde kosten zullen op den duur terugverdiend 
worden. 
 
Hoofdstuk 8 doet verslag van de kosten-utiliteitsanalyse waarbij het verschil in kosten en effecten van 
psychoanalyse en psychoanalytische psychotherapie werd geanalyseerd. De analyses zijn gedaan 
vanuit een maatschappelijk perspectief. Onderzocht werd hoeveel extra kosten geïnvesteerd moeten 
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worden om een extra quality-adjusted life year (QALY) te bewerkstelligen als gekozen wordt voor 
psychoanalyse in plaats van psychoanalytische psychotherapie. Psychoanalyse blijkt duurder te zijn 
dan psychoanalytische psychotherapie, maar ook effectiever als het gaat om kwaliteit van leven. De 
incremental cost-effectiveness ratio (ICER), i.e. het verschil in kosten gedeeld door het verschil in 
effect, ligt rond de €52.000. Het antwoord op de vraag of de hogere kosten van psychoanalyse ten 
opzichte van psychoanalytische psychotherapie opwegen tegen de extra QALY’s hangt af van welke 
ICER waarde nog als maatschappelijk acceptabel wordt gezien. Hierover bestaat geen duidelijke 
consensus, want de schattingen lopen uiteen van €12,000 tot €73,000 per extra QALY. Wanneer we 
een minder strikte afkapwaarde hanteren, blijkt de ICER van psychoanalyse ten opzichte van 
psychoanalytische psychotherapie nog binnen de maatschappelijk aanvaardbare grens te liggen. Dit 
betekent dat de meerwaarde van psychoanalyse ten opzichte van psychoanalytische psychotherapie 
nog steeds opweegt tegen de hogere behandelkosten. 
 
Hoofstuk 9 vat de voornaamste bevindingen van de voorafgaande hoofdstukken samen en presenteert 
een algemene discussie van de gevonden resultaten. Voor- en nadelen van de gebruikte 
onderzoeksmethodologie worden besproken. Ook zijn implicaties en aanbevelingen voor de praktijk, 
beleid en verder onderzoek aangegeven. Tot slot wordt stilgestaan bij het belang van empirisch 
onderzoek voor het voortbestaan van langdurige psychoanalytische behandelingen binnen het 
gezondheidszorgsysteem.  
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